UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~April 30,~~October 31, 2020


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File No. 001-34807

Verint Systems Inc

(Exact Name of Registrant as Specified in its Charter)

Delaware

11-3200514

(State or Other Jurisdiction of Incorporation or
Organization)

(I.R.S. Employer Identification No.)

175 Broadhollow Road

Melville,

New York

11747

(Address of Principal Executive Offices)

(Zip Code)

(631)

962-9600

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

The NASDAQ Stock Market, LLC

Common Stock, $.001 par value per share

VRNT

(NASDAQ Global Select Market)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑

No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑

No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☑	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

There were ~~64,525,660~~65,736,172 shares of the registrant’s common stock outstanding on ~~May 15,~~November 16, 2020.

Table of Contents

Verint Systems Inc. and Subsidiaries

Index to Form 10-Q

As of and For the Period Ended ~~April 30,~~October 31, 2020

Page

Cautionary Note on Forward-Looking Statements

Part I.

Financial Information

Item 1.

Financial Statements (Unaudited)

Condensed Consolidated Balance Sheets

Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Comprehensive ~~Loss~~Income

Condensed Consolidated Statements of Stockholders’ Equity

Condensed Consolidated Statements of Cash Flows

Notes to Condensed Consolidated Financial Statements

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

3641

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

5362

Item 4.

Controls and Procedures

Unregistered Sales of Equity Securities and Use of Proceeds

5665

Item 3.

Defaults Upon Senior Securities

5665

Item 4.

Mine Safety Disclosures

Cautionary Note on Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements include financial projections, statements of plans and objectives for future operations, statements of future economic performance, and statements of assumptions relating thereto. Forward-looking statements may appear throughout this report, including without limitation, Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and are often identified by future or conditional words such as “will”, “plans”, “expects”, “intends”, “believes”, “seeks”, “estimates”, or “anticipates”, or by variations of such words or by similar expressions. There can be no assurance that forward-looking statements will be achieved. By their very nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other important factors that could cause our actual results or conditions to differ materially from those expressed or implied by such forward-looking statements. Important risks, uncertainties, assumptions, and other factors that could cause our actual results or conditions to differ materially from our forward-looking statements include, among others:

•uncertainties regarding the impact of changes in macroeconomic and/or global conditions, including as a result of slowdowns, recessions, economic instability, political unrest, armed conflicts, natural disasters, or outbreaks of disease, such as the COVID-19 pandemic, as well as the resulting impact on information technology spending and government budgets in both developed countries and developing countries, on our business;

•risks that our customers delay, cancel, or refrain from placing orders, refrain from renewing subscriptions or service contracts, or are unable to honor contractual commitments or payment obligations due to liquidity issues or other challenges in their budgets and business, due to the COVID-19 pandemic or otherwise;

•risks that ~~continuing~~ restrictions resulting from the COVID-19 pandemic or actions taken in response to the pandemic adversely impact our operations or our ability to fulfill orders, complete implementations, or recognize revenue;

•risks associated with our ability to keep pace with technological advances and challenges and evolving industry standards; to adapt to changing market potential from area to area within our markets; and to successfully develop, launch, and drive demand for new, innovative, high-quality products that meet or exceed customer needs, while simultaneously preserving our legacy businesses and migrating away from areas of commoditization;

•risks due to aggressive competition in all of our markets, including with respect to maintaining revenue, margins, and sufficient levels of investment in our business and operations;

•risks created by the continued consolidation of our competitors or the introduction of large competitors in our markets with greater resources than we have;

•risks associated with our ability to successfully compete for, consummate, and implement mergers and acquisitions, including risks associated with valuations, reputational considerations, capital constraints, costs and expenses, maintaining profitability levels, expansion into new areas, management distraction, post-acquisition integration activities, and potential asset impairments;

•risks relating to our ability to properly manage investments in our business and operations, execute on growth initiatives, and enhance our existing operations and infrastructure, including the proper prioritization and allocation of limited financial and other resources;

•risks associated with our ability to retain, recruit, and train qualified personnel in regions in which we operate, including in new markets and growth areas we may enter;

•risks that we may be unable to establish and maintain relationships with key resellers, partners, and systems integrators and risks associated with our reliance on third-party suppliers, partners, or original equipment manufacturers (“OEMs”) for certain components, products, or services, including companies that may compete with us or work with our competitors;

•risks associated with the mishandling or perceived mishandling of sensitive or confidential information, including information that may belong to our customers or other third parties, and with security vulnerabilities or lapses, including cyber-attacks, information technology system breaches, failures, or disruptions;

Table of Contents

•risks that our products or services, or those of third-party suppliers, partners, or OEMs which we use in or with our offerings or otherwise rely on, including third-party hosting platforms, may contain defects, develop operational problems, or be vulnerable to cyber-attacks;

•risks associated with our significant international operations, including, among others, in Israel, Europe, and Asia, exposure to regions subject to political or economic instability, fluctuations in foreign exchange rates, and challenges associated with a significant portion of our cash being held overseas;

•risks associated with political and reputational factors related to our business or operations, including reputational risks associated with our security solutions and our ability to maintain security clearances where required, as well as risks associated with a significant amount of our business coming from domestic and foreign government customers;

•risks associated with complex and changing local and foreign regulatory environments in the jurisdictions in which we operate, including, among others, with respect to trade compliance, anti-corruption, information security, data privacy and protection, tax, labor, government contracts, relating to our own operations, ~~as well as to~~the products and services we offer, and/or the use of our solutions by our customers;

•challenges associated with selling sophisticated solutions, including with respect to assisting customers in understanding and realizing the benefits of our solutions, and developing, offering, implementing, and maintaining a broad and sophisticated solution portfolio;

•challenges associated with pursuing larger sales opportunities, including with respect to longer sales cycles, transaction reductions, deferrals, or cancellations during the sales cycle; risk of customer concentration; challenges associated with our ability to accurately forecast when a sales opportunity will convert to an order, or to accurately forecast revenue and expenses;

•challenges associated with our Customer Engagement segment cloud transition and our Cyber Intelligence segment software model transition, and risk of increased volatility of our operating results from period to period;

•risks that our intellectual property rights may not be adequate to protect our business or assets or that others may make claims on our intellectual property, claim infringement on their intellectual property rights, or claim a violation of their license rights, including relative to free or open source components we may use;

•risks that we may experience liquidity or working capital issues and related risks that financing sources may be unavailable to us on reasonable terms or at all;

•risks associated with significant leverage resulting from our current debt position or our ability to incur additional debt, including with respect to liquidity considerations, covenant limitations and compliance, fluctuations in interest rates, dilution considerations (with respect to our convertible notes), and our ability to maintain our credit ratings;

•risks arising as a result of contingent or other obligations or liabilities assumed in our acquisition of our former parent company, Comverse Technology, Inc. (“CTI”), or associated with formerly being consolidated with, and part of a consolidated tax group with, CTI, or as a result of the successor to CTI’s business operations, Mavenir Inc. (“Mavenir”), being unwilling or unable to provide us with certain indemnities to which we are entitled;

•risks relating to the adequacy of our existing infrastructure, systems, processes, policies, procedures, internal controls, and personnel, and our ability to successfully implement and maintain enhancements to the foregoing, for our current and future operations and reporting needs, including related risks of financial statement omissions, misstatements, restatements, or filing delays;

•risks associated with changing accounting principles or standards, tax laws and regulations, tax rates, and the continuing availability of expected tax benefits;

•risks associated with market volatility in the prices of our common stock and convertible notes based on our performance, third-party publications or speculation, or other factors and risks associated with actions of activist stockholders;

•risks associated with the issuance of preferred stock to an affiliate of Apax Partners, including with respect to completion of the second tranche of the investment and Apax's significant ownership position and potential that its interests will not be aligned with those of our common stockholders; and

iii

Table of Contents

•risks associated with the planned spin-off of our Cyber Intelligence Solutions business, including the possibility that the spin-off transaction may not be completed in the expected timeframe or at all, that it does not achieve the benefits anticipated, or that it negatively impacts our operations or stock price, including as a result of management distraction from our business.

These risks, uncertainties, assumptions, and challenges, as well as other factors, are discussed in greater detail in “Risk Factors” under Item 1A of our Annual Report on Form 10-K for the year ended January 31, 2020. You are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date of this report. We make no commitment to revise or update any forward-looking statements in order to reflect events or circumstances after the date any such statement is made, except as otherwise required under the federal securities laws. If we were in any particular instance to update or correct a forward-looking statement, investors and others should not conclude that we would make additional updates or corrections thereafter except as otherwise required under the federal securities laws.

Table of Contents

Part I

Item 1. Financial Statements

Table of Contents

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(Unaudited)


		April 30,		January 31,			October 31,		January 31,
(in thousands, except share and per share data)	(in thousands, except share and per share data)	2020		2020		(in thousands, except share and per share data)	2020		2020
Assets	Assets					Assets
Current Assets:	Current Assets:					Current Assets:
Cash and cash equivalents	Cash and cash equivalents	$	556,671	$	379,146	Cash and cash equivalents	$	526,815	$	379,146
Restricted cash and cash equivalents, and restricted bank time deposits	Restricted cash and cash equivalents, and restricted bank time deposits	46,451		43,860		Restricted cash and cash equivalents, and restricted bank time deposits	24,223		43,860
Short-term investments	Short-term investments	19,741		20,215		Short-term investments	104,454		20,215
Accounts receivable, net of allowance for doubtful accounts of $6.3 million and $5.3 million, respectively		308,304		382,435
Accounts receivable, net of allowance for doubtful accounts of $6.5 million and $5.3 million, respectively						Accounts receivable, net of allowance for doubtful accounts of $6.5 million and $5.3 million, respectively	346,565		382,435
Contract assets, net	Contract assets, net	62,249		64,961		Contract assets, net	63,095		64,961
Inventories	Inventories	25,030		20,495		Inventories	21,748		20,495
Prepaid expenses and other current assets	Prepaid expenses and other current assets	92,168		87,946		Prepaid expenses and other current assets	68,800		87,946
Total current assets	Total current assets	1,110,614		999,058		Total current assets	1,155,700		999,058
Property and equipment, net	Property and equipment, net	115,481		116,111		Property and equipment, net	108,578		116,111
Operating lease right-of-use assets	Operating lease right-of-use assets	97,878		102,149		Operating lease right-of-use assets	90,446		102,149
Goodwill	Goodwill	1,452,434		1,469,211		Goodwill	1,464,451		1,469,211
Intangible assets, net	Intangible assets, net	182,503		197,764		Intangible assets, net	159,120		197,764
Other assets	Other assets	135,798		131,765		Other assets	146,388		131,765
Total assets	Total assets	$	3,094,708	$	3,016,058	Total assets	$	3,124,683	$	3,016,058

Liabilities and Stockholders' Equity
Liabilities, Preferred Stock, and Stockholders' Equity						Liabilities, Preferred Stock, and Stockholders' Equity
Current Liabilities:	Current Liabilities:					Current Liabilities:
Accounts payable	Accounts payable	$	70,987	$	71,604	Accounts payable	$	66,807	$	71,604
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	228,256		233,948		Accrued expenses and other current liabilities	246,949		229,698
Current maturities of long-term debt						Current maturities of long-term debt	383,449		4,250
Contract liabilities	Contract liabilities	378,548		397,350		Contract liabilities	334,843		397,350
Total current liabilities	Total current liabilities	677,791		702,902		Total current liabilities	1,032,048		702,902
Long-term debt	Long-term debt	990,390		832,798		Long-term debt	403,292		832,798
Long-term contract liabilities	Long-term contract liabilities	40,566		40,565		Long-term contract liabilities	39,810		40,565
Operating lease liabilities	Operating lease liabilities	87,340		90,372		Operating lease liabilities	80,040		90,372
Other liabilities	Other liabilities	105,715		106,984		Other liabilities	98,016		106,984
Total liabilities	Total liabilities	1,901,802		1,773,621		Total liabilities	1,653,206		1,773,621
Preferred Stock - $0.001 par value; authorized 2,207,000 shares; Series A Preferred Stock; 200,000 shares issued and outstanding at October 31, 2020; 0 shares issued and outstanding at January 31, 2020; aggregate liquidation preference and current redemption value of $203,553 at October 31, 2020.						Preferred Stock - $0.001 par value; authorized 2,207,000 shares; Series A Preferred Stock; 200,000 shares issued and outstanding at October 31, 2020; 0 shares issued and outstanding at January 31, 2020; aggregate liquidation preference and current redemption value of $203,553 at October 31, 2020.	200,628		0
Commitments and Contingencies	Commitments and Contingencies					Commitments and Contingencies
Stockholders' Equity:	Stockholders' Equity:					Stockholders' Equity:
Preferred stock - $0.001 par value; authorized 2,207,000 shares at April 30, 2020 and January 31, 2020, respectively; none issued.		—		—
Common stock - $0.001 par value; authorized 120,000,000 shares. Issued 68,930,000 and 68,529,000 shares; outstanding 64,526,000 and 64,738,000 shares at April 30, 2020 and January 31, 2020, respectively.		69		68
Common stock - $0.001 par value; authorized 120,000,000 shares. Issued 70,140,000 and 68,529,000 shares; outstanding 65,736,000 and 64,738,000 shares at October 31, 2020 and January 31, 2020, respectively.						Common stock - $0.001 par value; authorized 120,000,000 shares. Issued 70,140,000 and 68,529,000 shares; outstanding 65,736,000 and 64,738,000 shares at October 31, 2020 and January 31, 2020, respectively.	70		68
Additional paid-in capital	Additional paid-in capital	1,677,775		1,660,889		Additional paid-in capital	1,717,384		1,660,889
Treasury stock, at cost - 4,404,000 and 3,791,000 shares at April 30, 2020 and January 31, 2020, respectively.		(208,124)		(174,134)
Treasury stock, at cost - 4,404,000 and 3,791,000 shares at October 31, 2020 and January 31, 2020, respectively.						Treasury stock, at cost - 4,404,000 and 3,791,000 shares at October 31, 2020 and January 31, 2020, respectively.	(208,124)		(174,134)
Accumulated deficit	Accumulated deficit	(112,544)		(105,590)		Accumulated deficit	(93,875)		(105,590)
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(178,774)		(151,865)		Accumulated other comprehensive loss	(162,806)		(151,865)
Total Verint Systems Inc. stockholders' equity	Total Verint Systems Inc. stockholders' equity	1,178,402		1,229,368		Total Verint Systems Inc. stockholders' equity	1,252,649		1,229,368
Noncontrolling interests	Noncontrolling interests	14,504		13,069		Noncontrolling interests	18,200		13,069
Total stockholders' equity	Total stockholders' equity	1,192,906		1,242,437		Total stockholders' equity	1,270,849		1,242,437
Total liabilities and stockholders' equity		$	3,094,708	$	3,016,058
Total liabilities, preferred stock, and stockholders' equity						Total liabilities, preferred stock, and stockholders' equity	$	3,124,683	$	3,016,058

See notes to condensed consolidated financial statements.

Table of Contents

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Unaudited)


		Three Months Ended April 30,							Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands, except per share data)	(in thousands, except per share data)	2020		2019		(in thousands, except per share data)	2020		2019		2020		2019
Revenue:	Revenue:					Revenue:
Product	Product	$	77,284	$	104,224	Product	$	105,865	$	116,331	$	279,225	$	330,538
Service and support	Service and support	210,011		211,035		Service and support	222,336		208,536		645,380		633,893
Total revenue	Total revenue	287,295		315,259		Total revenue	328,201		324,867		924,605		964,431
Cost of revenue:	Cost of revenue:					Cost of revenue:
Product	Product	21,318		28,120		Product	21,972		30,533		67,938		88,077
Service and support	Service and support	76,399		79,361		Service and support	76,961		76,771		222,383		237,562
Amortization of acquired technology	Amortization of acquired technology	4,609		6,707		Amortization of acquired technology	4,270		5,968		13,307		18,262
Total cost of revenue	Total cost of revenue	102,326		114,188		Total cost of revenue	103,203		113,272		303,628		343,901
Gross profit	Gross profit	184,969		201,071		Gross profit	224,998		211,595		620,977		620,530
Operating expenses:	Operating expenses:					Operating expenses:
Research and development, net	Research and development, net	59,079		57,169		Research and development, net	61,067		57,694		175,375		173,548
Selling, general and administrative	Selling, general and administrative	111,651		121,721		Selling, general and administrative	118,084		116,306		335,141		364,292
Amortization of other acquired intangible assets	Amortization of other acquired intangible assets	8,065		7,713		Amortization of other acquired intangible assets	8,106		7,778		24,229		23,130
Total operating expenses	Total operating expenses	178,795		186,603		Total operating expenses	187,257		181,778		534,745		560,970
Operating income	Operating income	6,174		14,468		Operating income	37,741		29,817		86,232		59,560
Other income (expense), net:	Other income (expense), net:					Other income (expense), net:
Interest income	Interest income	1,017		1,426		Interest income	536		1,404		2,392		4,517
Interest expense	Interest expense	(10,698)		(9,934)		Interest expense	(9,731)		(10,102)		(30,692)		(30,143)
Other expense, net		(2,230)		(790)
Other (expense) income, net						Other (expense) income, net	(8,562)		1,082		(23,003)		1,201
Total other expense, net	Total other expense, net	(11,911)		(9,298)		Total other expense, net	(17,757)		(7,616)		(51,303)		(24,425)
(Loss) income before (benefit) provision for income taxes		(5,737)		5,170
(Benefit) provision for income taxes		(1,762)		1,409
Net (loss) income		(3,975)		3,761
Income before provision for income taxes						Income before provision for income taxes	19,984		22,201		34,929		35,135
Provision for income taxes						Provision for income taxes	8,157		9,218		16,490		6,120
Net income						Net income	11,827		12,983		18,439		29,015
Net income attributable to noncontrolling interests	Net income attributable to noncontrolling interests	2,039		2,185		Net income attributable to noncontrolling interests	1,652		1,302		5,784		5,200
Net (loss) income attributable to Verint Systems Inc.		$	(6,014)	$	1,576
Net income attributable to Verint Systems Inc.						Net income attributable to Verint Systems Inc.	10,175		11,681		12,655		23,815
Dividends on preferred stock						Dividends on preferred stock	(2,658)		0		(5,142)		0
Net income attributable to Verint Systems Inc. common shares						Net income attributable to Verint Systems Inc. common shares	$	7,517	$	11,681	$	7,513	$	23,815

Net (loss) income per common share attributable to Verint Systems Inc.:
Net income per common share attributable to Verint Systems Inc.:						Net income per common share attributable to Verint Systems Inc.:
Basic	Basic	$	(0.09)	$	0.02	Basic	$	0.11	$	0.17	$	0.12	$	0.36
Diluted	Diluted	$	(0.09)	$	0.02	Diluted	$	0.11	$	0.17	$	0.11	$	0.35

Weighted-average common shares outstanding:	Weighted-average common shares outstanding:					Weighted-average common shares outstanding:
Basic	Basic	64,376		65,438		Basic	65,571		66,799		64,973		66,181
Diluted	Diluted	64,376		67,088		Diluted	66,234		67,442		66,000		67,452

See notes to condensed consolidated financial statements.

Table of Contents

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive ~~Loss~~Income

(Unaudited)

Three Months Ended
April 30,
(in thousands) 2020 2019
Net (loss) income $ (3,975) $ 3,761
Other comprehensive loss, net of reclassification adjustments:
Foreign currency translation adjustments (20,999) (3,962)
Net (decrease) increase from foreign exchange contracts designated as hedges (873) 1,281
Net decrease from interest rate swap designated as a hedge (6,944) (2,017)
Benefit from income taxes on net increase (decrease) from foreign exchange contracts and interest rate swap designated as hedges 1,548 294
Other comprehensive loss (27,268) (4,404)
Comprehensive loss (31,243) (643)
Comprehensive income attributable to noncontrolling interests 1,680 2,079
Comprehensive loss attributable to Verint Systems Inc. $ (32,923) $ (2,722)


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	2020		2019		2020		2019
Net income	$	11,827	$	12,983	$	18,439	$	29,015
Other comprehensive (loss) income, net of reclassification adjustments:
Foreign currency translation adjustments	(4,973)		20,635		(7,348)		(6,938)
Net (decrease) increase from foreign exchange contracts designated as hedges	(550)		(1,502)		57		1,416
Net increase (decrease) from interest rate swap prior to dedesignation as a hedge	1,356		(2,498)		(4,468)		(9,056)
(Provision) benefit from income taxes on net increase (decrease) from foreign exchange contracts and interest rate swap designated as hedges	(209)		674		914		1,758
Other comprehensive (loss) income	(4,376)		17,309		(10,845)		(12,820)
Comprehensive income	7,451		30,292		7,594		16,195
Comprehensive income attributable to noncontrolling interests	1,787		1,416		5,880		5,157
Comprehensive income attributable to Verint Systems Inc.	$	5,664	$	28,876	$	1,714	$	11,038

See notes to condensed consolidated financial statements.

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)


		Verint Systems Inc. Stockholders’ Equity																																Verint Systems Inc. Stockholders’ Equity
		Common Stock					Additional Paid-in Capital								Accumulated Other Comprehensive Loss		Total Verint Systems Inc. Stockholders’ Equity					Total Stockholders’ Equity		Common Stock				Additional Paid-in Capital						Accumulated Other Comprehensive Loss		Total Verint Systems Inc. Stockholders’ Equity					Total Stockholders’ Equity
(in thousands)	(in thousands)	Shares	Par Value						Treasury Stock			Accumulated Deficit									Non-controlling Interests				(in thousands)	Shares				Additional Paid-in Capital		Treasury Stock						Total Verint Systems Inc. Stockholders’ Equity				Total Stockholders’ Equity
Balances as of January 31, 2019		65,333	$	67	$	1,586,266	$	(57,598)		$	(134,274)		$	(145,225)	$	1,249,236	$	11,568	$	1,260,804
Net income		—	—		—		—			1,576			—		1,576		2,185		3,761
Other comprehensive loss		—	—		—		—			—			(4,298)		(4,298)		(106)		(4,404)
Stock-based compensation - equity-classified awards		—	—		14,890		—			—			—		14,890		—		14,890
Common stock issued for stock awards and stock bonuses		448	—		—		—			—			—		—		—		—
Treasury stock acquired		(8)	—		—		(474)			—			—		(474)		—		(474)
Balances as of April 30, 2019		65,773	$	67	$	1,601,156	$	(58,072)		$	(132,698)		$	(149,523)	$	1,260,930	$	13,647	$	1,274,577

Balances as of January 31, 2020	Balances as of January 31, 2020	64,738	$	68	$	1,660,889	$	(174,134)		$	(105,590)		$	(151,865)	$	1,229,368	$	13,069	$	1,242,437	Balances as of January 31, 2020		64,738	$	68	$	1,660,889	$	(174,134)	$	(105,590)	$	(151,865)	$	1,229,368	$	13,069		$	1,242,437
Net (loss) income	Net (loss) income	—	—		—		—			(6,014)			—		(6,014)		2,039		(3,975)		Net (loss) income		—	—		—		—		(6,014)		—		(6,014)		2,039			(3,975)
Other comprehensive loss	Other comprehensive loss	—	—		—		—			—			(26,909)		(26,909)		(359)		(27,268)		Other comprehensive loss		—	—		—		—		—		(26,909)		(26,909)		(359)			(27,268)
Stock-based compensation - equity-classified awards	Stock-based compensation - equity-classified awards	—	—		15,029		—			—			—		15,029		—		15,029		Stock-based compensation - equity-classified awards		—	—		15,029		—		—		—		15,029		—			15,029
Common stock issued, or to be issued, for stock awards and stock bonuses	Common stock issued, or to be issued, for stock awards and stock bonuses	399	1		1,845		—			—			—		1,846		—		1,846		Common stock issued, or to be issued, for stock awards and stock bonuses		399	1		1,845		—		—		—		1,846		—			1,846
Exercises of stock options	Exercises of stock options	2	—		12		—			—			—		12		—		12		Exercises of stock options		2	—		12		—		—		—		12		—			12
Treasury stock acquired	Treasury stock acquired	(613)	—		—		(33,990)			—			—		(33,990)		—		(33,990)		Treasury stock acquired		(613)	—		—		(33,990)		—		—		(33,990)		—			(33,990)
Distribution to noncontrolling interest	Distribution to noncontrolling interest	—	—		—		—			—			—		—		(245)		(245)		Distribution to noncontrolling interest		—	—		—		—		—		—		—		(245)			(245)
Cumulative effect of adoption of ASU No. 2016-13	Cumulative effect of adoption of ASU No. 2016-13	—	—		—		—			(940)			—		(940)		—		(940)		Cumulative effect of adoption of ASU No. 2016-13		—	—		—		—		(940)		—		(940)		—			(940)
Balances as of April 30, 2020	Balances as of April 30, 2020	64,526	$	69	$	1,677,775	$	(208,124)		$	(112,544)		$	(178,774)	$	1,178,402	$	14,504	$	1,192,906	Balances as of April 30, 2020		64,526	69		1,677,775		(208,124)		(112,544)		(178,774)		1,178,402		14,504			1,192,906
Net income																					Net income		—	—		—		—		8,494		—		8,494		2,093			10,587
Other comprehensive income																					Other comprehensive income		—	—		—		—		—		20,479		20,479		320			20,799
Stock-based-compensation- equity - classified awards																					Stock-based-compensation- equity - classified awards		—	—		13,420		—		—		—		13,420		—			13,420
Common stock issued for stock awards and stock bonuses																					Common stock issued for stock awards and stock bonuses		874	1		—		—		—		—		1		—			1
Preferred stock dividends																					Preferred stock dividends		—	—		(1,589)		—		—		—		(1,589)		—			(1,589)
Reacquisition of equity component from convertible notes repurchases, net of taxes																					Reacquisition of equity component from convertible notes repurchases, net of taxes		—	—		(218)		—		—		—		(218)		—			(218)
Distribution to noncontrolling interest																					Distribution to noncontrolling interest		—	—		—		—		—		—		—		(404)			(404)
Balances as of July 31, 2020																					Balances as of July 31, 2020		65,400	70		1,689,388		(208,124)		(104,050)		(158,295)		1,218,989		16,513			1,235,502
Net income																					Net income		—	—		—		—		10,175		—		10,175		1,652			11,827
Other comprehensive (loss) income																					Other comprehensive (loss) income		—	—		—		—		—		(4,511)		(4,511)		135			(4,376)
Stock-based-compensation- equity - classified awards																					Stock-based-compensation- equity - classified awards		—	—		15,733		—		—		—		15,733		—			15,733
Common stock issued for stock awards and stock bonuses																					Common stock issued for stock awards and stock bonuses		336	—		12,263		—		—		—		12,263		—			12,263
Distribution to noncontrolling interest																					Distribution to noncontrolling interest		—	—		—		—		—		—		—		(100)			(100)
Balances as of October 31, 2020																					Balances as of October 31, 2020		65,736	$	70	$	1,717,384	$	(208,124)	$	(93,875)	$	(162,806)	$	1,252,649	$	18,200		$	1,270,849


	Verint Systems Inc. Stockholders’ Equity
	Common Stock			Additional Paid-in Capital						Accumulated Other Comprehensive Loss		Total Verint Systems Inc. Stockholders’ Equity				Total Stockholders’ Equity
(in thousands)	Shares	Par Value				Treasury Stock		Accumulated Deficit						Non-controlling Interests
Balances as of January 31, 2019	65,333	$	67	$	1,586,266	$	(57,598)	$	(134,274)	$	(145,225)	$	1,249,236	$	11,568	$	1,260,804
Net income	—	—		—		—		1,576		—		1,576		2,185		3,761
Other comprehensive loss	—	—		—		—		—		(4,298)		(4,298)		(106)		(4,404)
Stock-based compensation - equity-classified awards	—	—		14,890		—		—		—		14,890		—		14,890
Common stock issued for stock awards and stock bonuses	448	—		—		—		—		—		—		—		0
Treasury stock acquired	(8)	—		—		(474)		—		—		(474)		—		(474)
Balances as of April 30, 2019	65,773	67		1,601,156		(58,072)		(132,698)		(149,523)		1,260,930		13,647		1,274,577
Net income	—	—		—		—		10,558		—		10,558		1,713		12,271
Other comprehensive loss	—	—		—		—		—		(25,674)		(25,674)		(51)		(25,725)
Stock-based-compensation- equity - classified awards	—	—		17,966		—		—		—		17,966		—		17,966
Common stock issued for stock awards and stock bonuses	998	1		9,543		—		—		—		9,544		—		9,544
Distribution to noncontrolling interest	—	—		—		—		—		—		—		(655)		(655)
Balances as of July 31, 2019	66,771	68		1,628,665		(58,072)		(122,140)		(175,197)		1,273,324		14,654		1,287,978
Net income	—	—		—		—		11,681		—		11,681		1,302		12,983
Other comprehensive income	—	—		—		—		—		17,195		17,195		114		17,309
Stock-based compensation - equity - classified awards	—	—		16,614		—		—		—		16,614		—		16,614
Common stock issued for stock awards and stock bonuses	53	0		0		—		—		—		0		—		0
Distribution to noncontrolling interest	—	—		—		—		—		—		—		(294)		(294)
Balances as of October 31, 2019	66,824	$	68	$	1,645,279	$	(58,072)	$	(110,459)	$	(158,002)	$	1,318,814	$	15,776	$	1,334,590

See notes to condensed consolidated financial statements.

Table of Contents

VERINT SYSTEMS INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Three Months Ended
April 30,
(in thousands) 2020 2019
Cash flows from operating activities:
Net (loss) income $ (3,975) $ 3,761
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization 23,931 22,954
Stock-based compensation, excluding cash-settled awards 14,192 17,065
Amortization of discount on convertible notes 3,226 3,061
Non-cash gains on derivative financial instruments, net (1,014) (549)
Other non-cash items, net (3,537) 2,646
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable 70,087 58,900
Contract assets 2,094 (39)
Inventories (5,118) (3,118)
Prepaid expenses and other assets (11,630) 5,268
Accounts payable and accrued expenses 564 8,487
Contract liabilities (14,776) (24,648)
Other, net 1,934 (725)
Net cash provided by operating activities 75,978 93,063
Cash flows from investing activities:
Cash paid for business combinations, including adjustments, net of cash acquired — (20,210)
Purchases of property and equipment (8,835) (8,331)
Purchases of investments (15,198) (9,995)
Maturities and sales of investments 15,648 2,965
Cash paid for capitalized software development costs (3,146) (2,819)
Change in restricted bank time deposits, and other investing activities, net 20,824 2,941
Net cash provided by (used in) investing activities 9,293 (35,449)
Cash flows from financing activities:
Proceeds from borrowings, net of original issuance discount 155,000 —
Repayments of borrowings and other financing obligations (1,898) (1,584)
Purchases of treasury stock (36,836) (474)
Distribution paid to noncontrolling interest (245) —
Payments of deferred purchase price and contingent consideration for business combinations (financing portion) and other financing activities (1,282) (11,674)
Net cash provided by (used in) financing activities 114,739 (13,732)
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents (3,106) (853)
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents 196,904 43,029
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period 411,657 412,699
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period $ 608,561 $ 455,728
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period to the condensed consolidated balance sheets:
Cash and cash equivalents $ 556,671 $ 412,024
Restricted cash and cash equivalents included in restricted cash and cash equivalents, and restricted bank time deposits 38,004 39,373
Restricted cash and cash equivalents included in other assets 13,886 4,331
Total cash, cash equivalents, restricted cash, and restricted cash equivalents $ 608,561 $ 455,728


	Nine Months Ended October 31,
(in thousands)	2020		2019
Cash flows from operating activities:
Net income	$	18,439	$	29,015
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	73,458		67,880
Stock-based compensation, excluding cash-settled awards	51,538		56,164
Change in fair value of future tranche right	22,834		0
Amortization of discount on convertible notes	9,620		9,306
Non-cash losses (gains) on derivative financial instruments, net	522		(460)
Other, net	(2,519)		3,894
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	31,128		26,791
Contract assets	1,468		(2,175)
Inventories	(2,793)		(605)
Prepaid expenses and other assets	1,552		(109)
Accounts payable and accrued expenses	8,534		(10,161)
Contract liabilities	(60,306)		(29,598)
Other, net	4,356		(13,472)
Net cash provided by operating activities	157,831		136,470

Cash flows from investing activities:
Cash paid for business combinations, including adjustments, net of cash acquired	0		(51,481)
Purchases of property and equipment	(20,596)		(28,388)
Purchases of investments	(142,153)		(31,760)
Maturities and sales of investments	58,210		49,994
Cash paid for capitalized software development costs	(8,740)		(12,431)
Change in restricted bank time deposits, and other investing activities, net	12,603		4,755
Net cash used in investing activities	(100,676)		(69,311)

Cash flows from financing activities:
Proceeds from issuance of preferred stock and future tranche right, net of issuance costs	197,254		0
Proceeds from borrowings	155,000		0
Repayments of borrowings and other financing obligations	(205,447)		(4,671)
Payments to repurchase convertible notes	(13,032)		0
Payments of debt-related costs	(2,287)		(212)
Purchases of treasury stock	(36,836)		(474)
Preferred stock dividend payments	(1,589)		0
Distributions paid to noncontrolling interest	(749)		(949)
Payments of deferred purchase price and contingent consideration for business combinations (financing portion) and other financing activities	(13,241)		(27,975)
Net cash provided by (used in) financing activities	79,073		(34,281)
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents	(2,093)		(1,251)
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	134,135		31,627
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	411,657		412,699
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$	545,792	$	444,326

Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period to the condensed consolidated balance sheets:
Cash and cash equivalents	$	526,815	$	412,838
Restricted cash and cash equivalents included in restricted cash and cash equivalents, and restricted bank time deposits	15,459		23,778
Restricted cash and cash equivalents included in other assets	3,518		7,710
Total cash, cash equivalents, restricted cash, and restricted cash equivalents	$	545,792	$	444,326

See notes to condensed consolidated financial statements.

Table of Contents

VERINT SYSTEMS INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Description of Business

Unless the context otherwise requires, the terms “Verint”, “we”, “us”, and “our” in these notes to condensed consolidated financial statements refer to Verint Systems Inc. and its consolidated subsidiaries.

Verint is a global leader in Actionable Intelligence solutions. In a world of massive information growth, our solutions empower organizations with crucial, actionable insights and enable decision makers to anticipate, respond, and take action. Today, over 10,000 organizations in more than 180 countries, including over 85 percent of the Fortune 100, use Verint’s Actionable Intelligence solutions, deployed in the cloud and on-premises, to make more informed, timely, and effective decisions.

Our Actionable Intelligence leadership is powered by innovative, enterprise-class software built with artificial intelligence, analytics, automation, and deep domain expertise established by working closely with some of the most sophisticated and forward-thinking organizations in the world. We believe we have one of the industry's strongest research and development (“R&D”) teams focused on actionable intelligence consisting of approximately ~~one-third of our approximately 6,300~~1,800 professionals. Our innovative solutions are backed-up by a strong IP portfolio with over 1,000 patents and patent applications worldwide across areas including data capture, artificial intelligence, machine learning, unstructured data analytics, predictive analytics and automation.

On December 4, 2019, we also announced that Valor Parent LP (the “Apax Investor”), an affiliate of Apax Partners (“Apax”) would make an investment in us in an amount of up to ~~$400~~$400.0 million. Under the terms of the Investment Agreement, dated as of December 4, 2019 (the “Investment Agreement”), the Apax Investor initially purchased ~~$200~~$200.0 million of our Series A convertible preferred stock (“Series A Preferred Stock”), which closed on May 7, ~~2020. Please refer to Note 16, “Subsequent Events” for additional information regarding the closing of the initial tranche.~~ 2020. Shortly following the Spin-Off, the Apax Investor will purchase, subject to certain conditions, up to ~~$200~~$200.0 million of Series B convertible preferred stock (“Series B Preferred Stock”) in the Company, as the entity holding the Customer Engagement Solutions business. Following the closing of the Series A investment, Apax’s ownership in us on an as-converted basis is approximately 5.5%. Following completion of the Spin-Off and assuming the issuance of the Series B ~~preferred stock,~~Preferred Stock, Apax’s ownership in us on an as-converted basis will be between 11.5% and 15%. ~~See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Overview” under Item 2 of this report~~Please refer to Note 9, “Convertible Preferred Stock” for a more detailed discussion of the ~~planned~~ Apax investment.

Headquartered in Melville, New York, we support our customers around the globe directly and with an extensive network of selling and support partners.

Impact of COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a global pandemic. The outbreak has reached all of the regions in which we do business, and governmental authorities around the world have implemented numerous measures attempting to contain and mitigate the effects of the virus, including travel bans and restrictions, border closings, quarantines, shelter-in-place orders, shutdowns, limitations or closures of non-essential businesses, and social distancing requirements. Companies around the world, including us, our customers, partners, and vendors, have implemented actions in response, including among others, office closings, site restrictions, and employee travel restrictions. The global spread of COVID-19 and actions taken in response have negatively affected us, our customers, partners, and vendors and caused significant economic and business disruption the extent and duration of which is not currently known. In response to these challenges, we quickly adjusted our operations to work from home and we believe our business continuity plan is working well.

~~Table of Contents~~

We are monitoring and assessing the impact of the COVID-19 pandemic daily, including recommendations and orders issued by government and public health authorities. We continue to work to help our customers meet their business continuity needs

Table of Contents

and help keep the world safe during this difficult time and are managing our operations with a view to resuming normal business activity as soon as possible.

See Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Overview—Recent Developments” of this report for a more detailed discussion of the impact of COVID-19 on our business.

Preparation of Condensed Consolidated Financial Statements

The condensed consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and on the same basis as the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2020 filed with the U.S. Securities and Exchange Commission (“SEC”), except for the recently adopted accounting pronouncements described below. The condensed consolidated statements of operations, comprehensive income, ~~(loss),~~ stockholders’ equity, and cash flows for the periods ended ~~April 30,~~October 31, 2020 and 2019, and the condensed consolidated balance sheet as of ~~April 30,~~October 31, 2020, are not audited but reflect all adjustments that are of a normal recurring nature and that are considered necessary for a fair presentation of the results for the periods shown. The condensed consolidated balance sheet as of January 31, 2020 is derived from the audited consolidated financial statements presented in our Annual Report on Form 10-K for the year ended January 31, 2020. Certain information and disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the SEC. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2020 filed with the SEC. The results for interim periods are not necessarily indicative of a full year’s results.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of Verint Systems Inc., our wholly owned or otherwise controlled subsidiaries, and a joint venture in which we hold a 50% equity interest. The joint venture is a variable interest entity in which we are the primary beneficiary. Noncontrolling interests in less than wholly owned subsidiaries are reflected within stockholders’ equity on our condensed consolidated balance sheet, but separately from our stockholders’ equity. We hold an option to acquire the noncontrolling interests in two majority owned subsidiaries and we account for the option as an in-substance investment in the noncontrolling common stock of each such subsidiary. We include the fair value of the option within other liabilities and do not recognize noncontrolling interests in these subsidiaries.

Equity investments in companies in which we have less than a 20% ownership interest and cannot exercise significant influence, and which do not have readily determinable fair values, are accounted for at cost, adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer, less any impairment.

We include the results of operations of acquired companies from the date of acquisition. All significant intercompany transactions and balances are eliminated.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires our management to make estimates and assumptions, which may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period.

In light of the currently unknown extent and duration of the COVID-19 pandemic, we face a greater degree of uncertainty than normal in making the judgments and estimates needed to apply to certain of our significant accounting policies. We assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to us and the unknown future impacts COVID-19 as of ~~April 30,~~October 31, 2020 and through the date of this report. These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.

Significant Accounting Policies

~~Table of Contents~~

There have been no material changes in our significant accounting policies during the ~~three~~nine months ended ~~April 30,~~October 31, 2020, as compared to the significant accounting policies described in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2020.

Table of Contents

Recently Adopted Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") No. 2016-13, Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments. This new standard requires entities to measure expected credit losses for certain financial assets held at the reporting date using a current expected credit loss model, which is based on historical experience, adjusted for current conditions and reasonable and supportable forecasts. The Company's financial instruments within the scope of this guidance primarily includes accounts receivable and contract assets. On February 1, 2020, we adopted the new standard under the modified retrospective approach, such that comparative information has not been restated and continues to be reported under accounting standards in effect for those periods. The adoption of ASU No. 2016-13 resulted in a $1.1 million increase in our allowance for expected credit losses related to accounts receivable and contract assets, a $0.2 million increase to deferred tax assets, and an impact of $0.9 million to our accumulated deficit. The new accounting standard did not have a material impact on our condensed consolidated financial statements, including accounting policies, given our limited historical write-off activity.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which requires customers in a hosting arrangement that is a service contract to follow existing internal-use software guidance to determine which implementation costs to capitalize and which costs to expense. Under the new standard, implementation costs are deferred and presented in the same financial statement caption on the condensed consolidated balance sheet as a prepayment of related arrangement fees. The deferred costs are recognized over the term of the arrangement in the same financial statement caption in the condensed consolidated income statement as the related fees of the arrangement. We adopted ASU No. 2018-15 prospectively to eligible costs incurred on or after February 1, 2020 and the implementation did not have a material impact on our condensed consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to The Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements on fair value measurements. Since the standard affects only disclosure requirements, the adoption of the standard did not have an impact on our condensed consolidated financial statements.

New Accounting Pronouncements Not Yet Effective

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which affects general principles within Topic 740, Income Taxes, and is meant to simplify and reduce the cost of accounting for income taxes. This standard is effective for interim and annual reporting periods beginning after December 15, 2020. We are currently reviewing this standard but do not expect that it will have a material impact on our consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by eliminating the requirement to separate embedded conversion features from the host contract when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital. By removing the separation model, a convertible debt instrument will be reported as a single liability instrument with no separate accounting for embedded conversion features. This new standard also removes certain settlement conditions that are required for contracts to qualify for equity classification and simplifies the diluted earnings per share calculations by requiring that an entity use the if-converted method and that the effect of potential share settlement be included in diluted earnings per share calculations. This new standard will be effective for us in fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. We are currently assessing the impact of adopting this standard on our consolidated financial statements.

2. REVENUE RECOGNITION

We derive our revenue primarily from the licensing of our software products and related services and support based on when control of the software passes to our customers or the services are provided, in an amount that reflects the consideration we expect to be entitled to in exchange for such goods or services. Revenue is reported net of applicable sales and use tax, ~~value-added~~value-

Table of Contents

added tax and other transaction taxes imposed on the related transaction, including mandatory government charges that are passed through to our customers.

We determine revenue recognition through the following five steps:

•Identification of the contract, or contracts, with a customer

•Identification of the performance obligations in the contract

•Determination of the transaction price

•Allocation of the transaction price to the performance obligations in the contract

•Recognition of revenue when, or as, performance obligations are satisfied.

~~Table of Contents~~

We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.

Disaggregation of Revenue

The following table provides information about disaggregated revenue for our Customer Engagement and Cyber Intelligence segments by product revenue and service and support revenue, as well as by the recurring or nonrecurring nature of revenue for each business segment. Recurring revenue is the portion of our revenue that we believe is likely to be renewed in the future. The recurrence of these revenue streams in future periods depends on a number of factors including contractual periods and customers' renewal decisions.

For our Customer Engagement segment:

•Recurring revenue primarily consists of cloud revenue and initial and renewal support revenue.

◦Cloud revenue consists primarily of software as a service (“SaaS”) revenue with some optional managed services revenue.

◦SaaS revenue consists predominately of bundled SaaS (software with standard managed services) with some unbundled SaaS (software licensing rights sold separately from managed services and accounted for as term-based licenses). Unbundled SaaS can be deployed in the cloud either by us or a cloud partner.

◦Bundled SaaS revenue is recognized over time and unbundled SaaS revenue is recognized at a point in time. Unbundled SaaS contracts are eligible for renewal after the initial fixed term, which in most cases is between a ~~one-~~one- and three-year time frame.

•Nonrecurring revenue primarily consists of our perpetual licenses, consulting, implementation and installation services, and training.

For our Cyber Intelligence segment:

•Recurring revenue primarily consists of initial and renewal support, subscription software licenses, and SaaS in certain limited transactions.

•Nonrecurring revenue primarily consists of our perpetual licenses, long-term projects including software customizations that are recognized over time as control transfers to the customer using a percentage-of-completion (“POC”) method, consulting, implementation and installation services, training, and hardware.


		Three Months Ended April 30, 2020										Three Months Ended April 30, 2019											Three Months Ended October 31, 2020				Three Months Ended October 31, 2019
(in thousands)	(in thousands)	Customer Engagement		Cyber Intelligence		Total		Customer Engagement		Cyber Intelligence		Total		(in thousands)	Customer Engagement		Cyber Intelligence		Total		Customer Engagement		Cyber Intelligence		Total
Revenue:	Revenue:													Revenue:
Product	Product	$	33,997	$	43,287	$	77,284	$	54,002	$	50,222	$	104,224	Product	$	54,196	$	51,669	$	105,865	$	60,828	$	55,503	$	116,331
Service and support	Service and support	151,868		58,143		210,011		153,093		57,942		211,035		Service and support	161,026		61,310		222,336		157,108		51,428		208,536
Total revenue	Total revenue	$	185,865	$	101,430	$	287,295	$	207,095	$	108,164	$	315,259	Total revenue	$	215,222	$	112,979	$	328,201	$	217,936	$	106,931	$	324,867

Revenue by recurrence:	Revenue by recurrence:													Revenue by recurrence:
Recurring revenue	Recurring revenue	$	129,070	$	56,038	$	185,108	$	123,358	$	46,817	$	170,175	Recurring revenue	$	150,233	$	57,128	$	207,361	$	141,378	$	47,498	$	188,876
Nonrecurring revenue	Nonrecurring revenue	56,795		45,392		102,187		83,737		61,347		145,084		Nonrecurring revenue	64,989		55,851		120,840		76,558		59,433		135,991
Total revenue	Total revenue	$	185,865	$	101,430	$	287,295	$	207,095	$	108,164	$	315,259	Total revenue	$	215,222	$	112,979	$	328,201	$	217,936	$	106,931	$	324,867

Table of Contents


	Nine Months Ended October 31, 2020						Nine Months Ended October 31, 2019
(in thousands)	Customer Engagement		Cyber Intelligence		Total		Customer Engagement		Cyber Intelligence		Total
Revenue:
Product	$	134,084	$	145,141	$	279,225	$	169,298	$	161,240	$	330,538
Service and support	471,083		174,297		645,380		467,169		166,724		633,893
Total revenue	$	605,167	$	319,438	$	924,605	$	636,467	$	327,964	$	964,431

Recurring Revenue
Recurring revenue	$	418,570	$	164,817	$	583,387	$	394,068	$	140,486	$	534,554
Nonrecurring revenue	186,597		154,621		341,218		242,399		187,478		429,877
Total revenue	$	605,167	$	319,438	$	924,605	$	636,467	$	327,964	$	964,431

The following table provides a further disaggregation of revenue for our Customer Engagement segment.

~~Table of Contents~~


		Three Months Ended April 30,							Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	(in thousands)	2020		2019		(in thousands)	2020		2019		2020		2019
Customer Engagement revenue	Customer Engagement revenue					Customer Engagement revenue
Recurring revenue	Recurring revenue					Recurring revenue
Bundled SaaS revenue	Bundled SaaS revenue	$	33,393	$	27,204	Bundled SaaS revenue	$	37,406	$	30,107	$	106,617	$	84,519
Unbundled SaaS revenue	Unbundled SaaS revenue	5,472		6,252		Unbundled SaaS revenue	18,735		17,100		34,269		29,793
Optional managed services revenue	Optional managed services revenue	14,132		13,629		Optional managed services revenue	14,884		14,222		43,344		42,015
Total cloud revenue	Total cloud revenue	52,997		47,085		Total cloud revenue	71,025		61,429		184,230		156,327
Support revenue	Support revenue	76,073		76,273		Support revenue	79,208		79,949		234,340		237,741
Total recurring revenue	Total recurring revenue	129,070		123,358		Total recurring revenue	150,233		141,378		418,570		394,068
Nonrecurring revenue	Nonrecurring revenue					Nonrecurring revenue
Perpetual revenue	Perpetual revenue	28,525		47,602		Perpetual revenue	35,461		43,726		99,815		139,356
Professional services revenue	Professional services revenue	28,270		36,135		Professional services revenue	29,528		32,832		86,782		103,043
Total nonrecurring revenue	Total nonrecurring revenue	56,795		83,737		Total nonrecurring revenue	64,989		76,558		186,597		242,399
Total Customer Engagement revenue	Total Customer Engagement revenue	$	185,865	$	207,095	Total Customer Engagement revenue	$	215,222	$	217,936	$	605,167	$	636,467

Contract Balances

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:

(in thousands) April 30, 2020 January 31, 2020
Accounts receivable, net $ 308,304 $ 382,435
Contract assets, net $ 62,249 $ 64,961
Long-term contract assets (included in Other assets) $ 9,260 $ 1,358
Contract liabilities $ 378,548 $ 397,350
Long-term contract liabilities $ 40,566 $ 40,565


(in thousands)	October 31, 2020		January 31, 2020
Accounts receivable, net	$	346,565	$	382,435
Contract assets, net	$	63,095	$	64,961
Long-term contract assets (included in Other assets)	$	15,591	$	1,358
Contract liabilities	$	334,843	$	397,350
Long-term contract liabilities	$	39,810	$	40,565

We receive payments from customers based upon contractual billing schedules, and accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to multi-year unbundled SaaS contracts and arrangements where our right to consideration is subject to the contractually agreed upon billing schedule. We expect billing and collection of a majority of our contract assets to occur within the next twelve months and asset impairment charges related to contract assets were immaterial in the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019. There are two customers in our Cyber Intelligence segment that accounted for a combined ~~$47.3~~$76.6 million and $51.7 million of our aggregated accounts receivable and contract assets at ~~April 30,~~

Table of Contents

October 31, 2020 and January 31, 2020, respectively. These amounts result from both direct and indirect contracts with ~~governmental agencies~~governments outside of the U.S. which we believe present insignificant credit risk.

Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract. Revenue recognized during the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019 from amounts included in contract liabilities at the beginning of each period was ~~$139.1~~$324.1 million and ~~$134.6~~$294.9 million, respectively.

Remaining Performance Obligations

Transaction price allocated to remaining performance obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes contract liabilities and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. The majority of our arrangements are for periods of up to three years, with a significant portion being one year or less.

We elected to exclude amounts of variable consideration attributable to sales- or usage-based royalties in exchange for a license of our IP from the remaining performance obligations. The timing and amount of revenue recognition for our remaining performance obligations is influenced by several factors, including seasonality, the timing of support renewals, and the revenue recognition for certain projects, particularly in our Cyber Intelligence segment, that can extend over longer periods of time,

~~Table of Contents~~

delivery under which, for various reasons, may be delayed, modified, or canceled. Further, we have historically generated a large portion of our business each quarter by orders that are sold and fulfilled within the same reporting period. Therefore, the amount of remaining obligations may not be a meaningful indicator of future results.

The following table provides information about remaining performance obligations for each of our operating segments:


		April 30, 2020										January 31, 2020											October 31, 2020				January 31, 2020
(in thousands)	(in thousands)	Customer Engagement		Cyber Intelligence		Total		Customer Engagement		Cyber Intelligence		Total		(in thousands)	Customer Engagement		Cyber Intelligence		Total		Customer Engagement		Cyber Intelligence		Total
RPO:	RPO:													RPO:
Expected to be recognized within 1 year	Expected to be recognized within 1 year	$	363,496	$	363,710	$	727,206	$	374,982	$	356,677	$	731,659	Expected to be recognized within 1 year	$	350,805	$	358,982	$	709,787	$	374,982	$	356,677	$	731,659
Expected to be recognized in more than 1 year	Expected to be recognized in more than 1 year	113,340		197,729		311,069		117,497		225,056		342,553		Expected to be recognized in more than 1 year	143,016		175,389		318,405		117,497		225,056		342,553
Total RPO	Total RPO	$	476,836	$	561,439	$	1,038,275	$	492,479	$	581,733	$	1,074,212	Total RPO	$	493,821	$	534,371	$	1,028,192	$	492,479	$	581,733	$	1,074,212

3. NET ~~(LOSS)~~ INCOME PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.

The following table summarizes the calculation of basic and diluted net ~~(loss)~~ income per common share attributable to Verint Systems Inc. for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands, except per share amounts) 2020 2019
Net (loss) income $ (3,975) $ 3,761
Net income attributable to noncontrolling interests 2,039 2,185
Net (loss) income attributable to Verint Systems Inc. $ (6,014) $ 1,576
Weighted-average shares outstanding:
Basic 64,376 65,438
Dilutive effect of employee equity award plans — 1,650
Dilutive effect of 1.50% convertible senior notes — —
Dilutive effect of warrants — —
Diluted 64,376 67,088
Net (loss) income per common share attributable to Verint Systems Inc.:
Basic $ (0.09) $ 0.02
Diluted $ (0.09) $ 0.02

Table of Contents


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands, except per share amounts)	2020		2019		2020		2019
Net income	$	11,827	$	12,983	$	18,439	$	29,015
Net income attributable to noncontrolling interests	1,652		1,302		5,784		5,200
Net income attributable to Verint Systems Inc.	10,175		11,681		12,655		23,815
Dividends on preferred stock	(2,658)		0		(5,142)		0
Net income attributable to Verint Systems Inc. for basic net income per common share	7,517		11,681		7,513		23,815
Dilutive effect of dividends on preferred stock	0		0		0		0
Net income attributable to Verint Systems Inc. for diluted net income per common share	$	7,517	$	11,681	$	7,513	$	23,815
Weighted-average shares outstanding:
Basic	65,571		66,799		64,973		66,181
Dilutive effect of employee equity award plans	663		643		1,027		1,271
Dilutive effect of 1.50% convertible senior notes	0		0		0		0
Dilutive effect of warrants	0		0		0		0
Dilutive effect of assumed conversion of preferred stock	0		0		0		0
Diluted	66,234		67,442		66,000		67,452
Net income per common share attributable to Verint Systems Inc.:
Basic	$	0.11	$	0.17	$	0.12	$	0.36
Diluted	$	0.11	$	0.17	$	0.11	$	0.35

We excluded the following weighted-average potential common shares from the calculations of diluted net income per common share during the applicable periods because their inclusion would have been anti-dilutive:

Three Months Ended
April 30,
(in thousands) 2020 2019
Common shares excluded from calculation:
Stock options and restricted stock-based awards 1,491 606
1.50% convertible senior notes 6,205 6,205
Warrants 6,205 6,205

In periods for which we report a net loss attributable to Verint Systems Inc., basic net loss per common share and diluted net loss per common share are identical since the effect of all potential common shares is anti-dilutive and therefore excluded.


	Three Months Ended October 31,		Nine Months Ended October 31,
(in thousands)	2020	2019	2020	2019
Common shares excluded from calculation:
Stock options and restricted stock-based awards	867	1,545	240	1,122
1.50% convertible senior notes	6,002	6,205	6,114	6,205
Warrants	6,205	6,205	6,205	6,205
Series A Preferred Stock	3,738	0	2,411	0

Our 1.50% convertible senior notes (“Notes”) will not impact the calculation of diluted net income per share unless the average price of our common stock, as calculated in accordance with the terms of the indenture governing the Notes, exceeds the conversion price of $64.46 per share. Likewise, diluted net income per share will not include any effect from the Warrants (as defined in Note 7, “Long-Term Debt”) unless the average price of our common stock, as calculated under the terms of the Warrants, exceeds the exercise price of $75.00 per share.

~~Table of Contents~~

Our Note Hedges (as defined in Note 7, “Long-Term Debt”) do not impact the calculation of diluted net income per share under the treasury stock method, because their effect would be anti-dilutive. However, in the event of an actual conversion of any or all of the Notes, the common shares that would be delivered to us under the Note Hedges would neutralize the dilutive effect of the common shares that we would issue under the Notes. As a result, actual conversion of any or all of the outstanding Notes would not increase our outstanding common stock. Up to 6,205,000 common shares could be issued upon exercise of the Warrants. Further details regarding the Notes, Note Hedges, and the Warrants appear in Note 7, “Long-Term Debt”.

On December 4, 2019, we announced that Valor Parent LP, an affiliate of Apax Partners, would invest up to ~~$400~~$400.0 million in us, in the form of convertible preferred stock. On May 7, 2020, the initial purchase of ~~$200~~$200.0 million of our Series A ~~convertible preferred stock~~Preferred Stock closed. ~~As a result,~~The weighted-average common shares underlying the assumed conversion of the Series A Preferred Stock, on an as-converted basis, were excluded from the calculation of ~~basic and~~ diluted net income ~~(loss)~~ per common share ~~will be impacted beginning in the second quarter of this current fiscal year ending January 31, 2021.~~as their effect would have been anti-dilutive. Further details regarding the convertible preferred stock investment appear in Note ~~1, “Basis of Presentation and Significant Accounting Policies” under “Description of Business” and Note 16, “Subsequent Events”~~9, “Convertible Preferred Stock”.

Table of Contents

4. CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

The following tables summarize our cash, cash equivalents, and short-term investments as of ~~April 30,~~October 31, 2020 and January 31, 2020:


		April 30, 2020															October 31, 2020
(in thousands)	(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value		(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:	Cash and cash equivalents:									Cash and cash equivalents:
Cash and bank time deposits	Cash and bank time deposits	$	411,926	$	—	$	—	$	411,926	Cash and bank time deposits	$	396,730	$	—	$	—	$	396,730
Money market funds	Money market funds	144,745		—		—		144,745		Money market funds	130,085		—		—		130,085
Total cash and cash equivalents	Total cash and cash equivalents	$	556,671	$	—	$	—	$	556,671	Total cash and cash equivalents	$	526,815	$	—	$	—	$	526,815

Short-term investments:	Short-term investments:									Short-term investments:
Bank time deposits	Bank time deposits	$	19,741	$	—	$	—	$	19,741	Bank time deposits	$	104,454	$	0	$	0	$	104,454
Total short-term investments	Total short-term investments	$	19,741	$	—	$	—	$	19,741	Total short-term investments	$	104,454	$	0	$	0	$	104,454


		January 31, 2020															January 31, 2020
(in thousands)	(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value		(in thousands)	Cost Basis		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Cash and cash equivalents:	Cash and cash equivalents:									Cash and cash equivalents:
Cash and bank time deposits	Cash and bank time deposits	$	379,057	$	—	$	—	$	379,057	Cash and bank time deposits	$	379,057	$	—	$	—	$	379,057
Money market funds	Money market funds	89		—		—		89		Money market funds	89		—		—		89
Total cash and cash equivalents	Total cash and cash equivalents	$	379,146	$	—	$	—	$	379,146	Total cash and cash equivalents	$	379,146	$	—	$	—	$	379,146

Short-term investments:	Short-term investments:									Short-term investments:
Bank time deposits	Bank time deposits	$	20,215	$	—	$	—	$	20,215	Bank time deposits	$	20,215	$	0	$	0	$	20,215
Total short-term investments	Total short-term investments	$	20,215	$	—	$	—	$	20,215	Total short-term investments	$	20,215	$	0	$	0	$	20,215

Bank time deposits which are reported within short-term investments consist of deposits held outside of the U.S. with maturities of greater than 90 days, or without specified maturity dates which we intend to hold for periods in excess of 90 days. All other bank deposits are included within cash and cash equivalents.

During the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019, proceeds from maturities and sales of short-term investments were ~~$15.6~~$58.2 million and ~~$3.0~~$50.0 million, respectively.

5. BUSINESS COMBINATIONS

~~Three~~Nine Months Ended ~~April 30,~~October 31, 2020

~~Table of Contents~~

We did not complete any business combinations during the ~~three~~nine months ended ~~April 30,~~October 31, 2020.

Year Ended January 31, 2020

During the year ended January 31, 2020, we completed ~~four~~4 business combinations:

•On February 1, 2019, we completed the acquisition of a SaaS workforce optimization company focused on the small and medium-sized business (“SMB”) market as part of our strategy to expand our SMB portfolio. This company has been integrated into our Customer Engagement segment.

•On July 25, 2019, we completed the acquisition of a SaaS company focused on cloud-based knowledge management solutions as part of our strategy to add additional artificial intelligence and machine learning capabilities into our portfolio. This company has been integrated into our Customer Engagement segment.

•On December 18, 2019, we completed the acquisition of ~~two~~2 software companies under common control focused on multi source intelligence and fusion ~~analytics domains.~~analytics. These companies are being integrated into our Cyber Intelligence segment.

Table of Contents

•On January 13, 2020, we completed the acquisition of a SaaS based company providing web and mobile session replay solutions. This company ~~is being~~has been integrated into our Customer Engagement segment.

These business combinations were not individually material to our condensed consolidated financial statements.

The combined consideration for these business combinations was approximately ~~$89.3~~$90.0 million, and consisted of (i) $76.2 million of combined cash paid at closings or shortly thereafter, partially offset by $2.4 million of cash acquired, resulting in net cash consideration at closing of $73.8 million; and (ii) the fair value of the contingent consideration arrangements described below of $15.3 million; offset by (iii) ~~$2.1~~$1.5 million of other purchase price adjustments. For ~~three~~3 of the business combinations, we agreed to make potential additional cash payments to the respective former shareholders aggregating up to approximately $23.5 million, contingent upon the achievement of certain performance targets over periods extending through January 2022, the fair value of which was estimated to be $15.3 million at the acquisition date. Cash paid for these business combinations was funded by cash on hand.

The purchase prices for these business combinations were allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill. The fair value assigned to identifiable intangible assets acquired were determined primarily by using the income approach, which discounts expected future cash flows to present value using estimates and assumptions determined by management.

Included among the factors contributing to the recognition of goodwill in these transactions were synergies in products and technologies, and the addition of skilled, assembled workforces. Of the ~~$50.4~~$51.0 million of goodwill associated with these business combinations, $39.1 million and ~~$11.3~~$11.9 million was assigned to our Customer Engagement and Cyber Intelligence segments, respectively, and $15.7 million of which is deductible for income tax purposes.

Revenue and net income (loss) attributable to these acquisitions for the year ended January 31, 2020 were not material.

Transaction and related costs, consisting primarily of professional fees and integration expenses, directly related to these acquisitions, totaled ~~$1.1~~$0.2 million and ~~$1.0~~$1.1 million for the three months ended October 31, 2020 and 2019, respectively, and $1.6 million and $4.2 million for the nine months ended ~~April 30,~~October 31, 2020 and ~~April 30,~~ 2019, respectively. All transaction and related costs were expensed as incurred and are included in selling, general and administrative expenses.

The purchase price allocations for the business combinations completed subsequent to ~~April 30,~~October 31, 2019 have been prepared on a preliminary basis and changes to those allocations may occur as additional information becomes available during the respective measurement periods (up to one year from the respective acquisition dates). Fair values still under review include values assigned to identifiable intangible assets, goodwill, deferred income taxes, and reserves for uncertain income tax positions.

The following table sets forth the components and the allocations of the combined purchase prices for the business combinations completed during the year ended January 31, 2020 including adjustments identified subsequent to the valuation date, none of which were material:

1416

Table of Contents


(in thousands)	Amount
Components of Purchase Prices:
Cash	$	76,198
Fair value of contingent consideration	15,253
Other purchase price adjustments	~~(2,137)~~(1,480)
Total purchase prices	$	~~89,314~~89,971

Allocation of Purchase Prices:
Net tangible assets (liabilities):
Accounts receivable	$	3,950
Other current assets, including cash acquired	~~14,394~~14,511
Other assets	6,556
Current and other liabilities	~~(8,531)~~(8,648)
Contract liabilities - current and long-term	(3,794)
Deferred income taxes	(4,061)
Net tangible assets	8,514
Identifiable intangible assets:
Customer relationships	13,299
Developed technology	14,443
Trademarks and trade names	1,367
Non-compete agreements	1,307
Total identifiable intangible assets	30,416
Goodwill	~~50,384~~51,041
Total purchase prices allocation	$	~~89,314~~89,971

For these acquisitions, customer relationships, developed technology, trademarks and trade names, and non-compete agreements were assigned estimated useful lives of from five years to nine years, four years to five years, and three years to five years, and three years, respectively, the weighted average of which is approximately 6.1 years.

Other Business Combination Information

The acquisition date fair values of contingent consideration obligations associated with business combinations are estimated based on probability adjusted present values of the consideration expected to be transferred using significant inputs that are not observable in the market. Key assumptions used in these estimates include probability assessments with respect to the likelihood of achieving the performance targets and discount rates consistent with the level of risk of achievement. At each reporting date, we revalue the contingent consideration obligations to their fair values and record increases and decreases in fair value within selling, general, and administrative expenses in our condensed consolidated statements of operations. Changes in the fair value of the contingent consideration obligations result from changes in discount periods and rates, and changes in probability assumptions with respect to the likelihood of achieving the performance targets.

For the three months ended ~~April 30,~~October 31, 2020 and 2019, we recorded benefits of $2.3 million and $0.3 million, respectively, and for the nine months ended October 31, 2020 and 2019, we recorded a benefit of ~~$4.8~~$6.1 million and a charge of ~~$1.2~~$0.1 million, respectively, within selling, general and administrative expenses for changes in the fair values of contingent consideration obligations associated with business combinations. The aggregate fair values of the remaining contingent consideration obligations associated with business combinations was ~~$35.0~~$18.1 million at ~~April 30,~~October 31, 2020, of which ~~$20.4~~$10.1 million was recorded within accrued expenses and other current liabilities, and ~~$14.6~~$8.0 million was recorded within other liabilities.

Payments of contingent consideration earned under these agreements were ~~$3.0~~$1.5 million and ~~$6.4~~$6.0 million for the three months ended ~~April 30,~~October 31, 2020 and 2019, respectively, and $18.9 million and $29.7 million for the nine months ended October 31, 2020 and 2019, respectively.

6. INTANGIBLE ASSETS AND GOODWILL

Acquisition-related intangible assets consisted of the following as of ~~April 30,~~October 31, 2020 and January 31, 2020:

1517

Table of Contents


		April 30, 2020											October 31, 2020
(in thousands)	(in thousands)	Cost		Accumulated Amortization		Net		(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:	Intangible assets with finite lives:							Intangible assets with finite lives:
Customer relationships	Customer relationships	$	458,725	$	(330,492)	$	128,233	Customer relationships	$	462,866	$	(347,256)	$	115,610
Acquired technology	Acquired technology	291,603		(243,894)		47,709		Acquired technology	293,471		(254,858)		38,613
Trade names	Trade names	12,823		(7,411)		5,412		Trade names	12,838		(8,873)		3,965
Distribution network	Distribution network	4,440		(4,440)		—		Distribution network	4,440		(4,440)		0
Non-competition agreements	Non-competition agreements	1,307		(158)		1,149		Non-competition agreements	1,307		(375)		932
Total intangible assets	Total intangible assets	$	768,898	$	(586,395)	$	182,503	Total intangible assets	$	774,922	$	(615,802)	$	159,120


		January 31, 2020											January 31, 2020
(in thousands)	(in thousands)	Cost		Accumulated Amortization		Net		(in thousands)	Cost		Accumulated Amortization		Net
Intangible assets with finite lives:	Intangible assets with finite lives:							Intangible assets with finite lives:
Customer relationships	Customer relationships	$	465,130	$	(328,069)	$	137,061	Customer relationships	$	465,130	$	(328,069)	$	137,061
Acquired technology	Acquired technology	294,841		(241,585)		53,256		Acquired technology	294,841		(241,585)		53,256
Trade names	Trade names	12,957		(6,783)		6,174		Trade names	12,957		(6,783)		6,174
Distribution network	Distribution network	4,440		(4,440)		—		Distribution network	4,440		(4,440)		0
Non-competition agreements	Non-competition agreements	1,307		(34)		1,273		Non-competition agreements	1,307		(34)		1,273
Total intangible assets	Total intangible assets	$	778,675	$	(580,911)	$	197,764	Total intangible assets	$	778,675	$	(580,911)	$	197,764

We considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic to assess whether a triggering event had occurred that would result in a potential impairment of our indefinite-lived intangible assets. Based on this assessment, we concluded that a triggering event has not occurred which would require further impairment testing to be performed.

The following table presents net acquisition-related intangible assets by reportable segment as of ~~April 30,~~October 31, 2020 and January 31, 2020:

April 30, January 31,
(in thousands) 2020 2020
Customer Engagement $ 175,241 $ 189,896
Cyber Intelligence 7,262 7,868
Total $ 182,503 $ 197,764


	October 31,		January 31,
(in thousands)	2020		2020
Customer Engagement	$	152,939	$	189,896
Cyber Intelligence	6,181		7,868
Total	$	159,120	$	197,764

Total amortization expense recorded for acquisition-related intangible assets was ~~$12.7~~$12.4 million and ~~$14.4~~$13.7 million for the three months ended ~~April 30,~~October 31, 2020 and 2019, respectively, and $37.5 million and $41.4 million for the nine months ended October 31, 2020 and 2019, respectively. The reported amount of net acquisition-related intangible assets can fluctuate from the impact of changes in foreign currency exchange rates on intangible assets not denominated in U.S. dollars.

Estimated future amortization expense on finite-lived acquisition-related intangible assets is as follows:

(in thousands)
Years Ending January 31, Amount
2021 (remainder of year) $ 36,856
2022 45,885
2023 37,978
2024 27,805
2025 11,754
2026 and thereafter 22,225
Total $ 182,503


(in thousands)
Years Ending January 31,	Amount
2021 (remainder of year)	$	12,230
2022	46,268
2023	38,290
2024	28,120
2025	11,832
2026 and thereafter	22,380
Total	$	159,120

Goodwill activity for the ~~three~~nine months ended ~~April 30,~~October 31, 2020, in total and by reportable segment, was as follows:

Table of Contents


				Reportable Segment									Reportable Segment
(in thousands)	(in thousands)	Total		Customer Engagement		Cyber Intelligence		(in thousands)	Total		Customer Engagement		Cyber Intelligence
Three Months Ended April 30, 2020:
Nine Months Ended October 31, 2020:								Nine Months Ended October 31, 2020:
Goodwill, gross, at January 31, 2020	Goodwill, gross, at January 31, 2020	$	1,536,076	$	1,367,111	$	168,965	Goodwill, gross, at January 31, 2020	$	1,536,076	$	1,367,111	$	168,965
Accumulated impairment losses through January 31, 2020	Accumulated impairment losses through January 31, 2020	(66,865)		(56,043)		(10,822)		Accumulated impairment losses through January 31, 2020	(66,865)		(56,043)		(10,822)
Goodwill, net, at January 31, 2020	Goodwill, net, at January 31, 2020	1,469,211		1,311,068		158,143		Goodwill, net, at January 31, 2020	1,469,211		1,311,068		158,143
Foreign currency translation and other	Foreign currency translation and other	(16,420)		(15,764)		(656)		Foreign currency translation and other	(5,060)		(4,513)		(547)
Business combinations, including adjustments to prior period acquisitions	Business combinations, including adjustments to prior period acquisitions	(357)		—		(357)		Business combinations, including adjustments to prior period acquisitions	300		0		300
Goodwill, net, at April 30, 2020		$	1,452,434	$	1,295,304	$	157,130
Goodwill, net, at October 31, 2020								Goodwill, net, at October 31, 2020	$	1,464,451	$	1,306,555	$	157,896

Balance at April 30, 2020:
Goodwill, gross, at April 30, 2020		$	1,519,299	$	1,351,347	$	167,952
Accumulated impairment losses through April 30, 2020		(66,865)		(56,043)		(10,822)
Goodwill, net, at April 30, 2020		$	1,452,434	$	1,295,304	$	157,130
Balance at October 31, 2020:								Balance at October 31, 2020:
Goodwill, gross, at October 31, 2020								Goodwill, gross, at October 31, 2020	$	1,531,316	$	1,362,598	$	168,718
Accumulated impairment losses through October 31, 2020								Accumulated impairment losses through October 31, 2020	(66,865)		(56,043)		(10,822)
Goodwill, net, at October 31, 2020								Goodwill, net, at October 31, 2020	$	1,464,451	$	1,306,555	$	157,896

We evaluated whether there has been a change in circumstances as of ~~April 30,~~October 31, 2020 and as of the date of this filing in response to the economic impacts seen globally from COVID-19. The valuation methodology to determine the fair value of the reporting units is sensitive to management's forecasts of future revenue, profitability and market conditions. At this time, the impact of COVID-19 on our forecasts is uncertain and increases the subjectivity that will be involved in evaluating goodwill for potential impairment. ~~We do expect declines in our~~Our reporting unit fair values may decline as a result of delayed or reduced demand for our products and services, driving lower revenue and operating income across our businesses. However, given the significant difference between the reporting unit fair values and their carrying values in the most recent quantitative analyses completed as of November 1, 2019, as well as expected long-term recovery within all reporting units, management does not believe that these events were severe enough to result in an impairment trigger. We will continue to monitor the environment to determine whether the impacts to our reporting units represent an event or change in circumstances that may trigger a need to assess for impairment.

7. LONG-TERM DEBT

The following table summarizes our long-term debt at ~~April 30,~~October 31, 2020 and January 31, 2020:

April 30, January 31,
(in thousands) 2020 2020
1.50% Convertible Senior Notes $ 400,000 $ 400,000
June 2017 Term Loan 413,313 414,375
Borrowings under 2017 Revolving Credit Facility 200,000 45,000
Less: Unamortized debt discounts and issuance costs (18,673) (22,327)
Total debt 994,640 837,048
Less: current maturities 4,250 4,250
Long-term debt $ 990,390 $ 832,798

~~Current maturities of long-term debt are reported within accrued expenses and other current liabilities on our condensed consolidated balance sheet.~~


	October 31,		January 31,
(in thousands)	2020		2020
1.50% Convertible Senior Notes	$	386,887	$	400,000
June 2017 Term Loan	411,188		414,375
Borrowings under 2017 Revolving Credit Facility	0		45,000
Less: Unamortized debt discounts and issuance costs	(11,334)		(22,327)
Total debt	786,741		837,048
Less: current maturities	383,449		4,250
Long-term debt	$	403,292	$	832,798

1.50% Convertible Senior Notes

On June 18, 2014, we issued $400.0 million in aggregate principal amount of 1.50% convertible senior notes due June 1, 2021 (“Notes”), unless earlier converted by the holders pursuant to their terms. Net proceeds from the Notes after underwriting discounts were $391.9 million. The Notes pay interest in cash semiannually in arrears at a rate of 1.50% per annum.

The Notes were issued concurrently with our public issuance of 5,750,000 shares of common stock, the majority of the combined net proceeds of which were used to partially repay certain indebtedness under a prior credit agreement.

The Notes are unsecured and are convertible into, at our election, cash, shares of common stock, or a combination of both, subject to satisfaction of specified conditions and during specified periods. If converted, we currently intend to pay cash in

~~Table of Contents~~

respect of the principal amount of the Notes. We currently expect to ~~refinance~~retire the Notes at or prior to maturity using our existing cash and/or with proceeds from the issuance of new ~~convertible~~ notes or ~~other~~ debt.

Table of Contents

The Notes have a conversion rate of 15.5129 shares of common stock per $1,000 principal amount of Notes, which represents an effective conversion price of approximately $64.46 per share of common ~~stock and would result in the issuance of approximately 6,205,000 shares if all of the Notes were converted.~~stock. The conversion rate has not changed since issuance of the Notes, although throughout the term of the Notes, the conversion rate may be adjusted upon the occurrence of certain events.

On or after December 1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may surrender their Notes for conversion regardless of whether any of the other specified conditions for conversion have been satisfied. As of ~~April 30,~~October 31, 2020, the Notes were not convertible.

In accordance with accounting guidance for convertible debt with a cash conversion option, we separately accounted for the debt and equity components of the Notes in a manner that reflected our estimated nonconvertible debt borrowing rate. We estimated the debt and equity components of the Notes to be $319.9 million and $80.1 million, respectively, at the issuance date, assuming a 5.00% non-convertible borrowing rate. The equity component was recorded as an increase to additional paid-in capital. The excess of the principal amount of the debt component over its carrying amount (the “debt discount”) is being amortized as interest expense over the term of the Notes using the effective interest method. The equity component is not remeasured as long as it continues to meet the conditions for equity classification.

We allocated transaction costs related to the issuance of the Notes, including underwriting discounts, of $7.6 million and $1.9 million to the debt and equity components, respectively. Issuance costs attributable to the debt component of the Notes are presented as a reduction of long-term debt and are being amortized as interest expense over the term of the Notes, and issuance costs attributable to the equity component were netted with the equity component in additional paid-in capital, a component of stockholder’s equity.

During the three months ended July 31, 2020, we repurchased $13.1 million principal amount of our Notes (the “Repurchased Notes”) in open market transactions for an aggregate of $13.0 million in cash. As a result, we recorded a debt extinguishment loss of $0.1 million, representing the difference between the fair value of the liability component and carrying value of the Repurchased Notes at the repurchase dates. The remaining cash payments were allocated to the reacquisition of the equity component of the Repurchased Notes and were recorded as a charge to additional paid-in capital. The carrying amount of the equity component, net of issuance costs, was ~~$78.2~~$78.0 million at ~~April 30, 2020.~~October 31, 2020, inclusive of a $0.2 million reduction resulting from the repurchases during this period.

As of ~~April 30,~~October 31, 2020, the carrying value of the debt component was ~~$384.1~~$378.5 million, which is net of unamortized debt discount and issuance costs of ~~$14.5~~$7.7 million and ~~$1.4~~$0.7 million, respectively. Including the impact of the debt discount and related deferred debt issuance costs, the effective interest rate on the Notes was approximately ~~5.29%~~5.31% at ~~April 30,~~October 31, 2020. If all Notes outstanding at October 31, 2020 were converted, it would result in the issuance of approximately 6,002,000 shares of common stock.

Based on the closing market price of our common stock on ~~April 30,~~October 31, 2020, the if-converted value of the Notes was less than the aggregate principal amount of the Notes.

As the Notes are due June 1, 2021, they are classified as current maturities of long-term debt on our condensed consolidated balance sheet as of October 31, 2020.

Note Hedges and Warrants

Concurrently with the issuance of the Notes, we entered into convertible note hedge transactions (the “Note Hedges”) and sold warrants (the “Warrants”). The combination of the Note Hedges and the Warrants serves to increase the effective initial conversion price for the Notes to $75.00 per share. The Note Hedges and Warrants are each separate instruments from the Notes.

Note Hedges

Pursuant to the Note Hedges, we purchased call options on our common stock, under which we have the right to acquire from the counterparties up to approximately 6,205,000 shares of our common stock, subject to customary anti-dilution adjustments, at a price of $64.46, which equals the initial conversion price of the Notes. Our exercise rights under the Note Hedges generally trigger upon conversion of the Notes and the Note Hedges terminate upon maturity of the Notes, or the first day the Notes are no longer outstanding. The Note Hedges may be settled in cash, shares of our common stock, or a combination thereof, at our option, and are intended to reduce our exposure to potential dilution upon conversion of the Notes. We paid $60.8 million for

Table of Contents

the Note Hedges, which was recorded as a reduction to additional paid-in capital. As of ~~April 30,~~October 31, 2020, we had not purchased any shares of our common stock under the Note Hedges.

The Note repurchases executed during the three months ended July 31, 2020 described above did not change the number of common shares subject to the Note Hedges. However, since a Note conversion is a prerequisite to exercising the call right under the Note Hedges, the number of common shares subject to call under the Note Hedges was effectively reduced since the repurchased Notes can no longer be converted.

Warrants

We sold the Warrants to several counterparties. The Warrants provide the counterparties rights to acquire from us up to approximately 6,205,000 shares of our common stock at a price of $75.00 per share. The Warrants expire incrementally on a series of expiration dates beginning in August 2021. At expiration, if the market price per share of our common stock exceeds the strike price of the Warrants, we will be obligated to issue shares of our common stock having a value equal to such excess. The Warrants could have a dilutive effect on net income per share to the extent that the market value of our common stock

~~Table of Contents~~

exceeds the strike price of the Warrants. Proceeds from the sale of the Warrants were $45.2 million and were recorded as additional paid-in capital. As of ~~April 30,~~October 31, 2020, no Warrants had been exercised and all Warrants remained outstanding.

The Note Hedges and Warrants both meet the requirements for classification within stockholders’ equity, and their respective fair values are not remeasured and adjusted as long as these instruments continue to qualify for stockholders’ equity classification.

Credit Agreements

2017 Credit Agreement

On June 29, 2017, we entered into a credit agreement (the “2017 Credit Agreement”) with certain lenders and terminated a prior credit agreement.

The 2017 Credit Agreement provides for $725.0 million of senior secured credit facilities, comprised of a $425.0 million term loan maturing on June 29, 2024 (the “2017 Term Loan”) and a $300.0 million revolving credit facility maturing on June 29, 2022 (the “2017 Revolving Credit Facility”), subject to increase and reduction from time to time according to the terms of the 2017 Credit Agreement. The maturity dates of the 2017 Term Loan and 2017 Revolving Credit Facility will be accelerated to March 1, 2021 if on such date any Notes remain ~~outstanding.~~outstanding, unless such outstanding Notes are cash collateralized pursuant to the 2020 Amendment to the 2017 Credit Agreement, as further described below.

The majority of the proceeds from the 2017 Term Loan were used to repay all outstanding terms loans under our prior credit agreement.

The 2017 Term Loan was subject to an original issuance discount of approximately $0.5 million. This discount is being amortized as interest expense over the term of the 2017 Term Loan using the effective interest method.

Interest rates on loans under the 2017 Credit Agreement are periodically reset, at our option, at either a Eurodollar Rate or an ABR rate (each as defined in the 2017 Credit Agreement), plus in each case a margin.

On January 31, 2018, we entered into an amendment to the 2017 Credit Agreement (the “2018 Amendment”) providing for, among other things, a reduction of the interest rate margins on the 2017 Term Loan from 2.25% to 2.00% for Eurodollar loans, and from 1.25% to 1.00% for ABR loans. The vast majority of the impact of the 2018 Amendment was accounted for as a debt modification. For the portion of the 2017 Term Loan which was considered extinguished and replaced by new loans, we wrote off $0.2 million of unamortized deferred debt issuance costs as a loss on early retirement of debt during the three months ended January 31, 2018. The remaining unamortized deferred debt issuance costs and discount are being amortized over the remaining term of the 2017 Term Loan.

On June 8, 2020, we entered into a second amendment to the 2017 Credit Agreement (the ~~“Second~~“2020 Amendment”). Pursuant to the ~~Second~~2020 Amendment, we are permitted to effect the previously announced Spin-Off of our Cyber Intelligence business within the parameters set forth in the 2017 Credit Agreement, as amended, and our Notes will not be deemed to be outstanding if such Notes are cash collateralized in accordance with the 2017 Credit Agreement, as amended, for purposes of the determination of the maturity dates of the 2017 Term Loan and the 2017 Revolving Credit Facility discussed above. We currently ~~intend~~expect to ~~cash collateralize, or otherwise refinance or repurchase,~~retire the Notes at or prior to ~~their maturity. Refer to Note 16, “Subsequent Events” for further details regarding~~maturity using our existing cash and/or with proceeds from the ~~Second Amendment to the 2017 Credit Agreement.~~issuance of new notes or debt.

Table of Contents

As of ~~April 30,~~October 31, 2020, the interest rate on the 2017 Term Loan was ~~3.37%~~2.14%. Taking into account the impact of the original issuance discount and related deferred debt issuance costs, the effective interest rate on the 2017 Term Loan was approximately ~~3.55%~~2.34% at ~~April 30,~~October 31, 2020. As of January 31, 2020, the interest rate on 2017 Term Loan was 3.85%.

~~Borrowings~~During the three months ended October 31, 2020, we repaid in full the $200.0 million of borrowings then outstanding under the 2017 Revolving Credit Facility ~~were $200.0 million at April 30, 2020, which is included in long-term debt~~using available cash on ~~our condensed consolidated balance sheet.~~hand. For borrowings under the 2017 Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the 2017 Credit Agreement) leverage ratio (the "Leverage Ratio"). ~~As of April 30, 2020, the weighted average interest rate on our revolving credit facility borrowings was 2.33%.~~ In addition, we are required to pay a commitment fee with respect to unused availability under the 2017 Revolving Credit Facility at rates per annum determined by reference to our Leverage Ratio. The proceeds of borrowings under the 2017 Revolving Credit Facility were used to fund a portion of our stock repurchase program or will be used for general corporate purposes. Please refer to Note 9, “Stockholders’ Equity”, for more information regarding the stock repurchase program.

~~Table of Contents~~

The 2017 Term Loan requires quarterly principal payments of approximately $1.1 million, which commenced on August 1, 2017, with the remaining balance due on June 29, 2024. Optional prepayments of loans under the 2017 Credit Agreement are generally permitted without premium or penalty.

Our obligations under the 2017 Credit Agreement are guaranteed by each of our direct and indirect existing and future material domestic wholly owned restricted subsidiaries, and are secured by a security interest in substantially all of our assets and the assets of the guarantor subsidiaries, subject to certain exceptions.

The 2017 Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The 2017 Credit Agreement also contains a financial covenant that, solely with respect to the 2017 Revolving Credit Facility, requires us to maintain a Leverage Ratio of no greater than 4.50 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the 2017 Credit Agreement.

The 2017 Credit Agreement provides for events of default with corresponding grace periods that we believe are customary for credit facilities of this type. Upon an event of default, all of our obligations owed under the 2017 Credit Agreement may be declared immediately due and payable, and the lenders’ commitments to make loans under the 2017 Credit Agreement may be terminated.

2017 Credit Agreement Issuance and Amendment Costs

We incurred debt issuance costs of approximately $6.8 million in connection with the 2017 Credit Agreement, of which $4.1 million were associated with the 2017 Term Loan, and $2.7 million were associated with the 2017 Revolving Credit Facility, which were deferred and are being amortized as interest expense over the terms of the facilities under the 2017 Credit Agreement. As noted previously, during the three months ended January 31, 2018, we wrote off $0.2 million of deferred debt issuance costs associated with the 2017 Term Loan as a result of the 2018 Amendment. We incurred $2.1 million of debt modification costs related to the 2020 Amendment, $1.2 million of which were expensed, and $0.9 million of which were deferred (comprised of $0.5 million associated with the 2017 Term Loan, and $0.4 million associated with the 2017 Revolving Credit Facility), and are being amortized along with the existing unamortized debt issuance costs. Deferred debt issuance costs associated with the 2017 Term Loan are being amortized using the effective interest rate method, and deferred debt issuance costs associated with the 2017 Revolving Credit Facility are being amortized on a straight-line basis.

Future Principal Payments on Term Loan

As of ~~April 30,~~October 31, 2020, future scheduled principal payments on the 2017 Term Loan were as follows:


(in thousands)	(in thousands)			(in thousands)
Years Ending January 31,	Years Ending January 31,	Amount		Years Ending January 31,	Amount
2021 (remainder of year)	2021 (remainder of year)	$	3,188	2021 (remainder of year)	$	1,063
2022	2022	4,250		2022	4,250
2023	2023	4,250		2023	4,250
2024	2024	4,250		2024	4,250
2025	2025	397,375		2025	397,375
Total	Total	$	413,313	Total	$	411,188

Table of Contents

Interest Expense

The following table presents the components of interest expense incurred on the Notes and on borrowings under our credit agreements for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	2020		2019		2020		2019
1.50% Convertible Senior Notes:
Interest expense at 1.50% coupon rate	$	1,450	$	1,500	$	4,436	$	4,500
Amortization of debt discount	3,220		3,143		9,620		9,306
Amortization of deferred debt issuance costs	303		296		907		877
Total Interest Expense - 1.50% Convertible Senior Notes	$	4,973	$	4,939	$	14,963	$	14,683

Borrowings under Credit Agreements:
Interest expense at contractual rates	$	2,790	$	4,435	$	10,766	$	13,810
Impact of interest rate swap reclassified from accumulated other comprehensive loss	1,356		261		3,068		261
Amortization of debt discounts	18		17		55		50
Amortization of deferred debt issuance costs	497		396		1,327		1,171
Total Interest Expense - Borrowings under Credit Agreements	$	4,661	$	5,109	$	15,216	$	15,292

~~Table~~

On May 1, 2020, our interest rate swap agreement no longer qualified as a cash flow hedge for accounting purposes and as such, accumulated deferred losses on our interest rate swap that were previously recorded as a component of ~~Contents~~

Three Months Ended
April 30,
(in thousands) 2020 2019
1.50% Convertible Senior Notes:
Interest expense at 1.50% coupon rate $ 1,500 $ 1,500
Amortization of debt discount 3,226 3,061
Amortization of deferred debt issuance costs 304 289
Total Interest Expense - 1.50% Convertible Senior Notes $ 5,030 $ 4,850
Borrowings under Credit Agreements:
Interest expense at contractual rates $ 4,513 $ 4,645
Impact of interest rate swap 591 —
Amortization of debt discounts 18 16
Amortization of deferred debt issuance costs 391 374
Total Interest Expense - Borrowings under Credit Agreements $ 5,513 $ 5,035
accumulated other comprehensive loss will be reclassified to the condensed consolidated statement of operations as interest expense over the remaining term of the interest rate swap, as the previously hedged interest payments occur. Please refer to Note 13, “Derivative Financial Instruments” for a more detailed discussion of our interest rate swap agreement.

8. SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION

Condensed Consolidated Balance Sheets

Inventories consisted of the following as of ~~April 30,~~October 31, 2020 and January 31, 2020:


		April 30,		January 31,			October 31,		January 31,
(in thousands)	(in thousands)	2020		2020		(in thousands)	2020		2020
Raw materials	Raw materials	$	12,422	$	9,628	Raw materials	$	9,864	$	9,628
Work-in-process	Work-in-process	4,943		4,749		Work-in-process	5,797		4,749
Finished goods	Finished goods	7,665		6,118		Finished goods	6,087		6,118
Total inventories	Total inventories	$	25,030	$	20,495	Total inventories	$	21,748	$	20,495

Condensed Consolidated Statements of Operations

Other ~~expense,~~(expense) income, net consisted of the following for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands) 2020 2019
Foreign currency losses, net $ (3,254) $ (1,187)
Gains on derivative financial instruments, net 1,014 549
Other, net 10 (152)
Total other expense, net $ (2,230) $ (790)


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	2020		2019		2020		2019
Foreign currency (losses) gains, net	$	(1,998)	$	1,531	$	(2,220)	$	1,119
(Losses) gains on derivative financial instruments, net	(1,072)		(268)		(522)		460
Change in fair value of future tranche right	(9,224)		0		(22,834)		0
Other, net	3,732		(181)		2,573		(378)
Total other (expense) income, net	$	(8,562)	$	1,082	$	(23,003)	$	1,201

Table of Contents

Please refer to Note 9, “Convertible Preferred Stock” and Note 12, “Fair Value Measurements” for additional information regarding the future tranche right.

Condensed Consolidated Statements of Cash Flows

The following table provides supplemental information regarding our condensed consolidated cash flows for the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands) 2020 2019
Cash paid for interest $ 5,302 $ 4,673
Cash payments (refunds) of income taxes, net $ 9,557 $ (1,513)
Cash payments for operating leases $ 6,277 $ 6,841
Non-cash investing and financing transactions:
Liabilities for contingent consideration in business combinations $ — $ 5,200
Finance leases of property and equipment $ 760 $ —
Accrued but unpaid purchases of property and equipment $ 3,295 $ 3,301
Inventory transfers to property and equipment $ 153 $ 73


	Nine Months Ended October 31,
(in thousands)	2020		2019
Cash paid for interest	$	18,141	$	15,618
Cash payments of income taxes, net	$	16,609	$	20,286
Cash payments for operating leases	$	21,990	$	20,654
Non-cash investing and financing transactions:
Liabilities for contingent consideration in business combinations, including measurement period adjustments	$	0	$	5,200
Finance leases of property and equipment	$	841	$	377
Accrued but unpaid purchases of property and equipment	$	3,918	$	3,899
Inventory transfers to property and equipment	$	646	$	595

9. CONVERTIBLE PREFERRED STOCK

On December 4, 2019, we entered into an Investment Agreement with the Apax Investor, whereby, subject to certain closing conditions, the Apax Investor has agreed to make an investment in us in an amount up to $400.0 million as follows:

•On May 7, 2020, (the “Series A Closing Date”) we issued a total of 200,000 shares of our Series A Convertible Perpetual Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”), pursuant to a certificate of designation of preferences, rights, and limitations (the “Series A Certificate of Designation”) filed with the Delaware Secretary of State, for an aggregate purchase price of $200.0 million, or $1,000 per share(the “Series A Private Placement”) to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $2.7 million, including financial advisory fees, closing costs, legal fees and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series A Preferred Stock.

•Upon completion of the Spin-Off and certain customary closing conditions, we will issue up to 200,000 shares of Series B Convertible Perpetual Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock” and, together with the Series A Preferred Stock, the “Preferred Stock”) at a purchase price of $1,000 per share (the “Series B Private Placement”) to the Apax Investor, subject to certain conditions. The closing of the Series B Private Placement (the “Series B Closing Date”) is contingent on, among other conditions, completion of the Spin-Off and the respective enterprise values of our Customer Engagement Solutions business and Cyber Intelligence Solutions business at the time of the Spin-Off being above a specified floor, as well as satisfaction or waiver of certain customary closing conditions. The closing of the Series B Private Placement is expected to occur shortly after the consummation of the Spin-Off and determination of the relative enterprise values of the two businesses.

Voting Rights

Holders of the Series A Preferred Stock have the right to vote on matters submitted to a vote of the holders of our common stock, par value $0.001 per share (the “Common Stock”), on an as-converted basis; however, in no event will the holders of Preferred Stock have the right to vote shares of the Preferred Stock on an as-converted basis in excess of 19.9% of the voting power of the Common Stock outstanding immediately prior to December 4, 2019.

Dividends and Liquidation Rights

The Series A Preferred Stock ranks senior to the shares of our Common Stock, with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of our affairs. Shares of Series A

2124

Table of Contents

Preferred Stock have a liquidation preference of the greater of $1,000 per share or the amount that would be received if the shares are converted at the then applicable conversion price at the time of such liquidation.

Holders of the Series A Preferred Stock are entitled to a cumulative dividend at a rate of 5.2% per annum until the 48-month anniversary of the Series A Closing Date and thereafter at a rate of 4.0% per annum. Dividends on the Series A Preferred Stock are cumulative and payable semi-annually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of Series A Preferred Stock. The applicable dividend rate is subject to increase (i) to 6.0% per annum in the event the number of shares of Common Stock into which the Preferred Stock could be converted exceeds 19.9% of the voting power of outstanding Common Stock on the Series A Closing Date (unless we obtain shareholder approval of the issuance of Common Stock upon conversion of the Preferred Stock) and (ii) by 1.0% each year, up to a maximum dividend rate of 10.0% per annum, in the event we fail to satisfy our obligations to redeem the Series A Preferred Stock in specified circumstances.

For the three and nine months ended October 31, 2020, we paid $1.6 million of preferred stock dividends, which were declared during the three months ended July 31, 2020, and had $2.7 million and $3.6 million, respectively, of cumulative undeclared and unpaid preferred stock dividends. We reflected $2.7 million and $5.2 million of preferred stock dividends in our condensed consolidated results of operations, for purposes of computing net income attributable to Verint Systems Inc. commons shares, for the three and nine months ended October 31, 2020, respectively. As of October 31, 2020, we had 0 accrued dividends.

Conversion

The Series A Preferred Stock is convertible into Common stock at the election of the holder, subject to certain conditions including conditions associated with the Spin-Off, at an initial conversion price of $53.50 per share. Assuming completion of the Spin-Off, the Series A Preferred Stock will not participate in the Spin-Off distribution of the shares of the company holding our Cyber Intelligence Solutions business, and instead, the conversion price of the Series A Preferred Stock will be adjusted based on the ratio of the trading prices of the two post-Spin-Off companies over a short period following the Spin-Off, subject to a collar. As of October 31, 2020, the maximum number of shares of Common Stock that could be required to be issued upon conversion of the outstanding shares of Series A Preferred Stock was 3.7 million shares.

At any time after 36 months following the Series A Closing Date, we will have the option to require that all of the then-outstanding shares of Series A Preferred Stock convert into Common Stock if the volume-weighted average price per share of the Common Stock for at least 30 trading days in any 45 consecutive trading day period exceeds 175% of the then-applicable conversion price of the Series A Preferred Stock (a “Mandatory Conversion”).

We may redeem any or all of the Series A Preferred Stock for cash at any time after the 72-month anniversary of the Series A Closing Date at a redemption price equal to 100% of the liquidation preference of the shares of the Series A Preferred Stock, plus any accrued and unpaid dividends to, but excluding, the redemption date, plus a make-whole amount designed to allow the Apax Investor to earn a total 8.0% internal rate of return on such shares.

The Apax Investor has agreed to restrictions on its ability to dispose of shares of the Series A Preferred Stock until the earlier of (1) the 36-month anniversary of the Series A Closing Date or (2) the 24-month anniversary of the consummation of the Spin-Off (the “Preferred Stock Restricted Period”). Following the Preferred Stock Restricted Period, the Series A Preferred Stock may not be sold or transferred without the prior written consent of the Company. The Apax Investor has also agreed to restrictions on its ability to dispose of the Common Stock issued upon conversion of the Series A Preferred Stock. The Common Stock may not be disposed of until the earlier of (1) the 12-month anniversary of consummation of the Spin-Off or (2) the 24-month anniversary of the Series A Closing Date. These restrictions do not apply to certain transfers to one or more permitted co-investors or transfers or pledges of the Series A Preferred Stock or Common Stock pursuant to the terms of specified margin loans to be entered into by the Apax Investor as well as transfers effected pursuant to a merger, consolidation, or similar transaction consummated by us and transfers that are approved by our board of directors.

At any time after the 102-month anniversary of the Series A Closing Date or upon the occurrence of a change of control triggering event (as set forth in the Series A Certificate of Designation), the holders of the Series A Preferred Stock will have the right to cause us to redeem all of the outstanding shares of Series A Preferred Stock for cash at a redemption price equal to 100% of the liquidation preference of the shares of Series A Preferred Stock, plus any accrued and unpaid dividends to, but excluding, the redemption date. Therefore, the Series A Preferred Stock has been classified as mezzanine equity on our condensed consolidated balance sheet as of October 31, 2020, separate from permanent equity, as the potential required repurchase of the Series A Preferred Stock, however remote in likelihood, is not solely under our control.

Table of Contents

As of October 31, 2020, the Series A Preferred Stock is not redeemable, and we have concluded that it is currently not probable of becoming redeemable, including from the occurrence of a change in control triggering event. The holders’ redemption rights which occur at the 102-month anniversary of the Series A Closing Date are not considered probable because there is a more than remote likelihood that the Mandatory Conversion may occur prior to such redemption rights. We therefore did not adjust the carrying amount of the Series A Preferred Stock to its current redemption amount, which was its liquidation preference, at October 31, 2020 plus accrued and unpaid dividends. As of October 31, 2020, the stated value of the Series A Preferred Stock liquidation preference was $200.0 million and cumulative, unpaid dividends on the Series A Preferred Stock were $3.6 million.

Future Tranche Right

We have determined that our obligation to issue and the Apax Investor’s obligation to purchase up to 200,000 shares of the Series B Preferred Stock upon the completion of the Spin-Off and other customary closing conditions (the “Future Tranche Right”) meets the definition of a freestanding financial instrument as the Future Tranche Right is legally detachable and separately exercisable from the Series A Preferred Stock. Since the Future Tranche Right is subject to fair value accounting, we allocated the proceeds from the issuance of the Series A Preferred Stock to the Future Tranche Right based upon its fair value at the date of issuance, with the remaining proceeds being allocated to the Series A Preferred Stock. The Future Tranche Right is remeasured at fair value each reporting period until settlement, and changes in its fair value are recognized as a component of other income (expense), net on the condensed consolidated statement of operations.

At the Series A Closing Date, the Future Tranche Right was recorded as an asset of $3.4 million, as the purchase price of the Series B Preferred Stock was greater than its estimated fair value at the expected settlement date. This resulted in a $203.4 million carrying value, before direct and incremental issuance costs, for the Series A Preferred Stock.

At October 31, 2020, the fair value of the Future Tranche Right was a liability of $19.5 million, driven primarily by changes in our stock price and declining credit market interest rates associated with worsened and uncertain economic conditions occurring during the period.We recorded non-cash charges of $9.2 million and $22.8 million related to the change in fair value of the Future Tranche Right for the three and nine months ended October 31, 2020, respectively, within other (expense) income, net. The Future Tranche Right will be remeasured at each reporting period until the redemption feature is exercised in connection with the sale and issuance of the Series B Preferred Stock. The $19.5 million fair value of the Future Tranche Right is included within accrued expenses and other liabilities on our condensed consolidated balance sheet at October 31, 2020. Please refer to Note 12, “Fair Value Measurements” for additional information regarding valuations of the Future Tranche Right.

9.10. STOCKHOLDERS’ EQUITY

Dividends on Common Stock

We did ~~not~~0t declare or pay any dividends on our common stock during the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019. Under the terms of our 2017 Credit Agreement, we are subject to certain restrictions on declaring and paying dividends on our common stock.

Stock Repurchase Program

On December 4, 2019, we announced that our board of directors had authorized a stock repurchase program whereby we may repurchase up to $~~300~~300.0 million of common stock over the period ending on February 1, 2021. We made $34.0 million in repurchases under the program during the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and $116.1 million of repurchases during the year ended January 31, 2020. Due to the uncertainty surrounding the impact of the COVID-19 pandemic, we will consider further repurchases under the stock repurchase program based on economic and market conditions as they evolve.

Treasury Stock

Repurchased shares of common stock are recorded as treasury stock, at cost, but may from time to time be retired. We periodically purchase treasury stock from directors, officers, and other employees to facilitate income tax withholding by us or the payment of required income taxes by such holders in connection with the vesting of equity awards.

During the ~~three~~nine months ended ~~April 30,~~October 31, 2020, we repurchased approximately 613,000 shares of treasury stock for a cost of $34.0 million under the share repurchase program described above. During the ~~three~~nine months ended ~~April 30,~~October 31, 2019, we

Table of Contents

repurchased approximately 8,000 shares of treasury stock for a cost of $0.5 million to facilitate income tax withholding and payment requirements upon vesting of equity awards.

At ~~April 30,~~October 31, 2020, we held approximately 4,404,000 shares of treasury stock with a cost of $208.1 million. At January 31, 2020, we held approximately 3,791,000 shares of treasury stock with a cost of $174.1 million.

Issuance of Convertible Preferred Stock

On December 4, 2019, in conjunction with the planned separation of our businesses into two independent publicly traded companies, we announced that an affiliate of Apax Partners would invest up to ~~$400~~$400.0 million in us, in the form of convertible preferred stock. Under the terms of the Investment Agreement, the Apax Investor initially purchased ~~$200~~$200.0 million of our Series A ~~convertible preferred stock,~~Preferred Stock, which closed on May 7, 2020. Please refer to Note ~~16, “Subsequent Events”~~9, “Convertible Preferred Stock” for additional information regarding the closing of the initial tranche.

Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) includes items such as foreign currency translation adjustments and unrealized gains and losses on certain marketable securities and derivative financial instruments designated as hedges. Accumulated other comprehensive income (loss) is presented as a separate line item in the stockholders’ equity section of our condensed consolidated balance sheets. Accumulated other comprehensive income (loss) items have no impact on our net income ~~(loss)~~ as presented in our condensed consolidated statements of operations.

The following table summarizes changes in the components of our accumulated other comprehensive income (loss) by component for the ~~three~~nine months ended ~~April 30,~~October 31, 2020:

~~Table of Contents~~


(in thousands)	(in thousands)	Unrealized Gains (Losses) on Foreign Exchange Contracts Designated as Hedges		Unrealized Loss on Interest Rate Swap Designated as Hedge		Foreign Currency Translation Adjustments		Total		(in thousands)	Unrealized Gains (Losses) on Foreign Exchange Contracts Designated as Hedges		Unrealized Loss on Interest Rate Swap Designated as Hedge		Foreign Currency Translation Adjustments		Total
Accumulated other comprehensive income (loss) at January 31, 2020	Accumulated other comprehensive income (loss) at January 31, 2020	$	626	$	(10,528)	$	(141,963)	$	(151,865)	Accumulated other comprehensive income (loss) at January 31, 2020	$	626	$	(10,528)	$	(141,963)	$	(151,865)
Other comprehensive loss before reclassifications		(829)		(5,949)		(20,640)		(27,418)
Other comprehensive income (loss) before reclassifications										Other comprehensive income (loss) before reclassifications	230		(5,928)		(7,444)		(13,142)
Amounts reclassified out of accumulated other comprehensive income (loss)	Amounts reclassified out of accumulated other comprehensive income (loss)	(46)		(463)		—		(509)		Amounts reclassified out of accumulated other comprehensive income (loss)	200		(2,401)		0		(2,201)
Net other comprehensive loss		(783)		(5,486)		(20,640)		(26,909)
Accumulated other comprehensive loss at April 30, 2020		$	(157)	$	(16,014)	$	(162,603)	$	(178,774)
Net other comprehensive income (loss)										Net other comprehensive income (loss)	30		(3,527)		(7,444)		(10,941)
Accumulated other comprehensive income (loss) at October 31, 2020										Accumulated other comprehensive income (loss) at October 31, 2020	$	656	$	(14,055)	$	(149,407)	$	(162,806)

All amounts presented in the table above are net of income taxes, if applicable. The accumulated net losses in foreign currency translation adjustments primarily reflect the strengthening of the U.S. dollar against the British pound sterling, which has resulted in lower U.S. dollar-translated balances of British pound sterling-denominated goodwill and intangible assets.

The amounts reclassified out of accumulated other comprehensive income (loss) into the condensed consolidated statement of operations, with presentation location, for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019 were as follows:

Three Months Ended
April 30,
(in thousands) 2020 2019 Location
Unrealized losses on derivative financial instruments:
Foreign currency forward contracts $ (3) $ (72) Cost of product revenue
(5) (84) Cost of service and support revenue
(27) (472) Research and development, net
(17) (311) Selling, general and administrative
(52) (939) Total, before income taxes
6 94 Benefit from income taxes
$ (46) $ (845) Total, net of income taxes
Interest rate swap agreement $ (591) $ — Interest expense
(591) — Total, before income taxes
128 — Benefit from income taxes
$ (463) $ — Total, net of income taxes

Table of Contents


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	2020		2019		2020		2019		Location
Unrealized gains (losses) on derivative financial instruments:
Foreign currency forward contracts	$	13	$	38	$	12	$	(34)	Cost of product revenue
	19		47		17		(37)		Cost of service and support revenue
	136		271		130		(201)		Research and development, net
	75		186		71		(125)		Selling, general and administrative
	243		542		230		(397)		Total, before income taxes
	(32)		(55)		(30)		39		(Provision) benefit from income taxes
	$	211	$	487	$	200	$	(358)	Total, net of income taxes

Interest rate swap agreement	$	(1,356)	$	(261)	$	(3,067)	$	(261)	Interest expense
	(1,356)		(261)		(3,067)		(261)		Total, before income taxes
	294		58		666		58		Benefit from income taxes
	$	(1,062)	$	(203)	$	(2,401)	$	(203)	Total, net of income taxes

~~10.~~11. INCOME TAXES

Our interim ~~(benefit)~~ provision for income taxes is measured using an estimated annual effective income tax rate, adjusted for discrete items that occur within the periods presented.

For the three months ended ~~April 30,~~October 31, 2020, we recorded an income tax ~~benefit~~provision of ~~$1.8~~$8.2 million on a pre-tax ~~loss~~income of ~~$5.7~~$20.0 million, which represented an effective income tax rate of ~~30.7%~~40.8%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the impact of U.S. taxation of certain foreign activities, limitations on certain tax deductions, and a change in the fair value of the Future Tranche Right associated with the Preferred Stock issuance, offset by lower statutory rates in several foreign jurisdictions and ~~a deferred tax benefit due to a tax rate change in a foreign jurisdiction.~~the favorable impact of recently issued regulations.

For the three months ended ~~April 30,~~October 31, 2019, we recorded an income tax provision of ~~$1.4~~$9.2 million on pre-tax income of ~~$5.2~~$22.2 million, which represented an effective income tax rate of ~~27.3%~~41.5%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the impact of U.S. taxation of certain foreign activities and limitations on certain tax deductions, offset by lower statutory rates in several foreign jurisdictions.

For the nine months ended October 31, 2020, we recorded an income tax provision of $16.5 million on pre-tax income of $34.9 million, which represented an effective income tax rate of 47.2%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the impact of U.S. taxation of certain foreign activities, limitations on certain tax deductions, a change in the fair value of the Future Tranche Right associated with the Preferred Stock issuance, offset by lower statutory rates in several foreign jurisdictions and the favorable impact of recently issued regulations.

For the nine months ended October 31, 2019, we recorded an income tax provision of $6.1 million on pre-tax income of $35.1 million, which represented an effective income tax rate of 17.4%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to a net tax benefit of $6.7 million recorded in our second quarter in relation to changes in unrecognized income tax benefits and other items as a result of an audit settlement in a foreign jurisdiction and the impact of U.S. taxation of certain foreign activities and limitations on certain tax deductions, offset by lower statutory rates in several foreign jurisdictions. Excluding the income tax benefit attributable to the audit settlement, the result was an income tax provision of $12.8 million on pre-tax income of $35.1 million, resulting in an effective tax rate of 36.5%.

As required by the authoritative guidance on accounting for income taxes, we evaluate the realizability of deferred income tax assets on a jurisdictional basis at each reporting date. Accounting guidance for income taxes requires that a valuation allowance

~~Table of Contents~~

be established when it is more-likely-than-not that all or a portion of the deferred income tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred income tax assets are not more-likely-than-not realizable, we establish a valuation allowance. We determined that there is sufficient negative evidence to maintain the valuation allowances against certain state and foreign deferred income tax assets as a result of historical losses in the most

Table of Contents

recent three-year period in certain state and foreign jurisdictions. We intend to maintain valuation allowances until sufficient positive evidence exists to support a reversal.

We had unrecognized income tax benefits of ~~$92.3~~$93.6 million and $91.3 million (excluding interest and penalties) as of ~~April 30,~~October 31, 2020 and January 31, 2020, respectively. The accrued liability for interest and penalties was ~~$3.0~~$3.1 million and $2.9 million at ~~April 30,~~October 31, 2020 and January 31, 2020, respectively. Interest and penalties are recorded as a component of the provision for income taxes in our condensed consolidated statements of operations. As of ~~April 30,~~October 31, 2020 and January 31, 2020, the total amount of unrecognized income tax benefits that, if recognized, would impact our effective income tax rate were approximately ~~$92.3~~$93.6 million and $91.3 million, respectively. We regularly assess the adequacy of our provisions for income tax contingencies in accordance with the applicable authoritative guidance on accounting for income taxes. As a result, we may adjust the reserves for unrecognized income tax benefits for the impact of new facts and developments, such as changes to interpretations of relevant tax law, assessments from taxing authorities, settlements with taxing authorities, and lapses of statutes of limitation. Further, we believe that it is reasonably possible that the total amount of unrecognized income tax benefits at ~~April 30,~~October 31, 2020 could decrease by approximately ~~$1.3~~$1.4 million in the next twelve months as a result of settlement of certain tax audits or lapses of statutes of limitation. Such decreases may involve the payment of additional income taxes, the adjustment of deferred income taxes including the need for additional valuation allowances, and the recognition of income tax benefits. Our income tax returns are subject to ongoing tax examinations in several jurisdictions in which we operate. We also believe that it is reasonably possible that new issues may be raised by tax authorities or developments in tax audits may occur, which would require increases or decreases to the balance of reserves for unrecognized income tax benefits; however, an estimate of such changes cannot reasonably be made.

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was enacted and signed into U.S. law to provide economic relief to individuals and businesses facing economic hardship as a result of the COVID-19 pandemic. ~~Changes in tax laws or rates are accounted for in the period of enactment.~~ The income tax provisions of the CARES Act do not have a significant impact on our current taxes, deferred taxes, or uncertain tax positions. However, we plan to defer the timing of employer payroll taxes and accelerate the refund of AMT credits as permitted by the CARES Act.

~~11.~~12. FAIR VALUE MEASUREMENTS

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our assets and liabilities measured at fair value on a recurring basis consisted of the following as of ~~April 30,~~October 31, 2020 and January 31, 2020:


		April 30, 2020											October 31, 2020
		Fair Value Hierarchy Category											Fair Value Hierarchy Category
(in thousands)	(in thousands)	Level 1		Level 2		Level 3		(in thousands)	Level 1		Level 2		Level 3
Assets:	Assets:							Assets:
Money market funds	Money market funds	$	144,745	$	—	$	—	Money market funds	$	130,085	$	0	$	0
Foreign currency forward contracts	Foreign currency forward contracts	—		1,270		—		Foreign currency forward contracts	0		1,059		0
Contingent consideration receivable	Contingent consideration receivable	—		—		668		Contingent consideration receivable	0		0		587
Total assets	Total assets	$	144,745	$	1,270	$	668	Total assets	$	130,085	$	1,059	$	587
Liabilities:	Liabilities:							Liabilities:
Foreign currency forward contracts	Foreign currency forward contracts	$	—	$	724	$	—	Foreign currency forward contracts	$	0	$	367	$	0
Interest rate swap agreement	Interest rate swap agreement	—		20,445		—		Interest rate swap agreement	0		18,744		0
Future tranche right								Future tranche right	0		0		19,460
Contingent consideration - business combinations	Contingent consideration - business combinations	—		—		35,002		Contingent consideration - business combinations	0		0		18,102
Option to acquire noncontrolling interests of consolidated subsidiaries	Option to acquire noncontrolling interests of consolidated subsidiaries	—		—		2,650		Option to acquire noncontrolling interests of consolidated subsidiaries	0		0		3,200
Total liabilities	Total liabilities	$	—	$	21,169	$	37,652	Total liabilities	$	0	$	19,111	$	40,762

2429

Table of Contents


		January 31, 2020											January 31, 2020
		Fair Value Hierarchy Category											Fair Value Hierarchy Category
(in thousands)	(in thousands)	Level 1		Level 2		Level 3		(in thousands)	Level 1		Level 2		Level 3
Assets:	Assets:							Assets:
Money market funds	Money market funds	$	89	$	—	$	—	Money market funds	$	89	$	0	$	0
Foreign currency forward contracts	Foreign currency forward contracts	—		812		—		Foreign currency forward contracts	0		812		0
Contingent consideration receivable	Contingent consideration receivable	—		—		738		Contingent consideration receivable	0		0		738
Total assets	Total assets	$	89	$	812	$	738	Total assets	$	89	$	812	$	738
Liabilities:	Liabilities:							Liabilities:
Foreign currency forward contracts	Foreign currency forward contracts	$	—	$	132	$	—	Foreign currency forward contracts	$	0	$	132	$	0
Interest rate swap agreements	Interest rate swap agreements	—		13,501		—		Interest rate swap agreements	0		13,501		0
Contingent consideration - business combinations	Contingent consideration - business combinations	—		—		42,875		Contingent consideration - business combinations	0		0		42,875
Option to acquire noncontrolling interests of consolidated subsidiaries	Option to acquire noncontrolling interests of consolidated subsidiaries	—		—		2,900		Option to acquire noncontrolling interests of consolidated subsidiaries	0		0		2,900
Total liabilities	Total liabilities	$	—	$	13,633	$	45,775	Total liabilities	$	0	$	13,633	$	45,775

On May 7, 2020, we issued a total of 200,000 shares of our Series A Preferred Stock, and upon completion of the Spin-Off, we will issue up to 200,000 shares of Series B Preferred Stock, subject to certain conditions. Please refer to Note 9, “Convertible Preferred Stock” for additional information regarding the preferred stock investment. The Future Tranche Right associated with the Series A Preferred Stock was initially recorded as an asset, as the purchase price of the Series B Preferred Stock was greater than its estimated value at the expected settlement date. As of October 31, 2020, the Future Tranche Right was recorded as a liability as the purchase price of the Series B Preferred Stock was less than its estimated value at the expected settlement date, and is included in accrued expenses and other liabilities on our condensed consolidated balance sheet. Due to the nature of and inputs in the model used to assess the fair value of the Future Tranche Right as described further below, we may experience significant fluctuations in its fair value during each remeasurement period.

The following table presents the changes in the estimated fair value of the Future Tranche Right measured using significant unobservable inputs (Level 3) for the nine months ended October 31, 2020.



	Nine Months Ended October 31,
(in thousands)	2020		2019
Fair value measurement at beginning of period	$	0	$	0
Fair value of future tranche right upon issuance of the Series A Preferred Stock	3,374		0
Change in fair values, recorded in other (expense) income, net	(22,834)		0
Fair value measurement at end of period	$	(19,460)	$	0

In January 2020, we completed the sale of an insignificant subsidiary in our Customer Engagement segment. In accordance with the terms of the sale agreement, 100% of the aggregate purchase price is contingent in nature based on a percentage of net sales of the former subsidiary’s products during the thirty-six month period following the transaction closing. We include the fair value of the contingent consideration receivable within prepaid expenses and other current assets and other assets on our consolidated balance sheet. The estimated fair value of this asset as of ~~April 30,~~October 31, 2020, which is measured using Level 3 inputs, was ~~$0.7~~$0.6 million. We ~~did not receive any~~received payments of $0.1 million, and the change in the estimated fair value of this contingent receivable was not material, during the ~~three~~nine months ended ~~April 30,~~October 31, 2020.

The following table presents the changes in the estimated fair values of our liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands) 2020 2019
Fair value measurement at beginning of period $ 42,875 $ 61,340
Contingent consideration liabilities recorded for business combinations, including measurement period adjustments — 5,200
Changes in fair values, recorded in operating expenses (4,803) 1,213
Payments of contingent consideration (3,031) (6,361)
Foreign currency translation and other (39) (13)
Fair value measurement at end of period $ 35,002 $ 61,379

Table of Contents



	Nine Months Ended October 31,
(in thousands)	2020		2019
Fair value measurement at beginning of period	$	42,875	$	61,340
Contingent consideration liabilities recorded for business combinations, including measurement period adjustments	0		5,200
Changes in fair values, recorded in operating expenses	(6,060)		62
Payments of contingent consideration	(18,900)		(29,712)
Foreign currency translation and other	187		(34)
Fair value measurement at end of period	$	18,102	$	36,856

Our estimated liability for contingent consideration represents potential payments of additional consideration for business combinations, payable if certain defined performance goals are achieved. Changes in fair value of contingent consideration are recorded in the condensed consolidated statements of operations within selling, general and administrative expenses.

During the year ended January 31, 2017, we acquired ~~two~~2 majority owned subsidiaries for which we hold an option to acquire the noncontrolling interests. We account for the option as an in-substance investment in the noncontrolling common stock of each such subsidiary. We include the fair value of the option within other liabilities and do not recognize noncontrolling interests in these subsidiaries. The following table presents the change in the estimated fair value of this liability, which is measured using Level 3 inputs, for the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands) 2020 2019
Fair value measurement at beginning of period $ 2,900 $ 3,000
Change in fair value, recorded in operating expenses (250) (150)
Fair value measurement at end of period $ 2,650 $ 2,850



	Nine Months Ended October 31,
(in thousands)	2020		2019
Fair value measurement at beginning of period	$	2,900	$	3,000
Change in fair value, recorded in operating expenses	300		50
Fair value measurement at end of period	$	3,200	$	3,050

There were no transfers between levels of the fair value measurement hierarchy during the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019.

Fair Value Measurements

~~Table of Contents~~

Money Market Funds - We value our money market funds using quoted active market prices for such funds.

Short-term Investments, Corporate Debt Securities, and Commercial Paper - The fair values of short-term investments, as well as corporate debt securities and commercial paper classified as cash equivalents, are estimated using observable market prices for identical securities that are traded in less-active markets, if available. When observable market prices for identical securities are not available, we value these short-term investments using non-binding market price quotes from brokers which we review for reasonableness using observable market data; quoted market prices for similar instruments; or pricing models, such as a discounted cash flow model.

Foreign Currency Forward Contracts - The estimated fair value of foreign currency forward contracts is based on quotes received from the counterparties thereto. These quotes are reviewed for reasonableness by discounting the future estimated cash flows under the contracts, considering the terms and maturities of the contracts and market foreign currency exchange rates using readily observable market prices for similar contracts.

Future Tranche Right - The fair value of the Future Tranche Right is classified within Level 3 of the fair value hierarchy because it is valued using pricing models that incorporate management assumptions that cannot be corroborated with observable market data. The fair value of the Future Tranche Right was estimated using a binomial tree model to estimate the value the Series B Preferred Stock and a Monte Carlo simulation to estimate the stock price of our Customer Engagement Solutions business post-Spin-Off, which we believe is reflective of all significant assumptions that market participants would likely consider in negotiating the transfer of the Future Tranche Right. The fair value of the Future Tranche Right also reflects the likelihood of the Series B Preferred Stock being issued, which management currently considers to be highly probable.

Significant inputs and assumptions used in the valuation model as of the issuance date, May 7, 2020, and October 31, 2020 are as follows:

Table of Contents


	October 31,			May 7,
	2020			2020
Risk-free interest rate for preferred stock	1.64		%	1.31		%
Implied credit spread	7.78		%	10.78		%
Expected volatility	30.00		%	30.00		%
Verint common stock price	$	48.52		$	45.44

Interest Rate Swap Agreements - The fair value of our interest rate swap agreements are based in part on data received from the counterparty, and represents the estimated amount we would receive or pay to settle the agreements, taking into consideration current and projected future interest rates as well as the creditworthiness of the parties, all of which can be validated through readily observable data from external sources.

Contingent Consideration Asset or Liability - Business Combinations and Divestitures - The fair value of the contingent consideration related to business combinations and divestitures is estimated using a probability-adjusted discounted cash flow model. These fair value measurements are based on significant inputs not observable in the market. The key internally developed assumptions used in these models are discount rates and the probabilities assigned to the milestones to be achieved. We remeasure the fair value of the contingent consideration at each reporting period, and any changes in fair value resulting from either the passage of time or events occurring after the acquisition date, such as changes in discount rates, or in the expectations of achieving the performance targets, are recorded within selling, general, and administrative expenses. Increases or decreases in discount rates would have inverse impacts on the related fair value measurements, while favorable or unfavorable changes in expectations of achieving performance targets would result in corresponding increases or decreases in the related fair value measurements. We utilized discount rates ranging from ~~3.2%~~0.4% to ~~6.7%~~5.1%, with a weighted average discount rate of ~~4.8%~~3.1%, in our calculations of the estimated fair values of our contingent consideration liabilities as of ~~April 30,~~October 31, 2020. We utilized discount rates ranging from 2.1% to 4.9% in our calculations of the estimated fair values of our contingent consideration liabilities as of January 31, 2020. We utilized discount rates ranging from ~~6.4%~~4.3% to ~~6.8%~~4.9%, with a weighted average discount rate of ~~6.6%~~4.6%, in our calculation of the estimated fair value of our contingent consideration asset as of ~~April 30, 2020. We utilized discount rates ranging from 4.3% to 4.9%, in our calculation of the estimated fair value of our contingent consideration asset as of~~October 31, 2020 and January 31, 2020.

Option to Acquire Noncontrolling Interests of Consolidated Subsidiaries - The fair value of the option is determined primarily by using the income approach, which discounts expected future cash flows to present value using estimates and assumptions determined by management. This fair value measurement is based upon significant inputs not observable in the market. We remeasure the fair value of the option at each reporting period, and any changes in fair value are recorded within selling, general, and administrative expenses. We utilized a discount ~~rates~~rate of ~~11.0% and~~ 9.0% in our calculation of the estimated fair value of the option as of ~~April 30,~~October 31, 2020 and January 31, ~~2020, respectively.~~2020.

Other Financial Instruments

The carrying amounts of accounts receivable, contract assets, accounts payable, and accrued liabilities and other current liabilities approximate fair value due to their short maturities.

The estimated fair values of our term loan ~~and our revolving credit~~ borrowings ~~at April 30, 2020~~ were ~~$406~~$405 million and ~~$190~~$417 million at October 31, 2020 and January 31, 2020, respectively. The estimated fair ~~values~~value of ~~our term loan and~~ our revolving credit borrowings at January 31, 2020 ~~were $417 million and~~was $45 ~~million, respectively.~~million. The estimated fair values of the term loans are based upon indicative bid and ask prices as determined by the agent responsible for the syndication of our term loans. We consider these inputs to be within Level 3 of the fair value hierarchy because we cannot reasonably observe activity in the limited market in which participation in our term loans are traded. The indicative prices provided to us as at each of ~~April 30,~~October 31, 2020 and January 31, 2020 did not significantly differ from par value. The estimated fair value of our revolving credit borrowings is based upon indicative market values provided by one of our lenders.

~~Table of Contents~~

The estimated fair values of our Notes were approximately ~~$386~~$388 million and $438 million at ~~April 30,~~October 31, 2020 and January 31, 2020, respectively. The estimated fair values of the Notes are determined based on quoted bid and ask prices in the over-the-counter market in which the Notes trade. We consider these inputs to be within Level 2 of the fair value hierarchy.

Assets and Liabilities Not Measured at Fair Value on a Recurring Basis

In addition to assets and liabilities that are measured at fair value on a recurring basis, we also measure certain assets and liabilities at fair value on a nonrecurring basis. Our non-financial assets, including goodwill, intangible assets, operating lease right-of-use assets, and property, plant and equipment, are measured at fair value when there is an indication of impairment and

Table of Contents

the carrying amount exceeds the asset’s projected undiscounted cash flows. These assets are recorded at fair value only when an impairment charge is recognized.

As of ~~April 30,~~October 31, 2020, the carrying amount of our noncontrolling equity investments in privately-held companies without readily determinable fair values was ~~$3.8 million. There were no~~$6.8 million, of which $4.0 million was remeasured to fair value based on an observable ~~price changes in our investments in privately-held companies and we did not recognize any impairments or other adjustments~~transaction during the ~~three~~nine months ended ~~April 30,~~October 31, 2020. These investments are included within other assets on the condensed consolidated balance sheets. An unrealized gain of $3.2 million, which adjusted the carrying value of a noncontrolling equity investment, and a realized gain of $0.6 million upon the receipt of proceeds related to the partial sale of the same equity investment during the period was recorded in other income (expense), net on the condensed consolidated statement of operations for the three and nine months ended October 31, 2020.

~~12.~~13. DERIVATIVE FINANCIAL INSTRUMENTS

Our primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk and interest rate risk, when deemed appropriate. We enter into these contracts in the normal course of business to mitigate risks and not for speculative purposes.

Foreign Currency Forward Contracts

Under our risk management strategy, we periodically use foreign currency forward contracts to manage our short-term exposures to fluctuations in operational cash flows resulting from changes in foreign currency exchange rates. These cash flow exposures result from portions of our forecasted operating expenses, primarily compensation and related expenses, which are transacted in currencies other than the U.S. dollar, most notably the Israeli shekel. We also periodically utilize foreign currency forward contracts to manage exposures resulting from forecasted customer collections to be remitted in currencies other than the applicable functional currency, and exposures from cash, cash equivalents and short-term investments denominated in currencies other than the applicable functional currency. These foreign currency forward contracts generally have maturities of no longer than twelve months, although occasionally we will execute a contract that extends beyond twelve months, depending upon the nature of the underlying risk.

We held outstanding foreign currency forward contracts with notional amounts of ~~$106.2~~$66.0 million and $89.0 million as of ~~April 30,~~October 31, 2020 and January 31, 2020, respectively.

Interest Rate Swap Agreements

To partially mitigate risks associated with the variable interest rates on the term loan borrowings under the prior credit agreement, in February 2016, we executed a pay-fixed, receive-variable interest rate swap agreement with a multinational financial institution under which we paid interest at a fixed rate of 4.143% and received variable interest of three-month LIBOR (subject to a minimum of 0.75%), plus a spread of 2.75%, on a notional amount of $200.0 million (the “2016 Swap”). Although the prior credit agreement was terminated on June 29, 2017, the 2016 Swap agreement remained in effect until September 6, 2019, and served as an economic hedge to partially mitigate the risk of higher borrowing costs under our 2017 Credit Agreement resulting from increases in market interest rates. Settlements with the counterparty under the 2016 Swap occurred quarterly, and the 2016 Swap matured on September 6, 2019.

Prior to June 29, 2017, the 2016 Swap was designated as a cash flow hedge for accounting purposes and as such, changes in its fair value were recognized in accumulated other comprehensive income (loss) in the consolidated balance sheet and were reclassified into the statement of operations within interest expense in the period in which the hedged transaction affected earnings. Hedge ineffectiveness, if any, was recognized currently in the condensed consolidated statement of operations.

On June 29, 2017, concurrent with the execution of the 2017 Credit Agreement and termination of the prior credit agreement, the 2016 Swap was no longer designated as a cash flow hedge for accounting purposes and, because occurrence of the specific forecasted variable cash flows which had been hedged by the 2016 Swap was no longer probable, the $0.9 million fair value of the 2016 Swap at that date was reclassified from accumulated other comprehensive income (loss) into the condensed

~~Table of Contents~~

consolidated statement of operations as income within other income (expense), net. Ongoing changes in the fair value of the 2016 Swap were recognized within other income (expense), net in the condensed consolidated statement of operations.

Table of Contents

three-month LIBOR (subject to a minimum of 0.00%), on a notional amount of $200.0 million (the “2018 Swap”). The effective date of the 2018 Swap was September 6, 2019, and settlements with the counterparty ~~will~~began on November 1, 2019, and occur on a quarterly ~~basis, beginning on November 1, 2019.~~basis. The 2018 Swap will terminate on June 29, 2024.

~~During the operating term of~~Prior to May 1, 2020, the 2018 Swap if we elect three-month LIBOR at the periodic interest rate reset dates for at least $200.0 million of our 2017 Term Loan, the annual interest rate on that amount of the 2017 Term Loan will be fixed at 4.949% (including the impact of our current 2.00% interest rate margin on Eurodollar loans) for the applicable interest rate period.

~~The 2018 Swap is~~was designated as a cash flow hedge for accounting purposes and as such, changes in its fair value ~~are~~were recognized in accumulated other comprehensive income (loss) in the condensed consolidated balance sheet and ~~are~~were reclassified into the condensed consolidated statement of operations within interest expense in the periods in which the hedged transactions ~~affect~~affected earnings.

On May 1, 2020, which was an interest rate reset date on our 2017 Term Loan, we selected an interest rate other than three-month LIBOR. As a result, the 2018 Swap, which was designated specifically to hedge three-month LIBOR interest payments, no longer qualified as a cash flow hedge. Subsequent to May 1, 2020, changes in fair value of the 2018 Swap are being accounted for as a component of other income (expense), net. Accumulated deferred losses on the 2018 Swap of $20.4 million, or $16.0 million after tax, at May 1, 2020 that were previously recorded as a component of accumulated other comprehensive loss, will be reclassified to the condensed consolidated statement of operations as interest expense over the remaining term of the 2018 Swap, as the previously hedged interest payments occur.

Fair Values of Derivative Financial Instruments

The fair values of our derivative financial instruments and their classifications in our condensed consolidated balance sheets as of ~~April 30,~~October 31, 2020 and January 31, 2020 were as follows:

Fair Value at
April 30, January 31,
(in thousands) Balance Sheet Classification 2020 2020
Derivative assets:
Foreign currency forward contracts:
   Designated as cash flow hedges Prepaid expenses and other current assets $ 544 $ 710
   Not designated as hedging instruments Prepaid expenses and other current assets 726 102
      Total derivative assets $ 1,270 $ 812
Derivative liabilities:
Foreign currency forward contracts:
   Designated as cash flow hedges Accrued expenses and other current liabilities $ 724 $ 16
   Not designated as hedging instruments Accrued expenses and other current liabilities — 116
Interest rate swap agreements:
Designated as a cash flow hedge Accrued expenses and other current liabilities 3,897 2,060
Designated as a cash flow hedge Other liabilities 16,548 11,441
      Total derivative liabilities $ 21,169 $ 13,633


		Fair Value at
		October 31,		January 31,
(in thousands)	Balance Sheet Classification	2020		2020
Derivative assets:
Foreign currency forward contracts:
Designated as cash flow hedges	Prepaid expenses and other current assets	$	980	$	710
Not designated as hedging instruments	Prepaid expenses and other current assets	79		102
Total derivative assets		$	1,059	$	812

Derivative liabilities:
Foreign currency forward contracts:
Designated as cash flow hedges	Accrued expenses and other current liabilities	$	226	$	16
Not designated as hedging instruments	Accrued expenses and other current liabilities	141		116
Interest rate swap agreement:
Designated as a cash flow hedge	Accrued expenses and other current liabilities	0		2,060
Designated as a cash flow hedge	Other liabilities	0		11,441
Not designated as a hedging instrument	Accrued expenses and other current liabilities	4,165		0
Not designated as a hedging instrument	Other liabilities	14,579		0
Total derivative liabilities		$	19,111	$	13,633

Derivative Financial Instruments in Cash Flow Hedging Relationships

The effects of derivative financial instruments designated as cash flow hedges on accumulated other comprehensive loss (“AOCL”) and on the condensed consolidated statements of operations for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019 were as follows:

2834

Table of Contents


		Three Months Ended April 30,							Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	(in thousands)	2020		2019		(in thousands)	2020		2019		2020		2019
Net (losses) gains recognized in AOCL:	Net (losses) gains recognized in AOCL:					Net (losses) gains recognized in AOCL:
Foreign currency forward contracts	Foreign currency forward contracts	$	(925)	$	342	Foreign currency forward contracts	$	(307)	$	(960)	$	287	$	1,019
Interest rate swap agreement	Interest rate swap agreement	(7,535)		(2,017)		Interest rate swap agreement	0		(2,759)		(7,535)		(9,317)
		$	(8,460)	$	(1,675)		$	(307)	$	(3,719)	$	(7,248)	$	(8,298)

Net losses reclassified from AOCL to the condensed consolidated statements of operations:
Net gains (losses) reclassified from AOCL to the condensed consolidated statements of operations:						Net gains (losses) reclassified from AOCL to the condensed consolidated statements of operations:
Foreign currency forward contracts	Foreign currency forward contracts	$	(52)	$	(939)	Foreign currency forward contracts	$	243	$	542	$	230	$	(397)
Interest rate swap agreement	Interest rate swap agreement	(591)		—		Interest rate swap agreement	(1,356)		(261)		(3,067)		(261)
		$	(643)	$	(939)		$	(1,113)	$	281	$	(2,837)	$	(658)

For information regarding the line item locations of the net gains (losses) ~~gains~~ on derivative financial instruments reclassified out of AOCL into the condensed consolidated statements of operations, ~~see~~see Note 9,10, “Stockholders’ Equity”.

All of the foreign currency forward contracts underlying the ~~$0.2~~$0.7 million of net unrealized ~~losses~~gains recorded in our accumulated other comprehensive loss at ~~April 30,~~October 31, 2020 mature within twelve months, and therefore we expect all such ~~losses~~gains to be reclassified into earnings within the next twelve months. Approximately ~~$3.1~~$3.3 million of the ~~$16.0~~$14.1 million of net unrealized losses related to our interest rate swap agreement recorded in our accumulated other comprehensive loss at ~~April 30,~~October 31, 2020 settle within twelve months, and therefore we expect those losses to be reclassified into earnings within the next twelve months.

Derivative Financial Instruments Not Designated as Hedging Instruments

Gains (losses) recognized on derivative financial instruments not designated as hedging instruments in our condensed consolidated statements of operations for the three and nine months ended ~~months ended April 30,~~October 31, 2020 and 2019 were as follows:

Classification in Condensed Consolidated Statements of Operations Three Months Ended
April 30,
(in thousands) 2020 2019
Foreign currency forward contracts Other income (expense), net $ 1,014 $ 564
Interest rate swap agreement Other income (expense), net — (15)
$ 1,014 $ 549


	Classification in Condensed Consolidated Statements of Operations	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)		2020		2019		2020		2019
Foreign currency forward contracts	Other income (expense), net	$	(123)	$	(268)	290		$	508
Interest rate swap agreement	Other income (expense), net	(949)		0		(812)		(48)
		$	(1,072)	$	(268)	$	(522)	$	460

~~13.~~14. STOCK-BASED COMPENSATION

Stock-Based Compensation Plan

On June 20, 2019, our stockholders approved the Verint Systems Inc. 2019 Long-Term Stock Incentive Plan (the “2019 Plan”). Upon approval of the 2019 Plan, additional awards are no longer permitted under our prior stock-based compensation plan (the “2017 Amended Plan”). Awards outstanding at June 20, 2019 under the 2017 Amended Plan or other previous stock-based compensation plans were not impacted by the approval of the 2019 Plan. Collectively, our stock-based compensation plans are referred to herein as the “Plans”.

The 2019 Plan authorizes our board of directors to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance awards, other stock-based awards, and performance compensation awards. Subject to adjustment as provided in the 2019 Plan, up to an aggregate of (i) 9,475,000 shares of our common stock plus (ii) the number of shares of our common stock available for issuance under the 2017 Amended Plan as of June 20, 2019, plus (iii) the number of shares of our common stock that become available for issuance as a result of awards made under the 2017 Amended Plan or the 2019 Plan that are forfeited, cancelled, exchanged, or that terminate or expire, may be issued or transferred in connection with awards under the 2019 Plan. Each stock option or stock-settled stock appreciation right granted under the 2019 Plan will reduce the available plan capacity by ~~one~~1 share and each other award denominated in shares that is granted under the 2019 Plan will reduce the available plan capacity by 2.38 shares.

Stock-Based Compensation Expense

We recognized stock-based compensation expense in the following line items on the condensed consolidated statements of operations for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands) 2020 2019
Cost of revenue - product $ 310 $ 334
Cost of revenue - service and support 657 1,070
Research and development, net 2,336 2,590
Selling, general and administrative 10,881 13,109
Total stock-based compensation expense $ 14,184 $ 17,103


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	2020		2019		2020		2019
Cost of revenue - product	$	367	$	424	$	1,087	$	1,246
Cost of revenue - service and support	1,953		1,342		3,938		3,958
Research and development, net	2,900		2,988		8,192		8,925
Selling, general and administrative	14,787		13,805		38,371		42,084
Total stock-based compensation expense	$	20,007	$	18,559	$	51,588	$	56,213

The following table summarizes stock-based compensation expense by type of award for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands) 2020 2019
Restricted stock units and restricted stock awards $ 15,029 $ 14,890
Stock bonus program and bonus share program (837) 2,175
Total equity-settled awards 14,192 17,065
Phantom stock units (cash-settled awards) (8) 38
Total stock-based compensation expense $ 14,184 $ 17,103


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	2020		2019		2020		2019
Restricted stock units and restricted stock awards	$	15,733	$	16,615	$	44,182	$	49,471
Stock bonus program and bonus share program	4,238		1,944		7,356		6,693
Total equity-settled awards	19,971		18,559		51,538		56,164
Phantom stock units (cash-settled awards)	36		0		50		49
Total stock-based compensation expense	$	20,007	$	18,559	$	51,588	$	56,213

Awards under our stock bonus and bonus share programs are accounted for as liability-classified awards, because the obligations are based predominantly on fixed monetary amounts that are generally known at inception of the obligation, to be settled with a variable number of shares of our common stock, which for awards under our stock bonus program is determined using a discounted average price of our common stock.

Restricted Stock Units and Performance Stock Units

We periodically award RSUs to our directors, officers, and other employees. These awards contain various vesting conditions and are subject to certain restrictions and forfeiture provisions prior to vesting. Some of these awards to executive officers and certain employees vest upon the achievement of specified performance goals or market conditions (performance stock units or “PSUs”).

The following table (“Award Activity Table”) summarizes activity for RSUs, PSUs, and other stock awards that reduce available Plan capacity under the Plans for the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019:


		Three Months Ended April 30,											Nine Months Ended October 31,
		2020				2019						2020			2019
(in thousands, except per share data)	(in thousands, except per share data)	Shares or Units	Weighted-Average Grant Date Fair Value		Shares or Units	Weighted-Average Grant Date Fair Value		(in thousands, except per share data)	Shares or Units	Weighted-Average Grant Date Fair Value		Shares or Units	Weighted-Average Grant Date Fair Value
Beginning balance	Beginning balance	2,736	$	52.53	2,777	$	41.05	Beginning balance	2,736	$	52.53	2,777	$	41.05
Granted	Granted	107	$	51.26	1,444	$	61.10	Granted	1,936	$	46.79	1,600	$	60.54
Released	Released	(399)	$	46.96	(448)	$	39.50	Released	(1,577)	$	47.68	(1,402)	$	40.52
Forfeited	Forfeited	(81)	$	51.84	(60)	$	35.44	Forfeited	(220)	$	53.11	(184)	$	44.52
Ending balance	Ending balance	2,363	$	53.44	3,713	$	49.23	Ending balance	2,875	$	51.28	2,791	$	52.41

With respect to our stock bonus program, activity presented in the table above only includes shares earned and released in consideration of the discount provided under that program. Consistent with the provisions of the Plans under which such shares

are issued, other shares issued under the stock bonus program are not included in the table above because they do not reduce available plan capacity (since such shares are deemed to be purchased by the grantee at fair value in lieu of receiving an earned cash bonus).

Activity presented in the table above includes all shares awarded and released under the bonus share program.

Further details appear below under “Stock Bonus Program” and “Bonus Share Program”.

Our RSU awards may include a provision which allows the awards to be settled with cash payments upon vesting, rather than with delivery of common stock, at the discretion of our board of directors. As of ~~April 30,~~October 31, 2020, for such awards that are outstanding, settlement with cash payments was not considered probable, and therefore these awards have been accounted for as equity-classified awards and are included in the table above.

The following table summarizes PSU activity in isolation under the Plans for the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019 (these amounts are already included in the Award Activity Table above for 2020 and 2019):

Three Months Ended
April 30,
(in thousands) 2020 2019
Beginning balance 526 512
Granted 107 286
Released (231) (234)
Forfeited (20) (26)
Ending balance 382 538


	Nine Months Ended October 31,
(in thousands)	2020	2019
Beginning balance	526	512
Granted	381	286
Released	(233)	(245)
Forfeited	(32)	(31)
Ending balance	642	522

Excluding PSUs, we ~~did not grant any~~granted 1,555,000 RSUs ~~or other equity awards~~ during the ~~three~~nine months ended ~~April 30,~~October 31, 2020.

As of ~~April 30,~~October 31, 2020, there was approximately ~~$70.2~~$104.4 million of total unrecognized compensation expense, net of estimated forfeitures, related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of ~~1.4~~1.5 years.

Stock Bonus Program

Our stock bonus program permits eligible employees to receive a portion of their earned bonuses, otherwise payable in cash, in the form of discounted shares of our common stock. Executive officers are eligible to participate in this program to the extent that shares remain available for awards following the enrollment of all other participants. Shares awarded to executive officers with respect to the discount feature of the program are subject to a one-year vesting period. This program is subject to annual funding approval by our board of directors and an annual cap on the number of shares that can be issued. Subject to these limitations, the number of shares to be issued under the program for a given year is generally determined using a 5-day trailing average price of our common stock when the awards are calculated, reduced by a discount determined by the board of directors each year (the “discount”). To the extent that this program is not funded in a given year or the number of shares of common stock needed to fully satisfy employee enrollment exceeds the annual cap, the applicable portion of the employee bonuses will generally revert to being paid in cash.

~~There was no activity under the stock bonus program during the three months ended April 30, 2020 and 2019.~~

For bonuses in respect of the year ~~ending~~ended January 31, 2020, our board of directors approved the use of up to 200,000 shares of common stock, and a discount of 15%, under the stock bonus program. We ~~currently expect to issue no more than~~issued 32,000 shares under the stock bonus program for the performance period ended January 31, 2020 ~~which are expected to be issued~~ during the ~~second half~~three months ended October 31, 2020.

The following table summarizes activity under the stock bonus program during the nine months ended October 31, 2020 and 2019 in isolation. As noted above, shares issued in respect of the discount feature under the program reduce available plan capacity and are included in the Award Activity Table above. Other shares issued under the program do not reduce available plan capacity and are therefore excluded from the Award Activity Table above.


	Nine Months Ended October 31,
(in thousands)	2020	2019
Shares in lieu of cash bonus - granted and released (not included in Award Activity Table above)	32	97
Shares in respect of discount (included in Award Activity Table above):
Granted	0	16
Released	0	13

For bonuses in respect of the year ending January 31, ~~2021.~~

~~In March 2020,~~2021, our board of directors has approved the use of up to 200,000 shares of common stock, and a discount of 15%, for awards under ~~our stock bonus program for the performance period ended January 31, 2021.~~this program.

Bonus Share Program

Under our bonus share program, we may provide discretionary bonuses to employees or pay earned bonuses that are outside the stock bonus program in the form of shares of common stock. Unlike the stock bonus program, there is no enrollment for this program and no discount feature. ~~As noted above, shares issued under this program are included in the Award Activity Table above.~~

For bonuses in respect of the year ~~ending~~ended January 31, 2020, our board of directors ~~has~~ approved the use of up to 305,000 shares of common stock under the bonus share program, reduced by any shares issued under the stock bonus program in respect of the same performance period. ~~For~~We issued 272,000 shares under the bonus share program for the performance period ended January 31, 2020 we currently expect to issue no more than 32,000 shares under the stock bonus program, with the remaining 273,000 shares authorized by the board of directors available for use under the bonus share program for the same performance period. Awards under the bonus share program for the

~~performance period ended January 31, 2020 are expected to be issued~~ during the ~~second half of the year ending January~~three months ended October 31, ~~2021.~~2020.

For bonuses in respect of the year ending January 31, 2021, our board of directors has approved the use of up to 300,000 shares of common stock under this program, reduced by any shares used under the stock bonus program in respect of the same performance ~~period.~~period (the maximum number of shares issuable under the stock bonus program and the bonus share program collectively for the performance period ending January 31, 2021 will not exceed 300,000).

The combined accrued liabilities for the stock bonus program and the bonus share program were ~~$14.6~~$10.5 million and $17.3 million at ~~April 30,~~October 31, 2020 and January 31, 2020, respectively.

~~14.~~15. COMMITMENTS AND CONTINGENCIES

Legal Proceedings

In March 2009, one of our former employees, Ms. Orit Deutsch, commenced legal actions in Israel against our primary Israeli subsidiary, Verint Systems Limited (“VSL”) (Case Number 4186/09) and against our affiliate CTI (Case Number 1335/09). Also, in March 2009, a former employee of Comverse Limited (CTI’s primary Israeli subsidiary at the time), Ms. Roni Katriel, commenced similar legal actions in Israel against Comverse Limited (Case Number 3444/09). In these actions, the plaintiffs generally sought to certify class action suits against the defendants on behalf of current and former employees of VSL and Comverse Limited who had been granted stock options in Verint and/or CTI and who were allegedly damaged as a result of a suspension on option exercises during an extended filing delay period that is discussed in our and CTI’s historical public filings. On June 7, 2012, the Tel Aviv District Court, where the cases had been filed or transferred, allowed the plaintiffs to consolidate and amend their complaints against the ~~three~~3 defendants: VSL, CTI, and Comverse Limited.

On October 31, 2012, CTI distributed of all of the outstanding shares of common stock of Comverse, Inc., its principal operating subsidiary and parent company of Comverse Limited, to CTI’s shareholders (the “Comverse Share Distribution”). In the period leading up to the Comverse Share Distribution, CTI either sold or transferred substantially all of its business operations and assets (other than its equity ownership interests in Verint and in its then-subsidiary, Comverse, Inc.) to Comverse, Inc. or to unaffiliated third parties. As the result of these transactions, Comverse, Inc. became an independent company and ceased to be affiliated with CTI, and CTI ceased to have any material assets other than its equity interests in Verint. Prior to the completion of the Comverse Share Distribution, the plaintiffs sought to compel CTI to set aside up to $150.0 million in assets to secure any future judgment, but the District Court did not rule on this motion. In February 2017, Mavenir Inc. became successor-in-interest to Comverse, Inc.

On February 4, 2013, Verint acquired the remaining CTI shell company in a merger transaction (the “CTI Merger”). As a result of the CTI Merger, Verint assumed certain rights and liabilities of CTI, including any liability of CTI arising out of the

foregoing legal actions. However, under the terms of a Distribution Agreement entered into in connection with the Comverse Share Distribution, we, as successor to CTI, are entitled to indemnification from Comverse, Inc. (now Mavenir) for any losses we may suffer in our capacity as successor to CTI related to the foregoing legal actions.

Following an unsuccessful mediation process, on August 28, 2016, the District Court (i) denied the plaintiffs’ motion to certify the suit as a class action with respect to all claims relating to Verint stock options and (ii) approved the plaintiffs’ motion to certify the suit as a class action with respect to claims of current or former employees of Comverse Limited (now part of Mavenir) or of VSL who held unexercised CTI stock options at the time CTI suspended option exercises. The court also ruled that the merits of the case would be evaluated under New York law.

As a result of this ruling (which excluded claims related to Verint stock options from the case), one of the original plaintiffs in the case, Ms. Deutsch, was replaced by a new representative plaintiff, Mr. David Vaaknin. CTI appealed portions of the District Court’s ruling to the Israeli Supreme Court. On August 8, 2017, the Israeli Supreme Court partially allowed CTI’s appeal and ordered the case to be returned to the District Court to determine whether a cause of action exists under New York law based on the parties’ expert opinions.

Following two unsuccessful rounds of mediation in mid to late 2018 and in mid-2019, the proceedings resumed. On April 16, 2020, the District Court accepted plaintiffs’ application to amend the motion to certify a class action and set deadlines for filing amended pleadings by the parties. CTI ~~recently~~ submitted a motion to appeal the District Court’s decision to the Supreme Court, as well as a motion to stay the proceedings in the District Court pending the resolution of the appeal. On July 6, 2020, the Supreme Court granted the motion for a stay. On July 27, 2020, the plaintiffs filed their response on the merits of the motion for leave to appeal, and the parties are waiting for further instructions or decisions from the Supreme Court.

~~From~~We are a party to various litigation matters and claims that arise from time to time ~~we or our subsidiaries may be involved in legal proceedings and/or litigation arising~~ in the ordinary course of our business. While ~~the outcome of these matters cannot be predicted with certainty,~~ we ~~do not~~ believe that the ultimate outcome of any such current ~~claims~~matters will not have a material adverse effect on us, their outcomes are not determinable and negative outcomes may adversely affect our ~~consolidated~~ financial position, liquidity, or results of ~~operations, or cash flows.~~operations.

~~15.~~16. SEGMENT INFORMATION

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the enterprise’s chief operating decision maker (“CODM”), or decision making group, in deciding how to allocate resources and in assessing performance. Our Chief Executive Officer is our CODM.

We report our results in 2 operating segments—Customer Engagement and Cyber Intelligence. Our Customer Engagement solutions help customer-centric organizations optimize customer engagement, increase customer loyalty, and maximize revenue opportunities, while generating operational efficiencies, reducing cost, and mitigating risk. Our Cyber Intelligence solutions are used for a wide range of applications, including predictive intelligence, advanced and complex investigations, security threat analysis, and electronic data and physical assets protection, as well as for generating legal evidence and preventing criminal activity and terrorism.

We measure the performance of our operating segments primarily based on segment revenue and segment contribution.

Segment revenue includes adjustments associated with revenue of acquired companies which are not recognizable within GAAP revenue. These adjustments primarily relate to the acquisition-date excess of the historical carrying value over the fair value of acquired companies’ future maintenance and service performance obligations. As the obligations are satisfied, we report our segment revenue using the historical carrying values of these obligations, which we believe better reflects our ongoing maintenance and service revenue streams, whereas GAAP revenue is reported using the obligations’ acquisition-date fair values. Segment revenue adjustments can also result from aligning an acquired company’s historical revenue recognition policies to our policies.

Segment contribution includes segment revenue and expenses incurred directly by the segment, including material costs, service costs, research and development, selling, marketing, and certain administrative expenses. When determining segment contribution, we do not allocate certain operating expenses which are provided by shared resources or are otherwise generally not controlled by segment management. These expenses are reported as “Shared support expenses” in our table of segment operating results, the majority of which are expenses for administrative support functions, such as information technology, human resources, finance, legal, and other general corporate support, and for occupancy expenses. These unallocated expenses also include procurement, manufacturing support, and logistics expenses. We share resources across our segments for efficiency and to avoid duplicative costs.

In addition, segment contribution does not include amortization of acquired intangible assets, stock-based compensation, and other expenses that either can vary significantly in amount and frequency, are based upon subjective assumptions, or in certain cases are unplanned for or difficult to forecast, such as restructuring expenses and business combination transaction and integration expenses, all of which are not considered when evaluating segment performance.

Revenue from transactions between our operating segments is not material.

Operating results by segment for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019 were as follows:


		Three Months Ended April 30,							Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands)	(in thousands)	2020		2019		(in thousands)	2020		2019		2020		2019
Revenue:	Revenue:					Revenue:
Customer Engagement	Customer Engagement					Customer Engagement
Segment revenue	Segment revenue	$	189,127	$	215,867	Segment revenue	$	217,449	$	224,149	$	613,722	$	658,440
Revenue adjustments	Revenue adjustments	(3,262)		(8,772)		Revenue adjustments	(2,227)		(6,213)		(8,555)		(21,973)
		185,865		207,095			215,222		217,936		605,167		636,467
Cyber Intelligence	Cyber Intelligence					Cyber Intelligence
Segment revenue	Segment revenue	102,522		108,291		Segment revenue	113,671		106,931		322,460		328,115
Revenue adjustments	Revenue adjustments	(1,092)		(127)		Revenue adjustments	(692)		0		(3,022)		(151)
		101,430		108,164			112,979		106,931		319,438		327,964
Total revenue	Total revenue	$	287,295	$	315,259	Total revenue	$	328,201	$	324,867	$	924,605	$	964,431

Segment contribution:	Segment contribution:					Segment contribution:
Customer Engagement	Customer Engagement	$	65,797	$	78,818	Customer Engagement	$	92,537	$	91,788	$	248,636	$	249,394
Cyber Intelligence	Cyber Intelligence	24,964		27,290		Cyber Intelligence	38,896		28,000		99,535		86,861
Total segment contribution	Total segment contribution	90,761		106,108		Total segment contribution	131,433		119,788		348,171		336,255

Reconciliation of segment contribution to operating income:	Reconciliation of segment contribution to operating income:					Reconciliation of segment contribution to operating income:
Revenue adjustments	Revenue adjustments	4,354		8,899		Revenue adjustments	2,919		6,213		11,577		22,124
Shared support expenses	Shared support expenses	43,341		43,854		Shared support expenses	44,564		45,350		128,727		133,620
Amortization of acquired intangible assets	Amortization of acquired intangible assets	12,674		14,420		Amortization of acquired intangible assets	12,376		13,746		37,536		41,392
Stock-based compensation	Stock-based compensation	14,184		17,103		Stock-based compensation	20,007		18,559		51,588		56,213
Acquisition, integration, restructuring, and other unallocated expenses	Acquisition, integration, restructuring, and other unallocated expenses	10,034		7,364		Acquisition, integration, restructuring, and other unallocated expenses	13,826		6,103		32,511		23,346
Total reconciling items, net	Total reconciling items, net	84,587		91,640		Total reconciling items, net	93,692		89,971		261,939		276,695
Operating income	Operating income	$	6,174	$	14,468	Operating income	$	37,741	$	29,817	$	86,232	$	59,560

With the exception of goodwill and acquired intangible assets, we do not identify or allocate our assets by operating segment. Consequently, it is not practical to present assets by operating segment. The allocations of goodwill and acquired intangible assets by operating segment appear in Note 6, “Intangible Assets and Goodwill”.

~~16. SUBSEQUENT EVENTS~~

~~Apax Convertible Preferred Stock Investment~~

On May 7, 2020, we closed the initial tranche of the previously announced strategic partnership (the “Closing”) with the Apax Investor. Pursuant to the Investment Agreement, dated as of December 4, 2019, at the Closing, we sold 200,000 shares of our Series A Convertible Perpetual Preferred Stock, par value $0.001 per share, for an aggregate purchase price of $200.0 million. See “Management’s discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Overview” under Item 2 of this report for a more detailed discussion regarding the Apax investment.

In connection with the Closing, we entered into a Registration Rights Agreement (the “Registration Rights Agreement”), pursuant to which, among other things, we have agreed to use commercially reasonable efforts to prepare and file a shelf registration statement with the SEC no later than the first business day after the Common Stock Restricted Period (as defined in the agreement) and to use commercially reasonable efforts to cause such shelf registration statement to be declared effective as promptly as is reasonably practicable after its filing to permit the public resale of registrable securities covered by the Registration Rights Agreement. The registrable securities generally include any shares of our common stock, par value $0.001 per share (“Common Stock”), into which the Preferred Stock is convertible, and any other securities issued or issuable with respect to any such shares of Common Stock by way of share split, share dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise.

We generally will be required to effect registrations for up to three underwritten offerings of the registrable securities within any twelve-month period during the term of the Registration Rights Agreement, subject to certain limitations, including that the anticipated gross proceeds of any offering be at least $50.0 million. The Apax Investor is also entitled to customary “piggy-back” registration and shelf take-down rights. The rights of any particular holder to cause us to register securities under the

Registration Rights Agreement will terminate with respect to that holder upon the date on which the holder no longer holds any Preferred Stock or any registrable securities covered thereby. The registration rights set forth in the Registration Rights Agreement will terminate on the date on which all shares of Common Stock issuable (or actually issued) upon conversion of the Preferred Stock cease to be registrable securities covered thereby.

~~Amendment to 2017 Credit Agreement~~

On June 8, 2020, we entered into the Second Amendment to the 2017 Credit Agreement, pursuant to which (i) we are permitted to effect the previously announced Spin-Off of our Cyber Intelligence business within the parameters set forth in the 2017 Credit Agreement, as amended, and (ii) for purposes of the acceleration of the maturity of the 2017 Term Loan and 2017 Revolving Credit Facility under the 2017 Credit Agreement, our Notes will not be deemed to be outstanding if such Notes are cash collateralized in accordance with the 2017 Credit Agreement, as amended.

~~Other than the changes described above, all other material provisions of the 2017 Credit Agreement as described in Note 7, “Long-Term Debt” remain unchanged.~~

3540

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following management’s discussion and analysis is provided to assist readers in understanding our financial condition, results of operations, and cash flows. This discussion should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended January 31, 2020 and our unaudited condensed consolidated financial statements and notes thereto contained in this report. This discussion contains a number of forward-looking statements, all of which are based on our current expectations and all of which could be affected by uncertainties and risks. Our actual results may differ materially from the results contemplated in these forward-looking statements as a result of many factors including, but not limited to, those described under “Cautionary Note on Forward-Looking Statements”.

Overview

Recent Developments

Separation of Businesses

On December 4, 2019, we announced our intention to separate into two independent publicly traded companies: one which will consist of our Customer Engagement Solutions business, and one which will consist of our Cyber Intelligence Solutions business. We expect to implement the separation through a pro-rata distribution of common stock of a new entity that will hold the Cyber Intelligence Solutions business to our stockholders (the “Spin-Off”) that is intended to be tax-free to our stockholders for U.S. federal income tax purposes. We currently expect to complete the Spin-Off shortly after the end of this fiscal year ending January 31, 2021, though this timeline may be impacted by the current business environment brought on by the COVID-19 pandemic. We believe the two independent, publicly traded companies will both benefit from the separation and be well positioned to pursue their own strategies, drive opportunities to accelerate growth and extend their market leadership. The separation will make it easier for investors to evaluate and make independent investment decisions in each business. We believe that both our businesses are leaders in their respective markets and the separation will enable them to achieve better performance over the long term as a result of several factors, including ~~having;~~having: separate boards of directors with further differentiated skillsets to support tailored strategic plans; specific incentive programs more closely aligned with standalone business performance; capital structures tailored to the unique characteristics of each business; and enhanced appeal to a broader set of investors suited to the strategic and financial characteristics of each company.

We expect to incur significant costs in connection with the planned separation of our Cyber Intelligence Solutions business. The costs include developing stand-alone Cyber Intelligence Solutions information systems and related IT costs, third-party advisory, consulting, legal and professional services, as well as other items that are incremental and one-time in nature that are related to the planned Spin-Off. We capitalized ~~$1.5~~$6.6 million of these costs and expensed ~~$7.8~~$28.7 million during the ~~three~~nine months ended ~~April 30,~~October 31, 2020. We have capitalized ~~$5.5~~$10.6 million and expensed ~~$13.1~~$34.0 million of separation related costs since commencing in the year ended January 31, 2020. The expense portion is primarily reflected in selling, general and administrative expenses.

Apax Investment

On December 4, 2019, we also announced that Valor Parent LP, an affiliate of Apax Partners, would make an investment in us in an amount of up to ~~$400~~$400.0 million. Under the terms of the Investment Agreement, on May 7, 2020 the Apax Investor initially purchased ~~$200~~$200.0 million of our Series A convertible preferred stock ~~which closed on May 7, 2020.~~(“Series A Preferred Stock”). Further discussion regarding the Apax investment and the initial closing appears in ~~Note 16, “Subsequent Events” to our condensed consolidated financial statements included under Part I, Item 1 of this report and~~ the “Liquidity and Capital Resources-Overview” section below.

COVID-19 Pandemic

We are monitoring and assessing the impact of the COVID-19 pandemic daily, including recommendations and orders issued

by government and public health authorities. We continue to work to help our customers meet their business continuity needs and help keep the world safe during this difficult time and are managing our operations with a view to resuming normal business activity as soon as possible.

During the ~~first quarter,~~nine months ended October 31, 2020, revenue in both of our operating segments was negatively impacted by delays and reduced spending attributed to the impact of the COVID-19 pandemic on our customers’ operational priorities and as a result of cost containment measures they have implemented. Due to the pandemic, we have seen a reduction or delay in large customer contracts, particularly on-premises arrangements, and we have in most cases been unable to conduct face-to-face meetings with existing or prospective customers and partners, present in-person demonstrations of our solutions, or host or attend in-person trade shows and conferences. Limitations on access to the facilities of our customers have also impacted our ability to deliver some of our products, complete certain implementations, and provide in-person consulting and training services, negatively impacting our ability to recognize revenue. We continued to experience high recurring revenue renewal rates during this fiscal year and our visibility for the ~~first quarter. We have also begun~~near term has improved compared to ~~offer new versions of our solutions~~earlier in ~~both of our segments designed to help our customers address challenges created by~~ the ~~pandemic and to offer simpler packages of software and services for some of our Customer Engagement solutions to make it easier and faster for customers to make purchases.~~year. Notwithstanding our strong ~~first quarter~~ recurring renewal rates and ~~these new offerings, we cannot~~our improved visibility, our ability to predict how the pandemic will impact our results in future periods is limited, including to the extent ~~that~~to which customers may delay or miss payments, customers may defer, reduce, or refrain from placing orders or ~~renewing~~renew subscriptions or support arrangements, or to which travel restrictions and site access restrictions may remain necessary.

In light of the adverse impact of COVID-19 on global economic conditions and our revenue, along with the uncertainty associated with the extent and timing of a potential recovery, we have implemented several cost-reduction actions ~~some~~ of ~~which did not take effect until the beginning of our second quarter.~~varying durations. Such actions have included, but are not limited to, reducing our discretionary spending, substantially decreasing capital expenditures, extending days payable outstanding, considering the optimal uses of our cash and other capital resources, including with respect to our stock repurchase program, and reducing workforce-related costs. ~~These~~Some of the COVID-19 cost reduction actions referred to periodically within this Management’s Discussion and Analysis of Financial Condition and Results of Operations were temporary in nature and are complete, and the associated cost savings did not extend beyond July 31, 2020. Other cost reduction actions are still in place and may also be rescinded at some point, depending upon our ongoing assessment of business conditions and other factors, while other cost reduction actions are expected to be permanent in nature. Where we have resumed investments or other spending, these actions may ~~have an adverse impact~~need to be reassessed depending on ~~us, particularly if they remain in place for an extended period.~~how the facts and circumstances surrounding the pandemic evolve. We continue to evaluate and may decide to implement further cost control strategies to help us mitigate the impact of the pandemic.

The ultimate impact of the COVID-19 pandemic and the effects of the operational alterations we have made in response on our business, financial condition, liquidity and financial results cannot be predicted at this time.

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was enacted and signed into U.S. law to provide economic relief to individuals and businesses facing economic hardship as a result of the COVID-19 pandemic. The CARES Act did not have a material impact on our consolidated financial condition or results of operations as of and for the ~~quarter~~nine months ended ~~April 30,~~October 31, 2020. However, we plan to defer the timing of employer payroll taxes and accelerate the refund of AMT credits as permitted by the CARES Act.

Our Business

Our Actionable Intelligence leadership is powered by innovative, enterprise-class software built with artificial intelligence, analytics, automation, and deep domain expertise established by working closely with some of the most sophisticated and forward-thinking organizations in the world. We believe we have one of the industry’s strongest R&D teams focused on actionable intelligence consisting of approximately ~~one-third of our approximately 6,300~~1,800 professionals. Our innovative solutions are backed-up by a strong IP portfolio with over 1,000 patents and patent applications worldwide across areas including data capture, artificial intelligence, machine learning, unstructured data analytics, predictive analytics, and automation.

Verint’s Actionable Intelligence strategy is focused on two use cases and the Company has two operating segments: Customer Engagement and Cyber Intelligence. Generally, we make business decisions by evaluating the risks and rewards of the opportunities available to us in the markets served by each of our segments. We view each operating segment differently and allocate capital, personnel, resources, and management attention accordingly. In reviewing each operating segment, we also review the performance of that segment by geography. Our marketing and sales strategies, expansion opportunities, and product

offerings may differ materially within a particular segment geographically, as may our allocation of resources between

segments. When making decisions regarding investments in our business, capital expenditures, or other decisions that may affect our profitability, we also consider the leverage ratio in our revolving credit facility. See "Liquidity and Capital Resources” for more information.

Key Trends and Factors That May Impact our Performance

In addition to the impact of the COVID-19 pandemic discussed above, we see the following business trends and factors which may impact our performance:

Customer Engagement

•Digital Transformation. Many organizations are going through digital transformations by expanding their customer service interactions to include digital channels, such as chat, virtual assistants, mobile apps and social media. Remote work arrangements and site restrictions due to the COVID-19 pandemic have increased this trend. While these new channels make it easier for consumers to connect, they caused organizations increased system complexity and new challenges. In many cases these new customer touch points reside in different functional groups and are not connected, resulting in siloed information, a decentralized customer service workforce and difficulty gaining insight into customer experiences. To facilitate effective digital transformations, organizations are looking for vendors that help them to connect silos across the enterprise, take proactive action to improve customer experience and facilitate open and modular design to simplify integration across systems.

•Cloud Migration. Many organizations are looking to modernize their legacy customer engagement operations by transitioning to the cloud, adopting modern architectures that facilitate the orchestration of disparate systems and the sharing of data across enterprise functions. Organizations which are at different stages of migrating to the cloud and other modernization initiatives are also looking for vendors that can help them evolve customer engagement at their own pace while protecting their legacy investments with minimal disruption to their operations. Remote work arrangements and site restrictions due to the COVID-19 pandemic have increased this trend.

•Automation Adoption. Many organizations are seeking solutions that incorporate artificial intelligence and analytics to reduce manual work and increase workforce efficiency through automation. They also seek to empower their customers with self-service backed by AI-powered bots and human/bot collaboration, to elevate the customer experience in a fast, personalized way.

Cyber Intelligence

•Security Threats Becoming Increasingly Pervasive and Complex. Governments, critical infrastructure providers, and enterprises face many types of security threats from criminal and terrorist organizations and foreign governments. Some of these security threats come from well-organized and well-funded organizations that utilize new and increasingly sophisticated methods. As a result, security and intelligence organizations find it more difficult and complicated to detect, investigate and neutralize threats. Many of these organizations are seeking to deploy more advanced data mining solutions that generate predictive intelligence and accelerate ~~investigations~~investigations. These solutions are effective by correlating massive amounts of data from a wide range of disparate sources to uncover previously unknown connections to identify suspicious behaviors and current and future threats.

•Shortage of Security Analysts Increasing the Need for Automation. Security organizations are using data mining solutions to help conduct investigations and generate actionable insights. Typically, data mining solutions require security organizations to employ analysts and data scientists to operate them. However, there is a shortage of such qualified personnel globally leading to elongated investigations and increased risk that security threats go undetected or are not addressed. To overcome this challenge, many security organizations are seeking advanced data mining solutions that automate functions historically performed manually to improve the quality and speed of investigations. These organizations are also increasingly seeking artificial intelligence and other advanced data analysis tools to gain actionable intelligence faster with fewer analysts and data scientists.

•Security Organizations Seeking Faster Innovation Through Open Software Solutions. As security threats have become more pervasive and complex, security organizations have been seeking faster innovation from security vendors. Historically, security organizations purchased customized solutions incorporating software, hardware and integration services. This project-based approach resulted in closed systems, limiting the pace of innovation as upgrades were complex, costly and time consuming. Today, we see a growing preference to purchase software

3843

solutions that are open and can run on standard hardware, that are faster and easier to deploy, and that can be refreshed more quickly to keep up with the accelerating pace of evolving threats.

Critical Accounting Policies and Estimates

Note 1, “Summary of Significant Accounting Policies” to the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended January 31, 2020 describes the significant accounting policies and methods used in the preparation of the condensed consolidated financial statements appearing in this report. The accounting policies that reflect our more significant estimates, judgments and assumptions in the preparation of our condensed consolidated financial statements are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of our Annual Report on Form 10-K for the year ended January 31, 2020, and include the following:

•Revenue recognition;

•Accounting for business combinations;

•Goodwill and other intangible assets;

•Income taxes; and

•Accounting for stock-based compensation.

There were no significant changes to our critical accounting policies and estimates during the ~~three~~nine months ended ~~April 30,~~October 31, 2020.

Results of Operations

Seasonality and Cyclicality

As is typical for many software and technology companies, our business is subject to seasonal and cyclical factors. In most years, our revenue and operating income are typically highest in the fourth quarter and lowest in the first quarter (prior to the impact of unusual or nonrecurring items). Moreover, revenue and operating income in the first quarter of a new year may be lower than in the fourth quarter of the preceding year, in some years, by a significant margin. In addition, we generally receive a higher volume of orders in the last month of a quarter, with orders concentrated in the later part of that month. We believe that these seasonal and cyclical factors primarily reflect customer spending patterns and budget cycles, as well as the impact of incentive compensation plans for our sales personnel. While seasonal and cyclical factors such as these are common in the software and technology industry, this pattern should not be considered a reliable indicator of our future revenue or financial performance. Many other factors, including general economic conditions, and more recently, the impact of the COVID-19 pandemic, also have an impact on our business and financial results.

Overview of Operating Results

The following table sets forth a summary of certain key financial information for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30,
(in thousands, except per share data) 2020 2019
Revenue $ 287,295 $ 315,259
Operating income $ 6,174 $ 14,468
Net (loss) income attributable to Verint Systems Inc. $ (6,014) $ 1,576
Net (loss) income per common share attributable to Verint Systems Inc.:
Basic $ (0.09) $ 0.02
Diluted $ (0.09) $ 0.02


	Three Months Ended October 31,				Nine Months Ended October 31,
(in thousands, except per share data)	2020		2019		2020		2019
Revenue	$	328,201	$	324,867	$	924,605	$	964,431
Operating income	$	37,741	$	29,817	$	86,232	$	59,560
Net income attributable to Verint Systems Inc. common shares	$	7,517	$	11,681	$	7,513	$	23,815
Net income per common share attributable to Verint Systems Inc.:
Basic	$	0.11	$	0.17	$	0.12	$	0.36
Diluted	$	0.11	$	0.17	$	0.11	$	0.35

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Our revenue ~~decreased~~increased approximately ~~$28.0~~$3.3 million, or 9%1%, to ~~$287.3~~$328.2 million in the three months ended ~~April 30,~~October 31, 2020 from ~~$315.3~~$324.9 million in the three months ended ~~April 30,~~October 31, 2019. The ~~decrease~~increase consisted of a ~~$27.0~~$13.8 million increase in service and support revenue, partially offset by a $10.5 million decrease in product revenue. In our Cyber Intelligence segment, revenue increased approximately $6.1 million, or 6%, from $106.9 million in the three months ended October 31, 2019 to $113.0 million in the three months ended October 31, 2020. The increase consisted of a $9.9 million increase in service and support revenue,

partially offset by a ~~$1.0~~$3.8 million decrease in ~~service and support~~product revenue. In our Customer Engagement segment, revenue decreased ~~$21.2~~approximately $2.7 million, or ~~approximately 10%~~1%, from ~~$207.1~~$217.9 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$185.9~~$215.2 million in the three months ended ~~April 30,~~October 31, 2020. The decrease consisted of a $20.0 million decrease in product revenue and a $1.2 million decrease in service and support revenue. In our Cyber Intelligence segment, revenue decreased approximately $6.8 million, from $108.2 million in the three months ended

~~April 30, 2019 to $101.4 million in the three months ended April 30, 2020. The decrease consisted of a $7.0~~$6.6 million decrease in product revenue, partially offset by a ~~$0.2~~$3.9 million increase in service and support revenue. For additional details on our revenue by segment, see “—Revenue by Operating Segment”. Revenue in the Americas, in Europe, the Middle East and Africa (“EMEA”), and in the Asia-Pacific (“APAC”) regions represented approximately ~~51%~~52%, ~~29%~~30%, and ~~20%~~18% of our total revenue, respectively, in the three months ended ~~April 30,~~October 31, 2020, compared to approximately 54%, ~~28%~~27%, and ~~18%~~19%, respectively, in the three months ended ~~April 30,~~October 31, 2019. Further details of changes in revenue are provided below.

We reported operating income of ~~$6.2~~$37.7 million in the three months ended ~~April 30,~~October 31, 2020 compared to operating income of ~~$14.5~~$29.8 million in the three months ended ~~April 30,~~October 31, 2019. The ~~decrease~~increase in operating income was primarily due to a ~~$16.1~~$13.4 million ~~decrease~~increase in gross profit, from ~~$201.1~~$211.6 million to ~~$185.0~~$225.0 million, partially offset by a ~~$7.8~~$5.5 million ~~decrease~~increase in operating expenses, from ~~$186.6~~$181.8 million to ~~$178.8~~$187.3 million. The ~~decrease~~increase in operating expenses consisted of a ~~$10.1 million decrease in selling, general and administrative expenses, partially offset by a $1.9~~$3.4 million increase in net research and development expenses, a $1.8 million increase in selling, general and administrative expenses and a ~~$0.4~~$0.3 million increase in amortization of other acquired intangible assets. Further details of changes in operating income are provided below.

Net ~~loss~~income attributable to Verint Systems Inc. common shares was ~~$6.0~~$7.5 million, and diluted net ~~loss~~income per common share was ~~$0.09,~~$0.11, in the three months ended ~~April 30,~~October 31, 2020 compared to net income attributable to Verint Systems Inc. common shares of ~~$1.6~~$11.7 million, and diluted net income per common share of ~~$0.02,~~$0.17, in the three months ended ~~April 30,~~October 31, 2019. ~~These reduced operating results~~The decrease in income attributable to Verint Systems Inc. common shares in the three months ended ~~April 30,~~October 31, 2020 ~~were~~was primarily due to ~~an $8.3 million decrease in operating income described above,~~ a ~~$2.6~~$10.1 million increase in total other expense, net ~~partially offset by~~primarily due to the change in fair value of the Future Tranche Right issued in connection with our preferred stock, a ~~$3.2~~$2.7 million ~~decrease~~increase in ~~provision from income taxes~~dividends on preferred stock, and a ~~$0.1~~$0.3 million ~~decrease~~increase in net income attributable to our noncontrolling ~~interests.~~interests, partially offset by a $7.9 million increase in operating income as described above, and a $1.0 million decrease in provision for income taxes. Further details of these changes are provided below.

A portion of our business is conducted in currencies other than the U.S. dollar, and therefore our revenue and operating expenses are affected by fluctuations in applicable foreign currency exchange rates. When comparing average exchange rates for the three months ended ~~April 30,~~October 31, 2020 to average exchange rates for the three months ended ~~April 30,~~October 31, 2019, the U.S. dollar ~~strengthened~~weakened relative to the ~~Singapore dollar, Australian dollar,~~euro, British pound sterling, ~~Brazilian real,~~our Israeli shekel rate (hedged and ~~euro~~unhedged), and Australian dollar, resulting in an overall ~~decrease~~increase in our revenue, cost of revenue, and operating expenses on a U.S. dollar-denominated basis. For the three months ended ~~April 30,~~October 31, 2020, had foreign currency exchange rates remained unchanged from rates in effect for the three months ended ~~April 30,~~October 31, 2019, our revenue would have been approximately ~~$3.8~~$3.0 million lower and our cost of revenue and operating expenses on a combined basis would have been approximately $3.6 million lower, which would have resulted in a $0.6 million increase in our operating income.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Our revenue decreased approximately $39.8 million, or 4%, to $924.6 million in the nine months ended October 31, 2020 from $964.4 million in the nine months ended October 31, 2019. The decrease consisted of a $51.3 million decrease in product revenue partially offset by a $11.5 million increase in service and support revenue. In our Customer Engagement segment, revenue decreased approximately $31.2 million, or 5%, from $636.4 million in the nine months ended October 31, 2019 to $605.2 million in the nine months ended October 31, 2020. The decrease consisted of a $35.2 million decrease in product revenue, partially offset by a $4.0 million increase in service and support revenue. In our Cyber Intelligence segment, revenue decreased approximately $8.6 million, or 3%, from $328.0 million in the nine months ended October 31, 2019 to $319.4 million in the nine months ended October 31, 2020. The decrease consisted of a $16.1 million decrease in product revenue, partially offset by a $7.5 million increase in service and support revenue. For additional details on our revenue by segment, see “—Revenue by Operating Segment”. Revenue in the Americas, EMEA, and in APAC regions represented approximately 52%, 27%, and 21% of our total revenue, respectively, in the nine months ended October 31, 2020, compared to approximately 53%, 28% and 19%, respectively, in the nine months ended October 31, 2019. Further details of changes in revenue are provided below.

We reported operating income of $86.2 million in the nine months ended October 31, 2020, compared to operating income of $59.6 million in the nine months ended October 31, 2019. The increase in operating income was primarily due to a $26.2 million decrease in operating expenses, from $561.0 million to $534.8 million, and a $0.4 million increase in gross profit. The decrease in operating expenses consisted of a $29.2 million decrease in selling, general and administrative expenses, partially offset by a $1.9 million increase in net research and development expenses, and a $1.1 million increase in amortization of other acquired intangible assets. Further details of changes in operating income are provided below.

Net income attributable to Verint Systems Inc. common shares was $7.5 million and diluted net income per common share was $0.11 in the nine months ended October 31, 2020 compared to net income attributable to Verint Systems Inc. common shares of $23.8 million, and a net income per common share of $0.35, in the nine months ended October 31, 2019. The decrease in

income attributable to Verint Systems Inc. common shares in the nine months ended October 31, 2020 was primarily due to a $26.9 million increase in total other expense, net primarily due the change in fair value of the Future Tranche Right issued in connection with our preferred stock, a $10.4 million increase in provision for income taxes, a $5.1 million increase in dividends on preferred stock and a $0.5 million increase in net income attributable to our noncontrolling interests, partially offset by a $26.6 million increase in operating income described above. Further details of these changes are provided below.

A portion of our business is conducted in currencies other than the U.S. dollar, and therefore our revenue and operating expenses are affected by fluctuations in applicable foreign currency exchange rates. When comparing average exchange rates for the nine months ended October 31, 2020 to average exchange rates for the nine months ended October 31, 2019, the U.S. dollar strengthened relative to the Brazilian real, Singapore dollar, and Australian dollar and weakened against the euro and our Israeli shekel rate (hedged and unhedged), resulting in an overall decrease in our revenue and cost of revenue, and an increase in operating expenses on a U.S. dollar-denominated basis. For the nine months ended October 31, 2020, had foreign currency exchange rates remained unchanged from rates in effect for the nine months ended October 31, 2019, our revenue would have been approximately $2.9 million higher and our cost of revenue and operating expenses on a combined basis would have been approximately ~~$3.2~~$0.3 million ~~higher,~~lower, which would have resulted in a ~~$0.6~~$3.2 million increase in our operating income.

As of ~~April 30,~~October 31, 2020, we employed approximately ~~6,300~~6,200 professionals, including part-time employees and certain contractors, as compared to approximately ~~6,200~~6,400 at ~~April 30,~~October 31, 2019.

Revenue by Operating Segment

The following table sets forth revenue for each of our two operating segments for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:


		Three Months Ended April 30,						% Change			Three Months Ended October 31,			% Change		Nine Months Ended October 31,			% Change
(in thousands)	(in thousands)	2020		2019		2020-2019	(in thousands)		2020		2019		2020-2019	2020		2019		2020-2019
Customer Engagement	Customer Engagement	$	185,865	$	207,095	(10)%	Customer Engagement		$	215,222	$	217,936	(1)%	$	605,167	$	636,467	(5)%
Cyber Intelligence	Cyber Intelligence	101,430		108,164		(6)%	Cyber Intelligence		112,979		106,931		6%	319,438		327,964		(3)%
Total revenue	Total revenue	$	287,295	$	315,259	(9)%	Total revenue		$	328,201	$	324,867	1%	$	924,605	$	964,431	(4)%

Customer Engagement Segment

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Customer Engagement revenue decreased approximately ~~$21.2~~$2.7 million, or ~~10%~~1%, from ~~$207.1~~$217.9 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$185.9~~$215.2 million in the three months ended ~~April 30,~~October 31, 2020. The decrease consisted of a ~~$20.0~~$6.6 million decrease in product revenue, ~~and~~partially offset by a ~~$1.2~~$3.9 million ~~decrease~~increase in service and support revenue. The decrease in product revenue was primarily due to delayed purchasing decisions on large contracts, particularly on-premises arrangements, due to COVID-19 and ~~reduced~~a shift in spending by our customers ~~both due to COVID-19. The impact of COVID-19 was most pronounced in the last month of the quarter when the vast majority of transactions typically close, as~~towards our ~~customers’ priorities shifted to maintaining the stability of their operations and the preservation of cash.~~cloud solutions. Our product revenue can fluctuate from period to period, as some large contracts can represent a significant share of our product revenue for a given period. The ~~slight decrease~~increase in service and support revenue was primarily

driven by growth in recurring revenue as we continue to see positive demand from customers across our portfolio of cloud-based solutions, partially offset by a decrease in implementation revenue due to COVID-19 and related containment measures, including customer facility closures and travel ~~restrictions, partially offset by growth in recurring revenue as we continue to see positive demand from customers across our portfolio of cloud-based solutions.~~restrictions. We expect our revenue mix to continue to shift to recurring sources, which is consistent with our cloud-first strategy and a general market shift from on-premises to cloud solutions.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Customer Engagement revenue decreased approximately $31.2 million, or 5%, from $636.4 million in the nine months ended October 31, 2019 to $605.2 million in the nine months ended October 31, 2020. The decrease consisted mainly of a $35.2 million decrease in product revenue, partially offset by a $4.0 million increase in service and support revenue. The decrease in product revenue was primarily driven by delayed purchasing decisions on large contracts, particularly on-premises arrangements, and reduced spending by customers, both due to COVID-19 and a shift in spending by our customers towards our cloud solutions. Our product revenue can fluctuate from period to period, as some large contracts can represent a significant share of our product revenue for a given period. The increase in service and support revenue was primarily driven by growth in recurring revenue as we continue to see positive demand from customers across our portfolio of cloud-based solutions, partially offset by a decrease in implementation revenue due to COVID-19 and related containment measures, including customer facility closures and travel restrictions. We expect our revenue mix to continue to shift to recurring sources, which is consistent with our cloud-first strategy and a general market shift from on-premises to cloud solutions.

Cyber Intelligence Segment

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Cyber Intelligence revenue ~~decreased~~increased approximately ~~$6.8~~$6.1 million, or 6% from ~~$108.2~~$106.9 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$101.4~~$113.0 million in the three months ended ~~April 30,~~October 31, 2020. The increase consisted of a $9.9 million increase in service and support revenue, partially offset by a $3.8 million decrease in product revenue. The increase in services and support revenue was primarily due to an increase in support revenue from existing customers, an increase in SaaS revenue and an increase in professional services revenue including progress realized during the current period on long-term projects for which revenue is recognized over time using the percentage-of-completion (“POC”) method. The decrease in product revenue was primarily due to a decrease in product deliveries due to delays attributed to the continued impact of COVID-19, as our customers shifted their attention to addressing operational challenges associated with the pandemic partially offset by an increase in our software subscription revenue.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Cyber Intelligence revenue decreased approximately $8.6 million, or 3%, from $328.0 million in the nine months ended October 31, 2019 to $319.4 million in the nine months ended October 31, 2020. The decrease consisted of a ~~$7.0~~$16.1 million decrease in product revenue partially offset by a ~~$0.2~~$7.5 million increase in service and support revenue. The decrease in product revenue was primarily due to a decrease in product deliveries due to delays attributed to the impact of COVID-19, as our customers shifted their attention to addressing operational challenges associated with the pandemic and a decrease in progress realized during the current period on long-term projects for which revenue is recognized over time using the ~~percentage-of-completion ("POC")~~POC method. The increase in service and support revenue was primarily attributable to an increase in support revenue from existing customers and ~~to a lesser extent~~ an increase in SaaS revenue partially offset by ~~a decrease in deployment services due to COVID-19 restrictions and~~ a decrease in progress realized during the current year on long-term projects for which revenue is recognized over time using the POC ~~method.~~method and a decrease in deployment services due to COVID-19 restrictions.

Volume and Price

We sell products in multiple configurations, and the price of any particular product varies depending on the configuration of the product sold. Due to the variety of customized configurations for each product we sell, we are unable to quantify the amount of any revenue changes attributable to a change in the price of any particular product and/or a change in the number of products sold.

Product Revenue and Service and Support Revenue

We derive and report our revenue in two categories: (a) product revenue, including licensing of software products, unbundled SaaS, and sale of hardware products (which include software that works together with the hardware to deliver the product’s essential functionality), and (b) service and support revenue, including revenue from installation services, initial and renewal support, project management, hosting services, cloud deployments, bundled SaaS, optional managed services, product warranties, and business advisory consulting and training services.

The following table sets forth product revenue and service and support revenue for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:


		Three Months Ended April 30,						% Change			Three Months Ended October 31,			% Change		Nine Months Ended October 31,			% Change
(in thousands)	(in thousands)	2020		2019		2020-2019	(in thousands)		2020		2019		2020-2019	2020		2019		2020-2019
Product revenue	Product revenue	$	77,284	$	104,224	(26)%	Product revenue		$	105,865	$	116,331	(9)%	$	279,225	$	330,538	(16)%
Service and support revenue	Service and support revenue	210,011		211,035		—%	Service and support revenue		222,336		208,536		7%	645,380		633,893		2%
Total revenue	Total revenue	$	287,295	$	315,259	(9)%	Total revenue		$	328,201	$	324,867	1%	$	924,605	$	964,431	(4)%

Product Revenue

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Product revenue decreased approximately ~~$26.9~~$10.4 million, or ~~26%~~9%, from ~~$104.2~~$116.3 million for the three months ended ~~April 30,~~October 31, 2019 to ~~$77.3~~$105.9 million for the three months ended ~~April 30,~~October 31, 2020, resulting from a ~~$20.0~~$6.6 million decrease in our Customer Engagement segment and a ~~$6.9~~$3.8 million decrease in our Cyber Intelligence segment.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Product revenue decreased approximately $51.3 million, or 16%, from $330.5 million for the nine months ended October 31, 2019 to $279.2 million for

the nine months ended October 31, 2020, resulting from a $35.2 million decrease in our Customer Engagement segment and a $16.1 million decrease in our Cyber Intelligence segment.

For additional information see “—Revenue by Operating Segment”.

Service and Support Revenue

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Service and support revenue ~~decreased~~increased approximately ~~$1.0~~$13.8 million, or 7%, from ~~$211.0~~$208.5 million for the three months ended ~~April 30,~~October 31, 2019 to ~~$210.0~~$222.3 million for the three

months ended ~~April 30,~~October 31, 2020. This ~~decrease~~increase was the result of a ~~$1.2 million decrease in our Customer Engagement segment, partially offset by a $0.2~~$9.9 million increase in our Cyber Intelligence segment and a $3.9 million increase in our Customer Engagement segment.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Service and support revenue increased approximately $11.5 million, or 2%, from $633.9 million for the nine months ended October 31, 2019 to $645.4 million for the nine months ended October 31, 2020. This increase was a result of a $7.6 million increase in our Cyber Intelligence segment and a $3.9 million increase in our Customer Engagement segment.

For additional information see “— Revenue by Operating Segment”.

Cost of Revenue

The following table sets forth cost of revenue by product and service and support, as well as amortization of acquired technology for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30, % Change
(in thousands) 2020 2019 2020-2019
Cost of product revenue $ 21,318 $ 28,120 (24)%
Cost of service and support revenue 76,399 79,361 (4)%
Amortization of acquired technology 4,609 6,707 (31)%
Total cost of revenue $ 102,326 $ 114,188 (10)%


	Three Months Ended October 31,				% Change	Nine Months Ended October 31,				% Change
(in thousands)	2020		2019		2020-2019	2020		2019		2020-2019
Cost of product revenue	$	21,972	$	30,533	(28)%	$	67,938	$	88,077	(23)%
Cost of service and support revenue	76,961		76,771		—%	222,383		237,562		(6)%
Amortization of acquired technology	4,270		5,968		(28)%	13,307		18,262		(27)%
Total cost of revenue	$	103,203	$	113,272	(9)%	$	303,628	$	343,901	(12)%

We exclude certain costs of both product revenue and service and support revenue, including shared support costs, stock-based compensation, and asset impairment charges, among others, when calculating our operating segment gross margins.

Cost of Product Revenue

Cost of product revenue primarily consists of hardware material costs and royalties due to third parties for software components that are embedded in our software solutions. Cost of product revenue also includes amortization of capitalized software development costs, employee compensation and related expenses associated with our global operations, facility costs, and other allocated overhead expenses. In our Cyber Intelligence segment, cost of product revenue also includes employee compensation and related expenses, contractor and consulting expenses, and travel expenses, in each case for resources dedicated to project management and associated product delivery.

As with many other technology companies, our software products tend to have higher gross margins than our hardware products, so the mix of products we sell in a particular period can have a significant impact on our gross margins in that period.

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Cost of product revenue decreased approximately ~~$6.8~~$8.5 million, or ~~24%~~28%, from ~~$28.1~~$30.5 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$21.3~~$22.0 million in the three months ended ~~April 30,~~October 31, 2020, ~~primarily~~ due to decreased cost of product revenue in ~~both~~ our Cyber Intelligence ~~and Customer Engagement segments,~~segment, driven primarily by a ~~corresponding decrease~~reduction in ~~product revenue as discussed above, and by~~the amount of pass-through hardware reselling costs, a decrease in ~~Cyber Intelligence~~employee compensation costs due to reallocating existing resources from custom development work to more generic R&D activities and a decrease in subcontractor costs resulting from prior investments to further productize our portfolio. Our overall product gross margins ~~decreased~~increased to ~~72%~~79% in the three months ended ~~April 30,~~October 31, 2020 from ~~73%~~74% in the three months ended ~~April 30,~~October 31, 2019. Product gross margins in our Cyber Intelligence segment increased from 64% in the three months ended ~~April 30,~~October 31, 2019 to ~~69%~~78% in the three months ended ~~April 30,~~October 31, 2020, primarily due to a favorable change in product mix, as a result of an increase in software

only transactions during the current period and a decrease in product customization work that is not considered a separate performance obligation driven by recent and ongoing investments to productize our portfolio. Cyber Intelligence product margins are subject to considerable fluctuation from period to period, based on the product mix sold. Product gross margins in our Customer Engagement segment decreased from ~~84%~~86% in the three months ended ~~April 30,~~October 31, 2019 to ~~79%~~83% in the three months ended ~~April 30,~~October 31, 2020, primarily due to lower sales volume due to COVID-19, which resulted in revenue decreasing at a faster rate than product costs, including software amortization costs.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Cost of product revenue decreased approximately $20.2 million, or 23%, from $88.1 million in the nine months ended October 31, 2019 to $67.9 million in the nine months ended October 31, 2020, primarily due to a decreased cost of product revenue in our Cyber Intelligence segment, and to a lesser extent, in our Customer Engagement segment, driven primarily by a corresponding decrease in product revenue as discussed above, cost reduction initiatives we implemented related to COVID-19, including reducing employee costs and travel expenses, and a decrease in Cyber Intelligence subcontractor costs resulting from prior investments to further productize our portfolio. Our overall product gross margins increased to 76% in the nine months ended October 31, 2020 from 73% in the nine months ended October 31, 2019. Product gross margins in our Cyber Intelligence segment increased from 65% in the nine months ended October 31, 2019 to 72% in the nine months ended October 31, 2020, primarily due to a favorable change in product mix, as a result of an increase in software only transactions during the current period, temporary cost reduction initiatives we implemented related to COVID-19, and a decrease in product customization work that is not considered a separate performance obligation driven by recent and ongoing investments to productize our portfolio. Cyber Intelligence product margins are subject to considerable fluctuation from period to period, based on the product mix sold. Product gross margins in our Customer Engagement segment decreased from 85% in the nine months ended October 31, 2019 to 82% in the nine months ended October 31, 2020, primarily due to lower sales volume due to COVID-19, which resulted in revenue decreasing at a faster rate than product costs, including software amortization costs.

Cost of Service and Support Revenue

Cost of service and support revenue primarily consists of employee compensation and related expenses, contractor costs, hosting infrastructure costs, and travel expenses relating to installation, training, consulting, and maintenance services. Cost of service and support revenue also includes stock-based compensation expenses, facility costs, and other overhead expenses. In accordance with GAAP and our accounting policy, the cost of service and support revenue is generally expensed as incurred in the period in which the services are performed.

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Cost of service and support revenue ~~decreased~~increased approximately ~~$3.0~~$0.2 million, ~~or 4%,~~ from ~~$79.4~~$76.8 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$76.4~~$77.0 million in the three months ended ~~April 30,~~October 31, 2020. The increase was driven primarily by an increase in data center and cloud costs associated with the increase in cloud revenue and an increase in employee compensation and related expenses, partially offset by a decrease in travel costs as a result of cost reduction initiatives related to COVID-19. Our overall service and support gross margins increased from 63% in the three months ended October 31, 2019 to 65% in the three months ended October 31, 2020, primarily due to temporary COVID-19 cost containment measures that we implemented.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Cost of service and support revenue decreased approximately $15.2 million, or 6%, from $237.6 million in the nine months ended October 31, 2019 to $222.4 million in the nine months ended October 31, 2020. The decrease was primarily due to a decrease in travel costs and employee compensation expenses as a result of cost reduction initiatives related to COVID-19, partially offset by an increase in data center and

cloud costs associated with the increase in cloud revenue. Our overall service and support gross margins increased from ~~62%~~63% in the ~~three~~nine months ended ~~April 30,~~October 31, 2019 to ~~64%~~66% in the ~~three~~nine months ended ~~April 30, 2020.~~October 31, 2020, primarily due to temporary COVID-19 cost containment measures that we implemented.

Amortization of Acquired Technology

Amortization of acquired technology consists of amortization of technology assets acquired in connection with business combinations.

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Amortization of acquired technology decreased approximately ~~$2.1~~$1.7 million, or ~~31%~~28%, from ~~$6.7~~$6.0 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$4.6~~$4.3 million in the three months ended ~~April 30,~~October 31, 2020. The decrease was attributable to acquired technology intangible assets from historical business combinations becoming fully amortized, partially offset by amortization expense of acquired technology intangible assets associated with recent business combinations.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Amortization of acquired technology decreased approximately $5.0 million, or 27%, from $18.3 million in the nine months ended October 31, 2019 to $13.3 million in the nine months ended October 31, 2020. The decrease was attributable to acquired technology intangible assets from historical business combinations becoming fully amortized, partially offset by amortization expense of acquired technology-based intangible assets associated with recent business combinations.

Further discussion regarding our business combinations appears in Note 5, “Business Combinations” to our condensed consolidated financial statements included under Part I, Item 1 of this report.

Research and Development, Net

Research and development expenses consist primarily of personnel and subcontracting expenses, facility costs, and other allocated overhead, net of certain software development costs that are capitalized, as well as reimbursements under government programs. Software development costs are capitalized upon the establishment of technological feasibility and continue to be capitalized through the general release of the related software product.

The following table sets forth research and development, net for the three and nine months ended ~~months ended April 30,~~October 31, 2020 and 2019:


		Three Months Ended April 30,						% Change			Three Months Ended October 31,			% Change		Nine Months Ended October 31,			% Change
(in thousands)	(in thousands)	2020		2019		2020-2019	(in thousands)		2020		2019		2020-2019	2020		2019		2020-2019
Research and development, net	Research and development, net	$	59,079	$	57,169	3%	Research and development, net		$	61,067	$	57,694	6%	$	175,375	$	173,548	1%

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019.Research and development, net increased approximately $3.4 million, or 6%, from $57.7 million in the three months ended October 31, 2019 to $61.1 million in the three months ended October 31, 2020. This increase was primarily attributable to a $2.5 million increase in employee compensation and related expenses and a $2.3 million reduction in capitalized software development costs, partially offset by cost reduction initiatives we implemented in response to the COVID-19 pandemic, which resulted in a $0.9 million decrease in contractor costs and a $0.7 million decrease in travel related expenses.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Research and development, net increased approximately $1.9 million, or 3%1%, from ~~$57.2~~$173.5 million in the ~~three~~nine months ended ~~April 30,~~October 31, 2019 to ~~$59.1~~$175.4 million in the ~~three~~nine months ended ~~April 30,~~October 31, 2020. The increase was primarily due to a ~~$2.9~~$3.9 million increase in employee compensation and related expenses ~~partially offset by~~and a $1.0 million ~~increase~~reduction in capitalized software development costs, partially offset by cost reduction initiatives we implemented in response to the COVID-19 pandemic, which resulted in a $1.9 million decrease in travel related expenses and a $1.1 million decrease in contractor costs. Certain R&D costs that were temporarily reduced due to COVID-19 cost-saving initiatives were restored in the ~~three months ended April 30, 2020 compared to the three months ended April 30, 2019.~~latter part of our fiscal second quarter.

Selling, General and Administrative Expenses

Selling, general and administrative expenses consist primarily of personnel costs and related expenses, professional fees, changes in the fair values of our obligations under contingent consideration arrangements, sales and marketing expenses, including travel costs, sales commissions and sales referral fees, facility costs, communication expenses, and other administrative expenses.

The following table sets forth selling, general and administrative expenses for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30, % Change
(in thousands) 2020 2019 2020-2019
Selling, general and administrative $ 111,651 $ 121,721 (8)%


	Three Months Ended October 31,				% Change	Nine Months Ended October 31,				% Change
(in thousands)	2020		2019		2020-2019	2020		2019		2020-2019
Selling, general and administrative	$	118,084	$	116,306	2%	$	335,141	$	364,292	(8)%

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Selling, general and administrative expenses ~~decreased~~increased approximately ~~$10.0~~$1.8 million, or 8%2%, from ~~$121.7~~$116.3 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$111.7~~$118.1 million in the three months ended ~~April 30,~~October 31, 2020. This increase was primarily attributable to a $12.6 million increase

in expenses related to the planned separation of our businesses (as discussed in “Overview” above) and a $1.0 million increase in stock-based compensation expense, partially offset by cost reduction initiatives we implemented in response to the COVID-19 pandemic, which resulted in a $5.2 million decrease in travel related costs, a $2.8 million decrease in contractors used for corporate support activities, and a $2.3 million decrease in employee compensation related expenses. Selling, general, and administrative expenses were also impacted by a $2.0 million decrease due to the change in the fair value of our obligations under contingent consideration arrangements, from a net benefit of $0.3 million in the three months ended October 31, 2019 to a net benefit of $2.3 million during the three months ended October 31, 2020, as a result of revised outlooks for achieving the performance targets under several unrelated contingent consideration arrangements.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Selling, general and administrative expenses decreased approximately $29.2 million, or 8%, from $364.3 million in the nine months ended October 31, 2019 to $335.1 million in the nine months ended October 31, 2020. This decrease was primarily attributable to cost reduction initiatives we implemented in response to the COVID-19 pandemic, which resulted in a ~~$3.7~~$15.1 million decrease in travel related costs, a ~~$1.6~~$10.6 million decrease in employee compensation related expenses, a $6.6 million decrease in marketing related expenses due to the cancellation of certain sales and marketing events and trade shows, a ~~$0.7~~$5.7 million decrease in ~~employee compensation related expenses,~~contractors used for corporate support activities, and a ~~$0.7~~$2.0 million decrease in facility expenses as a result of the majority of our workforce working from ~~home,~~home. Certain selling, general and ~~$0.5~~administrative costs that were temporarily reduced due to COVID-19 cost-saving initiatives were restored in the latter part of our fiscal second quarter. Additionally, professional fees decreased by $7.8 million ~~decrease in overhead expenses. Additionally,~~

due to a shareholder proxy contest that impacted the nine months ended October 31, 2019 and stock-based compensation decreased by ~~$2.2~~$3.7 million primarily due to a ~~year-over-year decrease~~change in ~~our stock price and professional fees decreased by $1.9 million.~~the timing of the annual employee grant. Selling, general, and administrative expenses were also impacted by a ~~$6.0~~$6.2 million decrease due to the change in the fair value of our obligations under contingent consideration arrangements, from a net expense of ~~$1.2~~$0.1 million in the ~~three~~nine months ended ~~April 30,~~October 31, 2019 to a net benefit of ~~$4.8~~$6.1 million during the ~~three~~nine months ended ~~April 30,~~October 31, 2020, as a result of revised outlooks for achieving the performance targets under several unrelated contingent consideration arrangements. These decreases were partially offset by a ~~$7.8~~$26.7 million increase in expenses related to the planned separation of our businesses (as discussed in “Overview” above). and by a $3.6 million increase in depreciation expense on fixed assets used for general administration purposes.

The impact of contingent consideration arrangements on our operating results can vary over time as we revise our outlook for achieving the performance targets underlying the arrangements. This impact on our operating results may be more significant in some periods than in others, depending on a number of factors, including the magnitude of the change in the outlook for each arrangement separately as well as the number of contingent consideration arrangements in place, the liabilities requiring adjustment in that period, and the net effect of those adjustments.

Amortization of Other Acquired Intangible Assets

Amortization of other acquired intangible assets consists of amortization of certain intangible assets acquired in connection with business combinations, including customer relationships, distribution networks, trade names, and non-compete agreements.

The following table sets forth amortization of other acquired intangible assets for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30, % Change
(in thousands) 2020 2019 2020-2019
Amortization of other acquired intangible assets $ 8,065 $ 7,713 5%


	Three Months Ended October 31,				% Change	Nine Months Ended October 31,				% Change
(in thousands)	2020		2019		2020-2019	2020		2019		2020-2019
Amortization of other acquired intangible assets	$	8,106	$	7,778	4%	$	24,229	$	23,130	5%

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Amortization of other acquired intangible assets increased approximately ~~$0.4~~$0.3 million, or 5%4%, from ~~$7.7~~$7.8 million in the three months ended ~~April 30,~~October 31, 2019 to $8.1 million in the three months ended ~~April 30,~~October 31, 2020. The increase was attributable to amortization expense associated with acquired intangible assets from recent business combinations, partially offset by acquired customer-related intangible assets from historical business combinations becoming fully amortized.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Amortization of other acquired intangible assets increased approximately $1.1 million, or 5%, from $23.1 million in the nine months ended October 31, 2019 to $24.2 million in the nine months ended October 31, 2020. The increase was attributable to amortization expense associated with acquired intangible assets from recent business combinations, partially offset by acquired customer-related intangible assets from historical business combinations becoming fully amortized.

Further discussion regarding our business combinations appears in Note 5, “Business Combinations” to our condensed consolidated financial statements included under Part I, Item 1 of this report.

Other Expense, Net

The following table sets forth total other expense, net for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:


		Three Months Ended April 30,						% Change			Three Months Ended October 31,			% Change		Nine Months Ended October 31,			% Change
(in thousands)	(in thousands)	2020		2019		2020-2019	(in thousands)		2020		2019		2020-2019	2020		2019		2020-2019
Interest income	Interest income	$	1,017	$	1,426	(29)%	Interest income		$	536	$	1,404	(62)%	$	2,392	$	4,517	(47)%
Interest expense	Interest expense	(10,698)		(9,934)		8%	Interest expense		(9,731)		(10,102)		(4)%	(30,692)		(30,143)		2%
Other income (expense):	Other income (expense):						Other income (expense):
Foreign currency losses, net		(3,254)		(1,187)		*
Gains on derivatives		1,014		549		85%
Foreign currency (losses) gains, net							Foreign currency (losses) gains, net		(1,998)		1,531		*	(2,220)		1,119		*
(Losses) gains on derivatives							(Losses) gains on derivatives		(1,072)		(268)		*	(522)		460		*
Fair value change in future tranche right							Fair value change in future tranche right		(9,224)		—		*	(22,834)		—		*
Other, net	Other, net	10		(152)		*	Other, net		3,732		(181)		*	2,573		(378)		*
Total other (expense) income, net							Total other (expense) income, net		(8,562)		1,082		*	(23,003)		1,201		*
Total other expense, net	Total other expense, net	(2,230)		(790)		*	Total other expense, net		$	(17,757)	$	(7,616)	133%	$	(51,303)	$	(24,425)	110%
Total other expense, net		$	(11,911)	$	(9,298)	28%

* Percentage is not meaningful.

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Total other expense, net, increased by ~~$2.6~~$10.2 million from ~~$9.3~~$7.6 million in the three months ended ~~April 30,~~October 31, 2019 to ~~$11.9~~$17.8 million in the three months ended ~~April 30,~~October 31, 2020.

Interest income decreased from $1.4 million in the three months ended October 31, 2019 to $0.5 million in the three months ended October 31, 2020 primarily due to a decrease in average interest rates, partially offset by interest earned on higher cash balances.

Interest expense decreased from $10.1 million in the three months ended October 31, 2019 to $9.7 million in the three months ended October 31, 2020 due to lower interest rates on outstanding borrowings.

We recorded $2.0 million of net foreign currency losses in the three months ended October 31, 2020 compared to $1.5 million of net foreign currency gains in the three months ended October 31, 2019. Our foreign currency losses in the current period resulted primarily from the strengthening of the U.S dollar against certain foreign currencies from July 31, 2020 to October 31, 2020, mainly the Brazilian real.

In the three months ended October 31, 2020, there were net losses on derivative financial instruments (not designated as hedging instruments) of $1.1 million, compared to net losses of $0.3 million on such instruments for the three months ended October 31, 2019. The net losses in the current period are primarily the result of the recognition of an unrealized loss associated with our interest rate swap contract, and to a lesser extent, losses on contracts executed to hedge movements in the exchange rate between the U.S. dollar and the Singapore dollar.

During the three months ended October 31, 2020, we recorded a non-cash Future Tranche Right revaluation loss of $9.2 million. The non-cash charge for the period relates to the change in fair value of the Future Tranche Right (right to purchase Series B Preferred Stock by the Apax Investor at a future date), associated with the Future Tranche Right issued in connection with the closing of the Series A Preferred Stock on May 7, 2020. The change in fair value was primarily due to changes in our stock price during the period. Please refer to Note 9, “Convertible Preferred Stock” and Note 12, “Fair Value Measurements” to our condensed consolidated financial statements included under Part I, Item 1 of this report for additional information regarding the Future Tranche Right.

We recorded $3.7 million of other, net income in the three months ended October 31, 2020 compared to $0.2 million of other, net expenses in the three months ended October 31, 2019. The other, net income in the current period is primarily due to the recognition of a $3.2 million unrealized gain from a fair value adjustment to a noncontrolling equity investment related to an

observable price change in the period and a $0.6 million realized gain recognized upon the receipt of proceeds related to the partial sale of the same equity investment during the period, partially offset by other expenses.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Total other expense, net, increased by $26.9 million from $24.4 million in the nine months ended October 31, 2019 to $51.3 million in the nine months ended October 31, 2020.

Interest income decreased from $4.5 million in the nine months ended October 31, 2019 to $2.4 million in the nine months ended October 31, 2020 primarily due to a decrease in average interest rates, partially offset by interest earned on higher cash balances.

Interest expense increased from ~~$9.9~~$30.1 million in the ~~three~~nine months ended ~~April 30,~~October 31, 2019 to ~~$10.7~~$30.7 million in the ~~three~~nine months ended ~~April 30,~~October 31, 2020 primarily due to an increase in ~~borrowings~~borrowing under our revolving credit facility, which were repaid in full during the period, partially offset by lower interest rates. Further discussion of our outstanding borrowings appears in Note 7, “Long-term Debt” to our condensed consolidated financial statements included under Part I, Item 1 of this report.

We recorded ~~$3.3~~$2.2 million of net foreign currency losses in the ~~three~~nine months ended ~~April 30,~~October 31, 2020 compared to ~~$1.2~~$1.1 million of net foreign currency ~~losses~~gains in the ~~three~~nine months ended ~~April 30,~~October 31, 2019. Our foreign currency gains and losses ~~resulted~~are primarily ~~from~~ the ~~strengthening~~result of the ~~U.S~~fluctuation of the value of the U.S. dollar ~~against certain~~relative to other foreign currencies, ~~from January 31, 2020 to April 30, 2020,~~ mainly the euro, Israeli shekel, Brazilian real ~~Israeli shekel~~ and British pound sterling.

In the ~~three~~nine months ended ~~April 30,~~October 31, 2020, there were net ~~gains~~losses on derivative financial instruments ~~(not designated as hedging instruments)~~ of ~~$1.0~~$0.5 million, compared to net gains of $0.5 million on such instruments for the ~~three~~nine months ended ~~April 30,~~October 31, 2019. The net ~~gains~~losses in the current period are primarily ~~reflected~~the result of an unrealized loss associated with our interest rate swap contract, partially offset by gains on contracts executed to hedge movements in the exchange rate between the U.S. dollar and the Singapore dollar.

~~(Benefit)~~ During the nine months ended October 31, 2020, we recorded a non-cash Future Tranche Right revaluation loss of $22.8 million. The non-cash charge for the period relates to the change in fair value of the Future Tranche Right (right to purchase Series B Preferred Stock by the Apax Investor at a future date), associated with the Future Tranche Right issued in connection with the closing of the Series A Preferred Stock on May 7, 2020. The change in fair value was primarily due to changes in our stock price and the declining credit market interest rates associated with worsened and uncertain economic conditions occurring during the period.

We recorded $2.6 million of other, net income in the nine months ended October 31, 2020 compared to $0.4 million of other, net expenses in the nine months ended October 31, 2019. The other, net income in the current period is due primarily to a $3.2 million unrealized gain from a fair value adjustment to a noncontrolling equity investment related to an observable price change in the period and a $0.6 million realized gain recognized upon the receipt of proceeds related to the partial sale of the same equity investment during the period, partially offset by fees in connection with our second amendment to the 2017 Credit Agreement. Further discussion of the second amendment to the 2017 Credit Agreement appears in Note 7, “Long-term Debt” to our condensed consolidated financial statements included under Part I, Item 1 of this report.

Provision for Income Taxes

The following table sets forth our ~~(benefit)~~ provision from income taxes for the three and nine months ended ~~April 30,~~October 31, 2020 and 2019:

Three Months Ended
April 30, % Change
(in thousands) 2020 2019 2020-2019
(Benefit) provision for income taxes $ (1,762) $ 1,409 (225)%


	Three Months Ended October 31,				% Change	Nine Months Ended October 31,				% Change
(in thousands)	2020		2019		2020-2019	2020		2019		2020-2019
Provision for income taxes	$	8,157	$	9,218	(12)%	$	16,490	$	6,120	169%

Three Months Ended ~~April 30,~~October 31, 2020 compared to Three Months Ended ~~April 30,~~October 31, 2019. Our effective income tax rate was ~~30.7%~~40.8% for the three months ended ~~April 30,~~October 31, 2020, compared to an effective income tax rate of ~~27.3%~~41.5% for the three months ended ~~April 30,~~October 31, 2019.

For the three months ended ~~April 30,~~October 31, 2020, the effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the impact of U.S. taxation of certain foreign activities, limitations on certain tax deductions, a change in the fair value of the Future Tranche Right associated with the Preferred Stock issuance, offset by lower statutory rates in several foreign

jurisdictions and ~~a deferred tax benefit due to a tax rate change in a foreign jurisdiction.~~the favorable impact of recently issued regulations. The result was an income tax ~~benefit~~provision of ~~$1.8~~$8.2 million on a pre-tax ~~loss~~income of ~~$5.7~~$20.0 million, which represented an effective income tax rate of ~~30.7%~~40.8%.

For the three months ended ~~April 30,~~October 31, 2019, the income tax rate no longer reflects a limitation of the tax benefit for U.S. losses due to a valuation allowance. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the impact of U.S. taxation of certain foreign activities and limitations on certain tax deductions, offset by lower statutory rates in several foreign jurisdictions. The result was an income tax provision of $9.2 million on pre-tax income of $22.2 million, which represented an effective income tax rate of 41.5%.

Nine Months Ended October 31, 2020 compared to Nine Months Ended October 31, 2019. Our effective income tax rate was 47.2% for the nine months ended October 31, 2020, compared to an effective income tax rate of 17.4% for the nine months ended October 31, 2019. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the impact of U.S. taxation of certain foreign activities, limitations on certain tax deductions, a change in the fair value of the Future Tranche Right associated with the Preferred Stock issuance, offset by lower statutory rates in several foreign jurisdictions and the favorable impact of recently issued regulations. The result was an income tax provision of $16.5 million on pre-tax income of $34.9 million, which represented an effective income tax rate of 47.2%.

For the nine months ended October 31, 2019, the income tax rate no longer reflects a limitation of the tax benefit for U.S. losses due to a valuation allowance. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to a net tax benefit of $6.7 million recorded in relation to changes in unrecognized income tax benefits and other items as a result of an audit settlement in a foreign jurisdiction and the impact of U.S. taxation of certain foreign activities, offset by lower statutory rates in several foreign jurisdictions. The result was an income tax provision of ~~$1.4~~$6.1 million on a pre-tax income of ~~$5.2~~$35.1 million, which represented an effective income tax rate of ~~27.3%~~17.4%. Excluding the income tax benefit attributable to the audit settlement, the result was an income tax provision of $12.8 million and an effective tax rate of 36.5%.

Liquidity and Capital Resources

Overview

Our primary recurring source of cash is the collection of proceeds from the sale of products and services to our customers, including cash periodically collected in advance of delivery or performance.

On December 4, 2019, we announced that Valor Parent LP (the “Apax Investor”), an affiliate of Apax Partners (“Apax”) would make an investment in us in an amount of up to ~~$400~~$400.0 million. Under the terms of the Investor Agreement, dated as of December 4, 2019, the Apax Investor initially purchased ~~$200~~$200.0 million of our Series A ~~convertible preferred stock,~~Preferred Stock, which closed on May 7, 2020, with an initial conversion price of $53.50. The initial conversion price represents a conversion premium of 17.1% over the volume-weighted average price per share of our common stock over the 45 consecutive trading days immediately prior to the signing date. Assuming completion of the Spin-Off described above, the Series A ~~convertible preferred stock~~Preferred Stock will not participate in the Spin-Off distribution of the shares of the company holding the Company’s Cyber Intelligence Solutions business, and instead, the conversion price will be adjusted based on the ratio of the trading prices of the two companies over a short period following the Spin-Off, subject to a collar. Shortly following the Spin-Off, the Apax Investor will purchase, subject to certain conditions, up to ~~$200~~$200.0 million of Series B convertible preferred stock (“Series B Preferred Stock”) in the Company, as the entity holding the Customer Engagement Solutions business. The Series B ~~convertible preferred stock~~Preferred Stock will be convertible at a conversion price that is 100% of the average of the volume-weighted average price per share of the common stock for the 20 consecutive trading days immediately following the consummation of the Spin-Off, subject to a collar on the minimum and maximum enterprise value of the

Company post consummation of the Spin-Off. Following the closing of the Series A Preferred Stock investment, Apax’s ownership in us on an as-converted basis is approximately 5.5%. Following completion of the Spin-Off and assuming the issuance of the Series B ~~preferred stock,~~Preferred Stock, Apax’s ownership in us on an as-converted basis will be between 11.5% and 15%. The convertible preferred stock will pay dividends at an annual rate of 5.2% until the 48-month anniversary of the closing of the Series A ~~preferred stock~~Preferred Stock investment, and thereafter at a rate of 4.0%, subject to adjustment under certain circumstances. Dividends will be cumulative and payable semiannually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of preferred stock. ~~We intend to use~~During the three months ended October 31, 2020, we used the proceeds from the initial Apax investment to repay outstanding indebtedness, including borrowings under our revolving credit facility, which were used to fund a portion of our stock repurchase program (as described below under “Liquidity and Capital Resources Requirements”), and/or for general corporate purposes. Please refer to Note ~~1, “Basis of Presentation and Significant Accounting Policies”, under “Description of Business” and Note 16, "Subsequent Events"~~9, “Convertible Preferred Stock”, to our condensed consolidated financial statements included under Part I, Item 1 of this report for more information regarding the Apax convertible preferred stock investment.

Our primary recurring use of cash is payment of our operating costs, which consist primarily of employee-related expenses, such as compensation and benefits, as well as general operating expenses for marketing, facilities and overhead costs, and capital expenditures. We also utilize cash for debt service, stock repurchases, dividends on the convertible preferred stock, and periodically for business acquisitions. Cash generated from operations, along with our existing cash, cash equivalents, and short-term investments, are our primary sources of operating liquidity, and we believe that our operating liquidity is currently sufficient to support our business operations, including debt service, capital expenditure requirements, and dividends on the convertible preferred stock.

On June 29, 2017, we entered into the 2017 Credit Agreement with certain lenders, and terminated a prior credit agreement. The 2017 Credit Agreement was amended on January 31, 2018 (the “2018 Amendment”), and again on June 8, 2020 (the “2020 Amendment”). Further discussion of our 2017 Credit Agreement ~~and 2018 Amendment~~as amended, appears below, under “Financing Arrangements”.

We have historically expanded our business in part by investing in strategic growth initiatives, including acquisitions of products, technologies, and businesses. We may finance such acquisitions using cash, debt, stock, or a combination of the foregoing, however, we have used cash as consideration for substantially all of our historical business acquisitions, including approximately $74 million of net cash expended for business acquisitions during the year ended January 31, 2020. There were no business acquisitions during the ~~three~~nine months ended ~~April 30,~~October 31, 2020.

We continually examine our options with respect to terms and sources of existing and future short-term and long-term capital resources to enhance our operating results and to ensure that we retain financial flexibility, and may from time to time elect to raise capital through the issuance of additional equity or the incurrence of additional debt. During the three months ended April 30, 2020, we increased borrowings under our revolving credit facility by $155.0 million to a total of $200.0 million as of April 30, 2020. The proceeds of these borrowings were used to fund a portion of our stock repurchase program or will be used for general corporate purposes.

A considerable portion of our operating income is earned outside the United States. Cash, cash equivalents, short-term investments, and restricted cash, cash equivalents, and bank time deposits (excluding any long-term portions) held by our subsidiaries outside of the United States w~~ere $458.8~~ere $469.0 million and $426.6 million as of ~~April 30,~~October 31, 2020 and January 31, 2020, respectively, and are generally used to fund the subsidiaries’ operating requirements and to invest in growth initiatives, including business acquisitions. These subsidiaries also held long-term restricted cash and cash equivalents, and restricted bank time deposits of ~~$22.5~~$22.0 million and $26.3 million, at ~~April 30,~~October 31, 2020 and January 31, 2020, respectively.

We currently intend to continue to indefinitely reinvest a portion of the earnings of our foreign subsidiaries, which, as a result of the 2017 Tax Act, may now be repatriated without incurring additional U.S. federal income taxes.

Should other circumstances arise whereby we require more capital in the United States than is generated by our domestic operations, or should we otherwise consider it in our best interests, we could repatriate future earnings from foreign jurisdictions, which could result in higher effective tax rates. As noted above, we currently intend to indefinitely reinvest a portion of the earnings of our foreign subsidiaries to finance foreign activities. Except to the extent of the U.S. tax provided on earnings of our foreign subsidiaries as of ~~April 30,~~October 31, 2020 and withholding taxes of approximately $15.0 million accrued as of ~~April 30,~~October 31, 2020, with respect to certain identified cash that may be repatriated to the U.S., we have not provided tax on the outside basis difference of foreign subsidiaries nor have we provided for any additional withholding or other tax that may be applicable should a future distribution be made from any unremitted earnings of foreign subsidiaries. Due to complexities in the laws of the foreign jurisdictions and the assumptions that would have to be made, it is not practicable to estimate the total amount of income and withholding taxes that would have to be provided on such earnings.

The following table summarizes our total cash, cash equivalents, restricted cash, cash equivalents, and bank time deposits, and short-term investments, as well as our total debt, as of ~~April 30,~~October 31, 2020 and January 31, 2020:

April 30, January 31,
(in thousands) 2020 2020
Cash and cash equivalents $ 556,671 $ 379,146
Restricted cash and cash equivalents, and restricted bank time deposits (excluding long term portions) 46,451 43,860
Short-term investments 19,741 20,215
Total cash, cash equivalents, restricted cash and cash equivalents, restricted bank time deposits, and short-term investments $ 622,863 $ 443,221
Total debt, including current portions $ 994,640 $ 837,048


	October 31,		January 31,
(in thousands)	2020		2020
Cash and cash equivalents	$	526,815	$	379,146
Restricted cash and cash equivalents, and restricted bank time deposits (excluding long term portions)	24,223		43,860
Short-term investments	104,454		20,215
Total cash, cash equivalents, restricted cash and cash equivalents, restricted bank time deposits, and short-term investments	$	655,492	$	443,221
Total debt, including current portions	$	786,741	$	837,048

Capital Allocation Framework

As noted above, after cash utilization required for working capital, capital expenditures, required debt service, and dividends on the convertible preferred stock, we expect that our primary usage of cash will be for business combinations, repayment of outstanding indebtedness, and our current stock repurchase ~~program (including the repayment of any borrowings under our revolving credit facility used to fund the stock repurchase program).~~program. Due to the uncertainty surrounding the impact of the COVID-19 pandemic, we will consider further repurchases under the stock repurchase program based on economic and market conditions as they evolve.

Condensed Consolidated Cash Flow Activity

The following table summarizes selected items from our condensed consolidated statements of cash flows for the ~~three~~nine months ended ~~April 30,~~October 31, 2020 and 2019:


		Three Months Ended April 30,							Nine Months Ended October 31,
(in thousands)	(in thousands)	2020		2019		(in thousands)	2020		2019
Net cash provided by operating activities	Net cash provided by operating activities	$	75,978	$	93,063	Net cash provided by operating activities	$	157,831	$	136,470
Net cash provided by (used in) investing activities		9,293		(35,449)
Net cash used in investing activities						Net cash used in investing activities	(100,676)		(69,311)
Net cash provided by (used in) financing activities	Net cash provided by (used in) financing activities	114,739		(13,732)		Net cash provided by (used in) financing activities	79,073		(34,281)
Effect of foreign currency exchange rate changes on cash and cash equivalents	Effect of foreign currency exchange rate changes on cash and cash equivalents	(3,106)		(853)		Effect of foreign currency exchange rate changes on cash and cash equivalents	(2,093)		(1,251)
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	$	196,904	$	43,029	Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	$	134,135	$	31,627

Our operating activities generated ~~$76.0~~$157.8 million of cash during the ~~three~~nine months ended ~~April 30,~~October 31, 2020, which was ~~in addition to $124.0~~offset by $21.6 million of net cash ~~provided by~~used in combined investing and financing activities during this period. Further discussion of these items appears below.

Net Cash Provided by Operating Activities

Net cash provided by operating activities is driven primarily by our net income or loss, as adjusted for non-cash items and working capital changes. Operating activities generated ~~$76.0~~$157.8 million of net cash during the ~~three~~nine months ended ~~April 30,~~October 31, 2020, compared to ~~$93.1~~$136.5 million generated during the ~~three~~nine months ended ~~April 30,~~October 31, 2019. Our ~~reduced~~increased operating cash flow in the current period was primarily due to ~~our net loss, the net effect of non-cash items, and $11.7~~$1.2 million of ~~higher~~lower combined interest and net income tax payments, ~~partially offset by~~a $2.2 million decrease in the non-financing portion of payments under contingent consideration arrangements, a favorable impact on operating cash flow from changes in operating assets and liabilities and the net effect of non-cash items, as compared to the prior ~~period.~~period, partially offset by lower net income.

Our cash flow from operating activities can fluctuate from period to period due to several factors, including the timing of our billings and collections, the timing and amounts of interest, income tax and other payments, and our operating results.

Net Cash ~~Provided by (Used in)~~Used in Investing Activities

During the ~~three~~nine months ended ~~April 30,~~October 31, 2020, our investing activities ~~provided $9.3~~used $100.7 million of net cash, including ~~$20.8~~$83.9 million of net purchases of short-term investments and $29.3 million of payments for property, equipment and capitalized software development costs, partially offset by $12.6 million of net cash provided by other investing activities, consisting primarily of a net decrease in restricted bank time deposits, proceeds from insurance recoveries, proceeds from the sale of a noncontrolling equity investment, and settlements of derivative instruments during the ~~period and $0.5 million of net sales and maturities of short-term~~

~~investments, partially offset by $12.0 million of payments for property, equipment and capitalized software development costs.~~period. Restricted bank time deposits are typically deposits, which do not qualify as cash equivalents, used to secure bank guarantees in connection with sales contracts, the amounts of which will fluctuate from period to period.

During the ~~three~~nine months ended ~~April 30,~~October 31, 2019, our investing activities used ~~$35.4~~$69.3 million of net cash, including ~~$20.2~~$51.5 million of net cash utilized for a business ~~acquisition, $11.2~~acquisitions and $40.8 million of payments for property, equipment, and capitalized software development costs, ~~and $7.0~~partially offset by $18.2 million of net ~~purchases~~sales and maturities of short-term investments ~~partially offset by $2.9~~and $4.8 million of net cash provided by other investing activities, consisting primarily of settlements of derivative instruments and a net decrease in restricted bank time deposits ~~and settlements~~during the period. Restricted bank time deposits are typically deposits, which do not qualify as cash equivalents, used to secure bank guarantees in connection with sales contracts, the amounts of ~~derivative instruments during the~~which will fluctuate from period to period.

We had no significant commitments for capital expenditures at ~~April 30,~~October 31, 2020.

Net Cash Provided by (Used in) Financing Activities

For the ~~three~~nine months ended ~~April 30,~~October 31, 2020, our financing activities generated ~~$114.7~~$79.1 million of net cash, primarily due to $197.3 million of net proceeds from the issuance of preferred stock and a $155.0 million increase in borrowings under our revolving credit facility, partially offset by $205.4 million of repayments of borrowings and other financing obligations, $36.8 million of payments to repurchase treasury stock, ~~$1.9~~$13.0 million ~~repayments~~ of ~~borrowings and other financing obligations, $1.3~~payments to repurchase $13.1 million principal amount of our convertible notes, $13.3 million for the financing portion of payments under contingent consideration arrangements related to prior business combinations, $2.3 million paid for debt-related costs, $1.6 million of payments of Series A Convertible Preferred Stock dividends, and ~~$0.2~~$0.7 million of distributions to a noncontrolling shareholder of one of our subsidiaries.

For the ~~three~~nine months ended ~~April 30,~~October 31, 2019, our financing activities used ~~$13.7~~$34.3 million of net cash, the most significant portions of which were payments of $6.0 million related to deferred purchase price of a prior period business combination, ~~$5.7~~$22.0 million for the financing portion of payments under contingent consideration arrangements related to prior business combinations, ~~$1.6~~$4.7 million repayments of borrowings and other financing obligations, $0.9 million of distributions and dividends to a noncontrolling shareholder of one of our subsidiaries, and $0.5 million of payments to repurchase treasury stock.

Liquidity and Capital Resources Requirements

Based on past performance and current expectations, we believe that our cash, cash equivalents, short-term investments and cash generated from operations will be sufficient to meet anticipated operating costs, required payments of principal and interest, dividends on ~~the~~ convertible preferred stock, working capital needs, ordinary course capital expenditures, research and development spending, and other commitments for at least the next 12 months. Currently, we have no plans to pay any cash dividends on our common stock, which are subject to certain restrictions under our 2017 Credit Agreement.

Our liquidity could be negatively impacted by a decrease in demand for our products and service and support, including the impact of changes in customer buying behavior due to circumstances over which we have no control, including, but not limited to, the effects of the COVID-19 pandemic. If we determine to make additional business acquisitions or otherwise require additional funds, we may need to raise additional capital, which could involve the issuance of additional equity or debt securities or increase our borrowings under our credit facility.

On December 4, 2019, we announced that our board of directors had authorized a stock repurchase program whereby we may repurchase up to ~~$300~~$300.0 million of common stock over the period ending on February 1, 2021. During the ~~three~~nine months ended ~~April 30,~~October 31, 2020, we acquired approximately 613,000 shares of treasury stock at a cost of $34.0 million under this program. During the year ended January 31, 2020, we acquired approximately 2,119,000 shares of treasury stock at a cost of $116.1 million under this program, of which $2.8 million was settled in cash in February 2020.

Financing Arrangements

1.50% Convertible Senior Notes

On June 18, 2014, we issued $400.0 million in aggregate principal amount of 1.50% convertible senior notes due June 1, 2021 ("Notes"), unless earlier converted by the holders pursuant to their terms. Net proceeds from the Notes after underwriting discounts were $391.9 million. The Notes pay interest in cash semiannually in arrears at a rate of 1.50% per annum.

The Notes are unsecured and rank senior in right of payment to our indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to our indebtedness that is not so subordinated; effectively subordinated in right

of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to indebtedness and other liabilities of our subsidiaries.

The Notes are convertible into, at our election, cash, shares of common stock, or a combination of both, subject to satisfaction of specified conditions and during specified periods, as described below. If converted, we currently intend to pay cash in respect of the principal amount of the Notes. We currently expect to ~~refinance~~retire the Notes at or prior to maturity using our existing cash and/or with proceeds from the issuance of new ~~convertible~~ notes or ~~other~~ debt.

issuance of the Notes, although throughout the term of the Notes, the conversion rate may be adjusted upon the occurrence of certain events.

Holders may surrender their Notes for conversion at any time prior to the close of business on the business day immediately preceding December 1, 2020, only under the following circumstances:

•during any calendar quarter commencing after the calendar quarter which ended on September 30, 2014, if the closing sale price of our common stock, for at least 20 trading days (whether or not consecutive) in the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter, is more than 130% of the conversion price of the Notes in effect on each applicable trading day;

•during the ten consecutive trading-day period following any five consecutive trading-day period in which the trading price for the Notes for each such trading day was less than 98% of the closing sale price of our common stock on such date multiplied by the then-current conversion rate; or

•upon the occurrence of specified corporate events, as described in the indenture governing the Notes, such as a consolidation, merger, or binding share exchange.

On or after December 1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may surrender their Notes for conversion regardless of whether any of the foregoing conditions have been satisfied. Holders of the Notes may require us to purchase for cash all or any portion of their Notes upon the occurrence of a “fundamental change” at a price equal to 100% of the principal amount of the Notes being purchased, plus accrued and unpaid interest.

During the nine months ended October 31, 2020, we repurchased $13.1 million principal amount of our Notes in open market transactions for an aggregate of $13.0 million in cash. As a result, the outstanding principal of the Notes was $386.9 million at October 31, 2020 and would result in the issuance of approximately 6,002,000 shares of common stock if all of the outstanding Notes were converted.

As of ~~April 30,~~October 31, 2020, the Notes were not convertible.

Note Hedges and Warrants

Note Hedges

The Note repurchases executed during the nine months ended October 31, 2020 described above did not change the number of common shares subject to the Note Hedges. However, since a Note conversion is a prerequisite to exercising the call right under the Note Hedges, the number of common shares subject to call under the Note Hedges was effectively reduced since the repurchased Notes can no longer be converted.

Warrants

4958

the strike price of the Warrants, we will be obligated to issue shares of our common stock having a value equal to such excess. The Warrants could have a dilutive effect on net income per share to the extent that the market value of our common stock exceeds the strike price of the Warrants. Proceeds from the sale of the Warrants were $45.2 million and were recorded as additional paid-in capital. As of ~~April 30,~~October 31, 2020, no Warrants had been exercised and all Warrants remained outstanding.

Credit Agreements

On June 29, 2017, we entered into the 2017 Credit Agreement with certain lenders, and terminated a prior credit agreement.

The 2017 Credit Agreement provides for $725.0 million of senior secured credit facilities, comprised of a $425.0 million term loan maturing on June 29, 2024 (the “2017 Term Loan”) and a $300.0 million revolving credit facility maturing on June 29, 2022 (the “2017 Revolving Credit Facility”), subject to increase and reduction from time to time according to the terms of the 2017 Credit Agreement. The majority of the proceeds from the 2017 Term Loan were used to repay all outstanding term loans under our prior credit agreement.

The maturity dates of the 2017 Term Loan and 2017 Revolving Credit Facility will be accelerated to March 1, 2021 if on such date any Notes remain ~~outstanding.~~outstanding, unless such outstanding Notes are cash collateralized pursuant to the 2020 Amendment to the 2017 Credit Agreement, as further described below.

We are required to pay a commitment fee with respect to unused availability under the 2017 Revolving Credit Facility at a rate per annum determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the 2017 Credit Agreement) leverage ratio (the “Leverage Ratio”).

On January 31, 2018, we entered into the 2018 Amendment to our 2017 Credit Agreement, providing for, among other things, a reduction of the interest rate margins on the 2017 Term Loan from 2.25% to 2.00% for Eurodollar loans, and from 1.25% to 1.00% for ABR loans. The vast majority of the impact of the 2018 Amendment was accounted for as a debt modification. For the portion of the 2017 Term Loan which was considered extinguished and replaced by new loans, we wrote off $0.2 million of unamortized deferred debt issuance costs as a loss on early retirement of debt during the three months ended January 31, 2018. The remaining unamortized deferred debt issuance costs and discount are being amortized over the remaining term of the 2017 Term Loan.

On June 8, 2020, we entered into a second amendment to the 2017 Credit Agreement (the ~~“Second~~“2020 Amendment”). Pursuant to the ~~Second~~2020 Amendment, we are permitted to effect the previously announced Spin-Off of our Cyber Intelligence business within the parameters set forth in the 2017 Credit Agreement, as amended, and our Notes will not be deemed to be outstanding if such Notes are cash collateralized in accordance with the 2017 Credit Agreement, as amended, for purposes of the determination of the maturity dates of the 2017 Term Loan and the 2017 Revolving Credit Facility discussed above. We currently ~~intend~~expect to ~~cash collateralize, or otherwise refinance or repurchase,~~retire the Notes at or prior to ~~their maturity. Refer to Note 16, “Subsequent Events” to~~maturity using our ~~condensed consolidated financial statements included under Part I, Item I~~existing cash and/or with proceeds from the issuance of ~~this report for further details regarding the Second Amendment to the 2017 Credit Agreement.~~new notes or debt.

For loans under the 2017 Revolving Credit Facility, the margin is determined by reference to our Leverage Ratio. ~~Borrowings~~During the six months ended July 31, 2020, we increased borrowings under ~~the 2017 Revolving Credit Facility were $200.0 million as of April 30, 2020. As of April 30, 2020, the weighted average interest rate on~~ our revolving credit facility by $155.0 million to a total of $200.0 million, the proceeds of which were used to fund a portion of our stock repurchase program or for general corporate purposes. During the three months ended October 31, 2020, we repaid the $200.0 million of borrowings ~~was 2.33%.~~in full using cash on hand.

In February 2016, we executed a pay-fixed, receive-variable interest rate swap agreement with a multinational financial institution to partially mitigate risks associated with the variable interest rate on the term loans under our prior credit agreement, under which we paid interest at a fixed rate of 4.143% and received variable interest of three-month LIBOR (subject to a

minimum of 0.75%), plus a spread of 2.75%, on a notional amount of $200.0 million (the “2016 Swap”). Although the prior credit agreement was terminated on June 29, 2017, the 2016 Swap remained in effect until September 6, 2019, and served as an economic hedge to partially mitigate the risk of higher borrowing costs under the 2017 Credit Agreement resulting from increases in market interest rates. Effective June 29, 2017, concurrent with the execution of the 2017 Credit Agreement and termination of the prior credit agreement, the 2016 Swap was no longer formally designated as a cash flow hedge for accounting purposes, and therefore subsequent settlements were reported within other income (expense), net on the condensed consolidated statement of operations, not within interest expense. The 2016 Swap matured on September 6, 2019.

In April 2018, we executed a pay-fixed, receive-variable interest rate swap agreement with a multinational financial institution to partially mitigate risks associated with the variable interest rate on our 2017 Term Loan for periods following the termination of the 2016 Swap, under which we pay interest at a fixed rate of 2.949% and receive variable interest of three-month LIBOR (subject to a minimum of 0.00%), on a notional amount of $200.0 million (the “2018 Swap”). The effective date of the 2018 Swap was September 6, 2019, and settlements with the counterparty ~~will be~~began on November 1, 2019 and occur on a quarterly ~~basis, beginning on November 1, 2019.~~basis. The 2018 Swap will terminate on June 29, 2024.

~~The 2018 Swap is~~was designated as a cash flow hedge for accounting purposes and as such, changes in its fair value ~~are~~were recognized in accumulated other comprehensive income (loss) in the condensed consolidated balance sheet and ~~are~~were reclassified into the condensed ~~consolidated~~ statement of operations within interest expense in the ~~period~~periods in which the hedged ~~transaction affects~~transactions affected earnings.

On May 1, 2020, which was an interest rate reset date on our 2017 Term Loan, we selected an interest rate other than three-month LIBOR. As a result, the 2018 Swap, which was designated specifically to hedge three-month LIBOR interest payments, no longer qualified as a cash flow hedge. Subsequent to May 1, 2020, changes in fair value of the 2018 Swap are being accounted for as a component of other income (expense), net. Accumulated deferred losses on the 2018 Swap of $20.4 million, or $16.0 million after tax, at May 1, 2020 that were previously recorded as a component of accumulated other comprehensive loss, will be reclassified to the statement of operations as interest expense over the remaining term of the 2018 Swap, as the hedged interest payments occur.

The 2017 Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The 2017 Credit Agreement also contains a financial covenant that, solely with respect to the 2017 Revolving Credit Facility, requires us to maintain a Leverage Ratio of no greater than 4.50 to 1. At ~~April 30,~~October 31, 2020, our Leverage Ratio was approximately ~~2.8~~1.9 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the 2017 Credit Agreement.

Contractual Obligations

~~Except for additional borrowings under our revolving credit facility of $155.0 million during the three months ended April 30, 2020, we~~We believe there have been no material changes to our contractual obligations disclosed in the contractual obligations section of our Annual Report on Form 10-K for the year ended January 31, 2020. That table appears under Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the report. For additional information regarding our leases, long-term debt and our commitments and contingencies, see Note 15, “Leases”, Note 7, “Long-Term Debt” and Note 16, “Commitments and Contingencies” in the Form 10-K and Note 7, “Long-Term Debt”, Note 9, “Convertible Preferred Stock”, and Note 1415, “Commitments and Contingencies” in the notes to our condensed consolidated financial statements included elsewhere in this Form 10-Q.

Please refer to Note 1, “Basis of Presentation and Significant Accounting Policies", under "Description of Business", to our condensed consolidated financial statements included under Part I, Item 1 of this report for information regarding dividends on expected issuances of convertible preferred stock.

Contingent Payments Associated with Business Combinations

In connection with certain of our business combinations, we have agreed to make contingent cash payments to the former owners of the acquired companies based upon achievement of performance targets following the acquisition dates.

For the ~~three~~nine months ended ~~April 30,~~October 31, 2020, we made ~~$3.0~~$18.9 million of payments under contingent consideration arrangements. As of ~~April 30,~~October 31, 2020, potential future cash payments, and earned consideration expected to be paid, subsequent to ~~April 30,~~October 31, 2020 under contingent consideration arrangements total ~~$133.6~~$100.4 million, the estimated fair value of which was ~~$35.0~~$18.1 million, including ~~$20.4~~$10.1 million reported in accrued expenses and other current liabilities, and ~~$14.6~~$8.0 million reported in other liabilities. The performance periods associated with these potential payments extend through January 2022.

Off-Balance Sheet Arrangements

As of ~~April 30,~~October 31, 2020, we did not have any off-balance sheet arrangements that we believe have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, and the potential impact of these pronouncements on our condensed consolidated financial statements, see Note 1, “Basis of Presentation and Significant Accounting Policies” to the condensed consolidated financial statements in Part I, Item 1 of this report.

5261

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk represents the risk of loss that may impact our financial condition due to adverse changes in financial market prices and rates. We are exposed to market risk related to changes in interest rates and foreign currency exchange rate fluctuations. To manage the volatility relating to interest rate and foreign currency risks, we periodically enter into derivative instruments including foreign currency forward exchange contracts and interest rate swap agreements. It is our policy to use derivative instruments only to the extent considered necessary to meet our risk management objectives. We use derivative instruments solely to reduce the financial impact of these risks and do not use derivative instruments for speculative purposes.

Interest Rate Risk on Our Debt

The 2017 Credit Agreement bears interest at variable rates based on LIBOR plus a margin. The margin for the 2017 Term Loan is fixed at 2.00% for Eurodollar loans, and 1.00% for ABR loans. For loans under the 2017 Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the 2017 Credit Agreement) leverage ratio. Because the interest rates applicable to borrowings under the 2017 Credit Agreement are variable, we are exposed to market risk from changes in the underlying index rates, which affect our cost of borrowing.

The Financial Conduct Authority of the United Kingdom plans to phase out LIBOR by the end of 2021, and we are considering the impact the planned phase out would have on this facility. The Alternative Reference Rates Committee has proposed the Secured Overnight Financing Rate (“SOFR”) as its recommended alternative to LIBOR. However, it is currently uncertain what, if any, alternative reference interest rates, including SOFR, or other reforms will be enacted in response to the planned phase out, and we cannot assure you that an alternative to LIBOR (on which the Eurodollar Rate is based) that we find acceptable will be available to us.

The section entitled “Quantitative and Qualitative Disclosures About Market Risk” under Part II, Item 7A of our Annual Report on Form 10-K for the year ended January 31, 2020 provides detailed quantitative and qualitative discussions of the market risks affecting our operations. Other than as described above under “Interest Rate Risk on Our Debt” and the market risk that is created by the global market disruptions and uncertainties resulting from COVID-19, we believe that our market risk profile did not materially change during the ~~three~~nine months ended ~~April 30,~~October 31, 2020.

5362

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Management conducted an evaluation under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of ~~April 30,~~October 31, 2020. Disclosure controls and procedures are those controls and other procedures that are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified by the rules and forms promulgated by the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. As a result of this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of ~~April 30,~~October 31, 2020.

Changes in Internal Control Over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended ~~April 30,~~October 31, 2020, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Due to the COVID-19 pandemic, a significant number of our employees are now working from home. The design of our financial reporting processes, systems, and controls allows for remote execution with accessibility to secure data.

Inherent Limitations on Effectiveness of Controls

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be achieved. Further, the design of a control system must reflect the impact of resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the possibility that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by individual acts, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all possible conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

5463

Table of Contents

Part II

Item 1. Legal Proceedings

See Note ~~14,~~15, “Commitments and Contingencies” of the Notes to the condensed consolidated financial statements under Part I, Item 1 for information regarding our legal proceedings.

Item 1A. Risk Factors

Other than as discussed below, there have been no material changes to the Risk Factors described in Part I “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended January 31, 2020. In addition to the other information set forth in this Quarterly Report, you should carefully consider the risks discussed in our Annual Report on Form 10-K, which could materially affect our business, financial condition, or operating results. The risks described in our Annual Report on Form 10-K are not the only risks facing us, however. Additional risks and uncertainties not currently known to us or that we currently deem to be insignificant also may materially and adversely affect our business, financial condition, or operating results in the future.

The full extent to which the COVID-19 pandemic will adversely affect our business and results of operations cannot be predicted at this time.

On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a global pandemic. The outbreak has reached all of the regions in which we do business, and governmental authorities around the world have implemented numerous measures attempting to contain and mitigate the effects of the virus, including travel bans and restrictions, border closings, quarantines, shelter-in-place orders, shutdowns, limitations or closures of non-essential businesses, and social distancing requirements. Companies around the world, including us, our customers, partners, and vendors, have implemented actions in response, including among others, office closings, site restrictions, and employee travel restrictions. ~~The~~Notwithstanding the loosening of these restrictions in certain countries in certain periods since the onset of the pandemic, the global spread of COVID-19 and actions taken in response have negatively affected us, our customers, partners, and vendors and caused significant economic and business disruption the extent and duration of which is not currently known. We are continuously monitoring and assessing the impact of the COVID-19 pandemic, ~~daily,~~ including recommendations and orders issued by government and public health ~~authorities.~~authorities in countries where we operate.

In light of the adverse impact of COVID-19 on global economic conditions and our revenue, along with the uncertainty associated with the extent and timing of a potential recovery, we have implemented several cost-reduction ~~actions.~~actions of varying durations, some of which remain in place and some of which have concluded. Such actions have included, but are not limited to, reducing our discretionary spending, substantially decreasing capital expenditures, extending days payable outstanding, considering the optimal uses of our cash and other capital resources, including with respect to our stock repurchase program, and reducing workforce-related costs. These actions may have an adverse impact on us, particularly if they remain in place for an extended period. Where we have resumed investments or other spending, these actions may need to be reassessed based on the facts and circumstances surrounding the pandemic as they evolve. We continue to evaluate and may decide to implement further cost control strategies to help us mitigate the impact of the pandemic.

5564

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

On December 4, 2019, we announced that our board of directors had authorized a stock repurchase program whereby we may repurchase up to $300 million of common stock over the period ending on February 1, 2021. ~~Share repurchase activity~~There were no share repurchases made under this share repurchase program during the three months ended ~~April 30, 2020 was as follows:~~

Period Total Number of Shares Purchased Average Price Paid per Share (1) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
(in thousands)
February 1, 2020 - February 29, 2020 359,379 $ 57.32 359,379 $ 163,381
March 1, 2020 - March 31, 2020 253,518 $ 52.77 253,518 $ 150,003
April 1, 2020 - April 30, 2020 — $ — — $ 150,003
Total 612,897 $ 55.44 612,897 $ 150,003

~~(1) Represents the approximate weighted-average price paid per share.~~October 31, 2020.

From time to time, we have purchased treasury stock from directors, officers, and other employees to facilitate income tax withholding and payment requirements upon vesting of equity awards during a Company-imposed trading blackout or lockup periods. There was no such activity during the three months ended ~~April 30,~~October 31, 2020.

Shortly after the conclusion of our first fiscal quarter ended April 30, 2020, on May 7, 2020, we closed the initial tranche of the previously announced strategic partnership with the Apax Investor. Pursuant to the agreement, dated as of December 4, 2019, at the Closing, we sold 200,000 shares of our Series A Convertible Perpetual Preferred Stock, par value $0.001 per share, for an aggregate purchase price of $200.0 million. See “Management’s discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Overview” under Item 2 of this report for a more detailed discussion regarding the Apax investment.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

5665

Table of Contents

Item 6. Exhibits

The following exhibit list includes agreements that we entered into or that became effective during the three months ended ~~April 30,~~October 31, 2020:

Number

Description

Filed Herewith /
Incorporated by
Reference from

~~10.2~~

Verint Systems Inc. Stock Bonus Program*

~~Form 10-K filed on March 31, 2020~~

~~10.3~~

Form of Performance-Based Restricted Stock Unit Award Agreement for Incentive Grants in Connection with the Planned Separation Transaction*

~~Form 10-K filed on March 31, 2020~~

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Filed herewith

31.2

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Filed herewith

32.1

Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350 (1)

Filed herewith

32.2

Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350 (1)

Filed herewith

101.INS

XBRL Instance Document

Filed herewith

101.SCH

XBRL Taxonomy Extension Schema Document

Filed herewith

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

Filed herewith

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

Filed herewith

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

Filed herewith

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

Filed herewith

(1)These exhibits are being “furnished” with this periodic report and are not deemed “filed” with the SEC and are not incorporated by reference in any filing of the company under the Securities Act of 1933, as amended or the Securities Exchange Act of 1934, as amended.

* Denotes a management contract or compensatory plan or arrangement required to be filed as an exhibit to this form pursuant to Item 6 of this report.

5766

Table of Contents

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			Verint Systems Inc.


~~June~~December 9, 2020			/s/ Douglas E. Robinson
			Douglas E. Robinson
			Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

5867


VERINT SYSTEMS INC. AND SUBSIDIARIES
Index to Condensed Consolidated Financial Statements (Unaudited)
			Page

Condensed Consolidated Balance Sheets as of ~~April 30,~~October 31, 2020 an dand January 31, 2020			2
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended ~~April 30,~~October 31, 2020 and 2019			3
Condensed Consolidated Statements of Comprehensive ~~Loss~~Income for the Three ~~Mont~~hsand Nine Months Ended ~~April 30,~~October 31, 2020 and 2019			4
Condensed Consolidated Statements of Stockholders’ Equity for the Three and Nine Months Ended ~~April 30,~~October 31, 2020 and 2019			5
Condensed Consolidated Statements of Cash Flows for the ~~Three~~Nine Months Ended ~~April 30,~~October 31, 2020 and 2019			67
Notes to Condensed Consolidated Financial Statements			78


Period	Total Number of Shares Purchased	Average Price Paid per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands)
February 1, 2020 - February 29, 2020	359,379	$	57.32	359,379	$	163,381
March 1, 2020 - March 31, 2020	253,518	$	52.77	253,518	$	150,003
April 1, 2020 - April 30, 2020	—	$	—	—	$	150,003
Total	612,897	$	55.44	612,897	$	150,003